FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Yun, KW
   Choi, EH
   Lee, HJ
AF Yun, Ki Wook
   Choi, Eun Hwa
   Lee, Hoan Jong
TI Genetic diversity of pneumococcal surface protein A in invasive
   pneumococcal isolates from Korean children, 1991-2016
SO PLOS ONE
LA English
DT Article
ID STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE DISTRIBUTION;
   ELICIT PROTECTION; PSPA SEQUENCE; UNITED-STATES; OTITIS-MEDIA;
   IMMUNIZATION; ANTIBODIES; DISEASE
AB Pneumococcal surface protein A (PspA) is an important virulence factor of pneumococci and has been investigated as a primary component of a capsular serotype-independent pneumococcal vaccine. Thus, we sought to determine the genetic diversity of PspA to explore its potential as a vaccine candidate. Among the 190 invasive pneumococcal isolates collected from Korean children between 1991 and 2016, two (1.1%) isolates were found to have no pspA by multiple polymerase chain reactions. The full length pspA genes from 185 pneumococcal isolates were sequenced. The length of pspA varied, ranging from 1,719 to 2,301 base pairs with 55.7-100% nucleotide identity. Based on the sequences of the clade-defining regions, 68.7% and 49.7% were in PspA family 2 and clade 3/family 2, respectively. PspA clade types were correlated with genotypes using multilocus sequence typing and divided into several subclades based on diversity analysis of the N-terminal a-helical regions, which showed nucleotide sequence identities of 45.7-100% and amino acid sequence identities of 23.1-100%. Putative antigenicity plots were also diverse among individual clades and subclades. The differences in antigenicity patterns were concentrated within the N-terminal 120 amino acids. In conclusion, the N-terminal a-helical domain, which is known to be the major immunogenic portion of PspA, is genetically variable and should be further evaluated for antigenic differences and cross-reactivity between various PspA types from pneumococcal isolates.
C1 [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea.
   [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea.
RP Lee, HJ (reprint author), Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea.; Lee, HJ (reprint author), Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea.
EM hoanlee@snu.ac.kr
FU National Research Foundation (NRF) of Korea - Ministry of Education,
   Science, and Technology [20110023092]
FX HJL is the recipient of a Grant of the the Basic Science Research
   Program through the National Research Foundation
   (NRF,http://www.nrf.re.kr) of Korea, which is funded by the Ministry of
   Education, Science, and Technology (20110023092). The funder had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065
   Beall B, 2000, J CLIN MICROBIOL, V38, P3663
   Beddows S, 1999, J VIROL, V73, P1740
   Brandileone MCC, 2004, VACCINE, V22, P3890, DOI 10.1016/j.vaccine.2004.04.009
   Cho EY, 2016, J KOREAN MED SCI, V31, P1082, DOI 10.3346/jkms.2016.31.7.1082
   Cho EY, 2014, DIAGN MICR INFEC DIS, V78, P481, DOI 10.1016/j.diagmicrobio.2013.12.016
   Coral MCV, 2001, EMERG INFECT DIS, V7, P832
   Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8
   Eun BW, 2010, DIAGN MICR INFEC DIS, V68, P345, DOI 10.1016/j.diagmicrobio.2010.07.008
   Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006
   Heeg C, 2007, VACCINE, V25, P1030, DOI 10.1016/j.vaccine.2006.09.061
   Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15
   MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078
   McDaniel LS, 1998, INFECT IMMUN, V66, P4748
   Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08
   Mollerach M, 2004, EPIDEMIOL INFECT, V132, P177, DOI 10.1017/S0950268803001626
   Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213
   Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7
   Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06
   Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003
   Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Vadesilho CFM, 2014, CLIN VACCINE IMMUNOL, V21, P940, DOI 10.1128/CVI.00239-14
   White P, 1999, ORL J OTO-RHINO-LARY, V61, P206, DOI 10.1159/000027672
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   Yamamoto M, 1998, J IMMUNOL, V161, P4115
   Yatim MM, 2013, J MICROBIOL IMMUNOL, V46, P180, DOI 10.1016/j.jmii.2012.04.004
   Yun KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134055
   Yun KW, 2011, J KOREAN MED SCI, V26, P971, DOI 10.3346/jkms.2011.26.8.971
   김경호, 2005, Korean Journal of Pediatrics, V48, P1206
NR 32
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 13
PY 2017
VL 12
IS 11
AR e0183968
DI 10.1371/journal.pone.0183968
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FM4OL
UT WOS:000414997800001
PM 29131872
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Santos, FLN
   Celedon, PAF
   Zanchin, NIT
   Brasil, TDC
   Foti, L
   de Souza, WV
   Silva, ED
   Gomes, YD
   Krieger, MA
AF Neves Santos, Fred Luciano
   Fiorani Celedon, Paola Alejandra
   Tonin Zanchin, Nilson Ivo
   Campos Brasil, Tatiana de Arruda
   Foti, Leonardo
   de Souza, Wayner Vieira
   Silva, Edmilson Domingos
   Gomes, Yara de Miranda
   Krieger, Marco Aurelio
TI Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based
   on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease
SO PLOS ONE
LA English
DT Article
ID SEROLOGICAL DIAGNOSIS; SYNTHETIC PEPTIDE; RECOMBINANT ANTIGENS;
   CLINICAL-DIAGNOSIS; PROTEIN ANTIGENS; ASSAY; SERODIAGNOSIS;
   DETERMINANTS; EPITOPE; INFECTION
AB The performance of serologic tests in chronic Chagas disease diagnosis largely depends on the type and quality of the antigen preparations that are used for detection of anti-Trypanosoma cruzi antibodies. Whole-cell T. cruzi extracts or recombinant proteins have shown variation in the performance and cross-reactivity. Synthetic chimeric proteins comprising fragments of repetitive amino acids of several different proteins have been shown to improve assay performances to detect Chagasic infections. Here, we describe the production of four chimeric T. cruzi proteins and the assessment of their performance for diagnostic purposes. Circular Dichroism spectra indicated the absence of well-defined secondary structures, while polydispersity evaluated by Dynamic Light Scattering revealed only minor aggregates in 50 mM carbonate-bicarbonate (pH 9.6), demonstrating that it is an appropriate buffering system for sensitizing microplates. Serum samples from T. cruzi-infected and non-infected individuals were used to assess the performance of these antigens for detecting antibodies against T. cruzi, using both enzyme-linked immunosorbent assay and a liquid bead array platform. Performance parameters (AUC, sensitivity, specificity, accuracy and J index) showed high diagnostic accuracy for all chimeric proteins for detection of specific anti-T. cruzi antibodies and differentiated seropositive individuals from those who were seronegative. Our data suggest that these four chimeric proteins are eligible for phase II studies.
C1 [Neves Santos, Fred Luciano; de Souza, Wayner Vieira; Gomes, Yara de Miranda] FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Fiorani Celedon, Paola Alejandra; Tonin Zanchin, Nilson Ivo; Foti, Leonardo; Krieger, Marco Aurelio] Mol Biol Inst Parana, Curitiba, PR, Brazil.
   [Tonin Zanchin, Nilson Ivo; Campos Brasil, Tatiana de Arruda; Foti, Leonardo; Krieger, Marco Aurelio] FIOCRUZ PR, Carlos Chagas Inst, Curitiba, PR, Brazil.
   [Silva, Edmilson Domingos] FIOCRUZ RJ, Biomanguinhos, Rio De Janeiro, RJ, Brazil.
   [Neves Santos, Fred Luciano] FIOCRUZ BA, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
RP Santos, FLN (reprint author), FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.; Santos, FLN (reprint author), FIOCRUZ BA, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
EM fred.santos@bahia.fiocruz.br
RI Foti, Leonardo/I-6677-2016; SANTOS, Fred/S-2954-2019; Foti,
   Leonardo/F-1763-2014
OI SANTOS, Fred/0000-0002-3944-0818; Foti, Leonardo/0000-0003-2948-9914;
   Zanchin, Nilson/0000-0002-1153-0694; Souza, Wayner/0000-0002-0939-9332
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   [404242/2012-0]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de
   Pernambuco-FACEPE [APQ-1257-2.11/12]; RVE Finep [Convenio
   01.13.0283.00-ref. 0473/12];  [304543/2012-8];  [306222/2013-2]; 
   [590032/2011-9]
FX Funding support was provided by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq (Proc. 404242/2012-0), Fundacao de Amparo
   a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE (Proc.
   APQ-1257-2.11/12) and RVE Finep (Convenio 01.13.0283.00-ref. 0473/12).
   Yara de Miranda Gomes, Wayner Vieira de Sousa, and Marco Aurelio Krieger
   are research fellows of CNPq Proc. No. 304543/2012-8, 306222/2013-2, and
   590032/2011-9, respectively.
CR Ackermann AA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-736
   Bottino CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-568
   Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09
   Thomas MC, 2012, CLIN VACCINE IMMUNOL, V19, P167, DOI 10.1128/CVI.05566-11
   Chang CD, 2006, TRANSFUSION, V46, P1737, DOI 10.1111/j.1537-2995.2006.00965.x
   Cheng KY, 2007, CLIN VACCINE IMMUNOL, V14, P355, DOI 10.1128/CVI.00401-06
   da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
   DaRocha W, 2002, PARASITOL RES, V88, P292, DOI 10.1007/s00436-001-0540-0
   Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001
   FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568
   Foti L, 2009, MEM I OSWALDO CRUZ, V104, P136, DOI 10.1590/S0074-02762009000900019
   Gadelha AAM, 2003, VOX SANG, V85, P165, DOI 10.1046/j.1423-0410.2003.00340.x
   Gomes YM, 2001, MEM I OSWALDO CRUZ, V96, P497, DOI 10.1590/S0074-02762001000400009
   Gonzalez J, 2013, DIAGNOSIS TREATMENT, P105, DOI [10. 5772/ 55387, DOI 10.5772/55387]
   Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08
   Hernandez P, 2010, CLIN VACCINE IMMUNOL, V17, P1598, DOI 10.1128/CVI.00489-08
   HOFT DF, 1989, INFECT IMMUN, V57, P1959
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498
   Houghton RL, 2009, CLIN VACCINE IMMUNOL, V16, P515, DOI 10.1128/CVI.00383-08
   Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723
   Houghton RL, 2000, J INFECT DIS, V181, P325, DOI 10.1086/315165
   IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6
   Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAFAILLE JJ, 1989, MOL BIOCHEM PARASIT, V35, P127, DOI 10.1016/0166-6851(89)90115-1
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530
   Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198
   Manne-Goehler J, 2015, AM J TROP MED HYG, V93, P108, DOI 10.4269/ajtmh.14-0826
   *MIN SAUD, 2005, REV SOC BRAS MED S3, V38, P7
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude, 2015, B EPIDEMIOL, V46, P1
   Neto V. A., 2000, REV PAT TROP, V29, P115
   Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820
   Ouchchane L, 2009, BIOSTATISTIQUE, P49
   Pitcovsky TA, 2001, INFECT IMMUN, V69, P1869, DOI 10.1128/IAI.69.3.1869-1875.2001
   Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002
   Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07
   Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539
   Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003
   SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L
   Teixeira-Carvalho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122938
   Umezawa ES, 2004, J CLIN MICROBIOL, V42, P449, DOI 10.1128/JCM.42.1.449-452.2004
   Umezawa ES, 1999, MEM I OSWALDO CRUZ, V94, P285, DOI 10.1590/S0074-02761999000700051
   Benedetti AFV, 2013, TROP MED INT HEALTH, V18, P1103, DOI 10.1111/tmi.12144
   WHO, 2007, WHO CONS INT BIOL RE
NR 46
TC 11
Z9 11
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 12
PY 2016
VL 11
IS 8
AR e0161100
DI 10.1371/journal.pone.0161100
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3LI
UT WOS:000381382100049
PM 27517281
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stephenson, RJ
   Toth, I
   Liang, JN
   Mangat, A
   McManus, DP
   You, H
AF Stephenson, Rachel J.
   Toth, Istvan
   Liang, Jiening
   Mangat, Amanjot
   McManus, Donald P.
   You, Hong
TI Identification of Host Insulin Binding Sites on Schistosoma japonicum
   Insulin Receptors
SO PLOS ONE
LA English
DT Article
ID MANSONI; VACCINE; THERAPY; REVEALS; EPITOPE; FAMILY; REGION; GENE
AB Schistosoma japonicum insulin receptors (SjIRs) have been identified as encouraging vaccine candidates. Interrupting or blocking the binding between host insulin and the schistosome insulin receptors (IRs) may result in reduced glucose uptake leading to starvation and stunting of worms with a reduction in egg output. To further understand how schistosomes are able to exploit host insulin for development and growth, and whether these parasites and their mammalian hosts compete for the same insulin source, we identified insulin binding sites on the SjIRs. Based on sequence analysis and the predicted antigenic structure of the primary sequences of the SjIRs, we designed nine and eleven peptide analogues from SjIR-1 and SjIR-2, respectively. Using the Octet RED system, we identified analogues derived from SjIR-1 (10) and SjIR-2 (20, 21 and 22) with insulin-binding sequences specific for S. japonicum. Nevertheless, the human insulin receptor (HIR) may compete with the SjIRs in binding human insulin in other positions which are important for HIR binding to insulin. However, no binding occurred between insulin and parasite analogues derived from SjIR-1 (2, 7 and 8) and SjIR-2 (14, 16 and 18) at the same locations as HIR sequences which have been shown to have strong insulin binding affinities. Importantly, we found two analogues (1 and 3), derived from SjIR-1, and two analogues (13 and 15) derived from SjIR-2, were responsible for the major insulin binding affinity in S. japonicum. These peptide analogues were shown to have more than 10 times (in KD value) stronger binding capacity for human insulin compared with peptides derived from the HIR in the same sequence positions. Paradoxically, analogues 1, 3, 13 and 15 do not appear to contain major antigenic determinants which resulted in poor antibody responses to native S. japonicum protein. This argues against their future development as peptide-vaccine candidates.
C1 [Stephenson, Rachel J.; Toth, Istvan; Liang, Jiening; Mangat, Amanjot] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
   [Toth, Istvan] Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia.
   [Toth, Istvan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.
   [McManus, Donald P.; You, Hong] QIMR Berghofer Med Res Inst, Div Infect Dis, Mol Parasitol Lab, Brisbane, Qld, Australia.
RP Stephenson, RJ (reprint author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.; You, H (reprint author), QIMR Berghofer Med Res Inst, Div Infect Dis, Mol Parasitol Lab, Brisbane, Qld, Australia.
EM r.stephenson@uq.edu.au; Hong.You@qimrberghofer.edu.au
RI Stephenson, Rachel J/C-4500-2016; Toth, Istvan/C-1965-2013
OI Stephenson, Rachel J/0000-0001-6424-7502; Toth,
   Istvan/0000-0002-4572-397X
FU Australian Infectious Disease Research Centre Seed Grant; National
   Health and Medical Research Council (NHMRC) of Australia [APP 1037304]
FX Australian Infectious Disease Research Centre Seed Grant
   (http://www.aidrc.org.au/project-seed-funding) and a Program Grant from
   the National Health and Medical Research Council (NHMRC) of Australia
   (APP 1037304) (https://www.nhmrc.gov.au/).
CR Alewood P, 1997, METHOD ENZYMOL, V289, P14
   Amrutkar SD, 2012, BIOPOLYMERS, V98, P567, DOI 10.1002/bip.22165
   BUEDING E, 1950, J GEN PHYSIOL, V33, P475, DOI 10.1085/jgp.33.5.475
   Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080
   Gallagher EJ, 2010, ENDOCR PRACT, V16, P864, DOI 10.4158/EP10098.RA
   Georgousakis MM, 2009, VACCINE, V27, P6799, DOI 10.1016/j.vaccine.2009.08.049
   Golubovskaya VM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-342
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Kastin AJ, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, pXXXIX, DOI 10.1016/B978-012369442-3/50002-7
   Khayath N, 2007, FEBS J, V274, P659, DOI 10.1111/j.1742-4658.2006.05610.x
   Konrad C, 2003, INT J PARASITOL, V33, P301, DOI 10.1016/S0020-7519(02)00265-5
   LEE JS, 1994, AM J PHYSIOL, V266, pC319
   Leenstra T, 2006, INFECT IMMUN, V74, P6398, DOI 10.1128/IAI.00757-06
   McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106
   Merrifield M, 2016, VACCINE, V34, P2988, DOI 10.1016/j.vaccine.2016.03.079
   NAKAMURA S, 1990, J PROTEIN CHEM, V9, P229, DOI 10.1007/BF01025313
   Pira GL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/325720
   Ranasinghe SL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1022-z
   Rodda SJ, 2002, J IMMUNOL METHODS, V267, P71, DOI 10.1016/S0022-1759(02)00141-2
   RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236
   Saltiel A. R., 2007, MECH INSULIN ACTION
   Secor WE, 2015, FUTURE MED CHEM, V7, P681, DOI [10.4155/FMC.15.9, 10.4155/fmc.15.9]
   SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114
   Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200
   Vanderstraete M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002226
   Vilar MM, 2003, VACCINE, V22, P137, DOI 10.1016/S0264-410X(03)00300-1
   Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h
   Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014
   You H, 2015, PLOS NEGLECTED TROPI, V9
   You H, 2012, INT J PARASITOL, V42, P801, DOI 10.1016/j.ijpara.2012.06.002
   You H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009868
   ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858
NR 32
TC 1
Z9 1
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2016
VL 11
IS 7
AR e0159704
DI 10.1371/journal.pone.0159704
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS5CG
UT WOS:000380797500125
PM 27441998
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Park, GW
   Collins, N
   Barclay, L
   Hu, LY
   Prasad, BVV
   Lopman, BA
   Vinje, J
AF Park, Geun Woo
   Collins, Nikail
   Barclay, Leslie
   Hu, Liya
   Prasad, B. V. Venkataram
   Lopman, Benjamin A.
   Vinje, Jan
TI Strain-Specific Virolysis Patterns of Human Noroviruses in Response to
   Alcohols
SO PLOS ONE
LA English
DT Article
ID MURINE NOROVIRUS; FELINE CALICIVIRUS; HAND SANITIZERS; GASTROENTERITIS;
   INACTIVATION; SURROGATES; VIRUS; CARE; INFECTION; OUTBREAKS
AB Alcohol-based hand sanitizers are widely used to disinfect hands to prevent the spread of pathogens including noroviruses. Alcohols inactivate norovirus by destruction of the viral capsid, resulting in the leakage of viral RNA (virolysis). Since conflicting results have been reported on the susceptibility of human noroviruses against alcohols, we exposed a panel of 30 human norovirus strains (14 GI and 16 GII strains) to different concentrations (50%, 70%, 90%) of ethanol and isopropanol and tested the viral RNA titer by RT-qPCR. Viral RNA titers of 10 (71.4%), 14 (100%), 3 (21.4%) and 7 (50%) of the 14 GI strains were reduced by > 1 log(10) RNA copies/ml after exposure to 70% and 90% ethanol, and 70% and 90% isopropanol, respectively. RNA titers of 6 of the 7 non-GII 4 strains remained unaffected after alcohol exposure. Compared to GII strains, GI strains were more susceptible to ethanol than to isopropanol. At 90%, both alcohols reduced RNA titers of 8 of the 9 GII. 4 strains by >= 1 log(10) RNA copies/ml. After exposure to 70% ethanol, RNA titers of GII. 4 Den Haag and Sydney strains decreased by >= 1.9 log(10), whereas RNA reductions for GII. 4 New Orleans strains were < 0.5 log(10). To explain these differences, we sequenced the complete capsid gene of the 9 GII. 4 strains and identified 17 amino acid substitutions in the P2 region among the 3 GII. 4 variant viruses. When comparing with an additional set of 200 GII. 4 VP1 sequences, only S310 and P396 were present in all GII. 4 New Orleans viruses but not in the ethanol-sensitive GII. 4 Sydney and GII. 4 Den Haag viruses Our data demonstrate that alcohol susceptibility patterns between different norovirus genotypes vary widely and that virolysis data for a single strain or genotype are not representative for all noroviruses.
C1 [Park, Geun Woo; Collins, Nikail; Barclay, Leslie; Lopman, Benjamin A.; Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
   [Collins, Nikail] AREF, Atlanta, GA USA.
   [Hu, Liya; Prasad, B. V. Venkataram] Baylor Coll Med, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.
RP Park, GW (reprint author), Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA.
EM gpark@cdc.gov
OI Prasad, B.V.Venkataram/0000-0002-1172-2071; Collins,
   Nikail/0000-0002-9987-6031; Vinje, Jan/0000-0002-1530-3675
FU NIH [P01 AI057788]; Robert Welch Foundation [Q1279]
FX BVVP acknowledges support from NIH grant (P01 AI057788) and the Robert
   Welch Foundation (Q1279).
CR [Anonymous], 2004, TENTATIVE FINAL MONO
   Barclay L, 2014, CLIN MICROBIOL INFEC, V20, P731, DOI 10.1111/1469-0691.12674
   Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07
   Blaney DD, 2011, AM J INFECT CONTROL, V39, P296, DOI 10.1016/j.ajic.2010.10.010
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761
   CDC, 2008, Jt Comm Perspect, V28, P4
   Cliver DO, 2009, FOOD ENVIRON VIROL, V1, P123, DOI 10.1007/s12560-009-9020-y
   Cromeans T, 2014, APPL ENVIRON MICROB, V80, P5743, DOI 10.1128/AEM.01532-14
   D'Agostino SR, 2006, INTRO APPL BIOSTATIS
   Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921
   GERBA CP, 1984, ADV APPL MICROBIOL, V30, P133, DOI 10.1016/S0065-2164(08)70054-6
   Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575
   Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Hill VR, 2010, FOOD ENVIRON VIROL, V2, P218, DOI 10.1007/s12560-010-9049-y
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147
   Knight A, 2013, CRIT REV MICROBIOL, V39, P295, DOI 10.3109/1040841X.2012.709820
   Kukkula M, 1999, J INFECT DIS, V180, P1771, DOI 10.1086/315145
   Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12
   Liu PB, 2011, FOOD ENVIRON VIROL, V3, P35, DOI 10.1007/s12560-011-9053-x
   Liu PB, 2010, APPL ENVIRON MICROB, V76, P394, DOI 10.1128/AEM.01729-09
   Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005
   Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057
   Macinga DR, 2008, APPL ENVIRON MICROB, V74, P5047, DOI 10.1128/AEM.00487-08
   Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118
   McKarns SC, 1997, FUND APPL TOXICOL, V36, P62, DOI 10.1006/faat.1996.2252
   Nuanualsuwan S, 2002, J VIROL METHODS, V104, P217, DOI 10.1016/S0166-0934(02)00089-7
   Park GW, 2015, APPL ENVIRON MICROB, V81, P5987, DOI 10.1128/AEM.01657-15
   Park GW, 2014, J PHOTOCH PHOTOBIO B, V140, P315, DOI 10.1016/j.jphotobiol.2014.08.009
   Park GW, 2011, FOODBORNE PATHOG DIS, V8, P1005, DOI 10.1089/fpd.2010.0782
   Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232
   Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Prince HNP, 2001, DISINFECTION STERILI, P543
   Rosenthal NA, 2011, EPIDEMIOL INFECT, V139, P286, DOI 10.1017/S095026881000083X
   Said Maria A., 2008, Infection Control and Hospital Epidemiology, V29, P1202, DOI 10.1086/592299
   Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11
   Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127
   Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003
   Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13
   Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025
   Wigginton KR, 2012, CURR OPIN VIROL, V2, P84, DOI 10.1016/j.coviro.2011.11.003
NR 43
TC 5
Z9 5
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 23
PY 2016
VL 11
IS 6
AR e0157787
DI 10.1371/journal.pone.0157787
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP3JL
UT WOS:000378389200044
PM 27337036
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Millen, SH
   Watanabe, M
   Komatsu, E
   Yamaguchi, F
   Nagasawa, Y
   Suzuki, E
   Monaco, H
   Weiss, AA
AF Millen, Scott H.
   Watanabe, Mineo
   Komatsu, Eiji
   Yamaguchi, Fuminori
   Nagasawa, Yuki
   Suzuki, Eri
   Monaco, Haleigh
   Weiss, Alison A.
TI Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB)
   Affect Protein Function
SO PLOS ONE
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; BORDETELLA-PERTUSSIS; IMMUNE-RESPONSES;
   UNITED-STATES; WHOLE-CELL; T-CELLS; VACCINE; PERTACTIN; STRAINS; ADULTS
AB Whooping cough due to Bordetella pertussis is increasing in incidence, in part due to accumulation of mutations which increase bacterial fitness in highly vaccinated populations. Polymorphisms in the pertussis toxin, ptxA and ptxB genes, and the pertactin, prn genes of clinical isolates of Bordetella pertussis collected in Cincinnati from 1989 through 2005 were examined. While the ptxA and prn genotypes were variable, all 48 strains had the ptxB2 genotype; ptxB1 encodes glycine at amino acid 18 of the S2 subunit of pertussis toxin, while ptxB2 encodes serine. We investigated antigenic and functional differences of PtxB1 and PtxB2. The S2 protein was not very immunogenic. Only a few vaccinated or individuals infected with B. pertussis developed antibody responses to the S2 subunit, and these sera recognized both polymorphic forms equally well. Amino acid 18 of S2 is in a glycan binding domain, and the PtxB forms displayed differences in receptor recognition and toxicity. PtxB1 bound better to the glycoprotein, fetuin, and Jurkat T cells in vitro, but the two forms were equally effective at promoting CHO cell clustering. To investigate in vivo activity of Ptx, one mu g of Ptx was administered to DDY mice and blood was collected on 4 days after injection. PtxB2 was more effective at promoting lymphocytosis in mice.
C1 [Millen, Scott H.; Monaco, Haleigh; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.
   [Watanabe, Mineo; Komatsu, Eiji; Yamaguchi, Fuminori; Nagasawa, Yuki; Suzuki, Eri] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo, Japan.
RP Weiss, AA (reprint author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.
EM alison.weiss@uc.edu
OI Weiss, Alison/0000-0002-4726-8376; Millen, Scott/0000-0001-5072-6844
FU United States National Institutes of Health, Institute of Allergy and
   Infectious Diseases [R01AI23695]; Ministry of Education, Science, Sports
   and Culture [2007-19590463]
FX This research was supported by R01AI23695 United States National
   Institutes of Health, Institute of Allergy and Infectious Diseases (PI:
   AAW), and the Ministry of Education, Science, Sports and Culture,
   Grant-in-Aid for Scientific Research (C) 2007-19590463 (PI: MW). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14
   Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627
   Bisgard KM, 2001, J INFECT DIS, V183, P1360, DOI 10.1086/319858
   Bodilis H, 2013, EMERG INFECT DIS, V19, P471, DOI [10.3201/1903.121475, 10.3201/eid1903121475]
   Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07
   Boursaux-Eude C, 1999, VACCINE, V17, P2651, DOI 10.1016/S0264-410X(99)00038-9
   Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881
   CHONG P, 1989, BIOCHEM CELL BIOL, V67, P387, DOI 10.1139/o89-061
   CHRISTIE CDC, 1994, NEW ENGL J MED, V331, P16, DOI 10.1056/NEJM199407073310104
   CUMMING DA, 1989, BIOCHEMISTRY-US, V28, P6500, DOI 10.1021/bi00441a051
   GILLENIUS P, 1985, J BIOL STAND, V13, P61, DOI 10.1016/S0092-1157(85)80034-2
   Guiso N, 2001, VACCINE, V19, P3248, DOI 10.1016/S0264-410X(01)00013-5
   Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5
   HEERZE LD, 1992, J BIOL CHEM, V267, P25810
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345
   KASUGA TADAYOSHI, 1953, KITASATO ARCH EXPTL MED, V26, P121
   Keitel WA, 1999, J INFECT DIS, V180, P397, DOI 10.1086/314869
   King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885
   Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09
   Le T, 2004, J INFECT DIS, V190, P535, DOI 10.1086/422035
   Liko J, 2013, NEW ENGL J MED, V368, P581, DOI 10.1056/NEJMc1212006
   LOCHT C, 1986, NUCLEIC ACIDS RES, V14, P3251, DOI 10.1093/nar/14.8.3251
   MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59
   Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z
   Millen SH, 2004, INFECT IMMUN, V72, P615, DOI 10.1128/IAI.72.1.615-620.2004
   MOOI FR, 2007, PHYLOGENY EVOLUTION, P17
   Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511
   MORSE SI, 1976, J EXP MED, V143, P1483, DOI 10.1084/jem.143.6.1483
   MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986
   NICOSIA A, 1986, P NATL ACAD SCI USA, V83, P4631, DOI 10.1073/pnas.83.13.4631
   Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178
   Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227
   Queenan AM, 2013, NEW ENGL J MED, V368, P583, DOI 10.1056/NEJMc1209369
   Schneider OD, 2007, INFECT IMMUN, V75, P4040, DOI 10.1128/IAI.00414-07
   Schneider OD, 2012, BIOCHEMISTRY-US, V51, P4126, DOI 10.1021/bi3002693
   Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364
   STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1
   Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824
   Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006
   Watanabe M, 2000, VACCINE, V19, P1199, DOI 10.1016/S0264-410X(00)00308-X
   Weingart CL, 2000, INFECT IMMUN, V68, P7175, DOI 10.1128/IAI.68.12.7175-7179.2000
   Weiss AA, 2004, INFECT IMMUN, V72, P7346, DOI 10.1128/IAI.72.12.7346-7351.2004
   World Health Organization, 2011, IMM VACC BIOL PERT
   Zhang SM, 2011, J BACTERIOL, V193, P4017, DOI 10.1128/JB.05184-11
NR 45
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 16
PY 2015
VL 10
IS 9
AR e0137379
DI 10.1371/journal.pone.0137379
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR8NH
UT WOS:000361610200037
PM 26375454
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sahillioglu, AC
   Ozoren, N
AF Sahillioglu, Ali Can
   Ozoren, Nesrin
TI Artificial Loading of ASC Specks with Cytosolic Antigens
SO PLOS ONE
LA English
DT Article
ID INFLAMMASOME ADAPTER ASC; DENDRITIC CELLS; MISFOLDED PROTEINS;
   ACTIVATION; DEATH; POLYMERIZATION; CASPASE-1; SECRETION; AUTOPHAGY;
   DEFENSE
AB Inflammasome complexes form upon interaction of Nod Like Receptor (NLR) proteins with pathogen associated molecular patterns (PAPMS) inside the cytosol. Stimulation of a subset of inflammasome receptors including NLRP3, NLRC4 and AIM2 triggers formation of the micrometer-sized spherical supramolecular complex called the ASC speck. The ASC speck is thought to be the platform of inflammasome activity, but the reason why a supramolecular complex is preferred against oligomeric platforms remains elusive. We observed that a set of cytosolic proteins, including the model antigen ovalbumin, tend to co-aggregate on the ASC speck. We suggest that co-aggregation of antigenic proteins on the ASC speck during intracellular infection might be instrumental in antigen presentation.
C1 [Sahillioglu, Ali Can; Ozoren, Nesrin] Bogazici Univ, Apoptosis & Canc Immunol Lab AKiL, Dept Mol Biol & Genet, Istanbul, Turkey.
   [Ozoren, Nesrin] Bogazici Univ, Life Sci & Technol Res Ctr, Istanbul, Turkey.
RP Ozoren, N (reprint author), Bogazici Univ, Apoptosis & Canc Immunol Lab AKiL, Dept Mol Biol & Genet, Istanbul, Turkey.
EM nesrin.ozoren@boun.edu.tr
OI OZOREN, NESRIN/0000-0002-8580-618X
FU European Molecular Biology Organization Installation Grant [EMBO-SDIG
   1468]; Bogazici University Research Fund [BAP-6526, BAP-TUG 8400]
FX This project was supported by the European Molecular Biology
   Organization Installation Grant (EMBO-SDIG 1468) and Bogazici University
   Research Fund (BAP-6526 and BAP-TUG 8400 Grants) Grant to N.O.
CR Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919
   Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007
   Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063
   Cheng J, 2010, J CELL PHYSIOL, V222, P738, DOI 10.1002/jcp.22005
   Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458
   De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108
   Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194
   Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913
   Gram AM, 2012, J GEN VIROL, V93, P2063, DOI 10.1099/vir.0.042978-0
   Guo XY, 2012, HUM IMMUNOL, V73, P871, DOI 10.1016/j.humimm.2012.06.008
   Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891
   Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095
   Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883
   Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107
   Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195
   Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006
   Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071
   Koizumi Y, 2012, CELL MICROBIOL, V14, P149, DOI 10.1111/j.1462-5822.2011.01707.x
   Kondylis V, 2013, AUTOPHAGY, V9, P861, DOI 10.4161/auto.24111
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008
   Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Pannerden HEVT, 2010, BIOL CELL, V102, P581, DOI 10.1042/BC20100046
   Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913
   Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968
   Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864
   Sahillioglu AC, 2014, STRUCTURE, V22, P1722, DOI 10.1016/j.str.2014.09.011
   Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215
   Stephen TL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030032
   Yazdi AS, 2010, J CLIN IMMUNOL, V30, P623, DOI 10.1007/s10875-010-9437-y
   Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510
NR 38
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 10
PY 2015
VL 10
IS 8
AR e0134912
DI 10.1371/journal.pone.0134912
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO7PJ
UT WOS:000359352600030
PM 26258904
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yun, KW
   Lee, H
   Choi, EH
   Lee, HJ
AF Yun, Ki Wook
   Lee, Hyunju
   Choi, Eun Hwa
   Lee, Hoan Jong
TI Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of
   Streptococcus pneumoniae Isolated from Invasive Diseases in Korean
   Children
SO PLOS ONE
LA English
DT Article
ID VACCINE CANDIDATE; CONJUGATE VACCINE; IMMUNOGENICITY; SAFETY;
   IMMUNIZATION; INFECTIONS; RESISTANCE; SEROTYPES; ADULTS
AB Pneumolysin (Ply) and pneumococcal histidine triad protein D (PhtD) are candidate proteins for a next-generation pneumococcal vaccine. We aimed to analyze the genetic diversity and antigenic heterogeneity of Ply and PhtD for 173 pneumococci isolated from invasive diseases in Korean children. Allele was designated based on the variation of amino acid sequence. Antigenicity was predicted by the amino acid hydrophobicity of the region. There were seven and 39 allele types for the ply and phtD genes, respectively. The nucleotide sequence identity was 97.2%-99.9% for ply and 91.4%-98.0% for phtD gene. Only minor variations in hydrophobicity were noted among the antigenicity plots of Ply and PhtD. Overall, the allele types of the ply and phtD genes were remarkably homogeneous, and the antigenic diversity of the corresponding proteins was very limited. The Ply and PhtD could be useful antigens for universal pneumococcal vaccines.
C1 [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.
   [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea.
   [Lee, Hyunju] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea.
RP Lee, HJ (reprint author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.
EM hoanlee@snu.ac.kr
OI Yun, Ki Wook/0000-0002-0798-6779
FU Basic Science Research Program through the National Research Foundation
   (NRF) of Korea; Ministry of Education, Science, and Technology
   [2011-0023092]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation (NRF) of Korea, which is funded
   by the Ministry of Education, Science, and Technology (2011-0023092).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683
   Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065
   Bersch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081168
   Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076
   Cho EY, 2014, DIAGN MICR INFEC DIS, V78, P481, DOI 10.1016/j.diagmicrobio.2013.12.016
   Choi EH, 2010, EMERG INFECT DIS, V16, P1751, DOI 10.3201/eid1611.100941
   Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051
   Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jefferies JMC, 2010, J MED MICROBIOL, V59, P808, DOI 10.1099/jmm.0.018663-0
   Kamtchoua T, 2013, VACCINE, V31, P327, DOI 10.1016/j.vaccine.2012.11.005
   Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x
   Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x
   MITCHELL TJ, 1990, NUCLEIC ACIDS RES, V18, P4010, DOI 10.1093/nar/18.13.4010
   Norcross EW, 2011, INVEST OPHTH VIS SCI, V52, P9232, DOI 10.1167/iovs.10-6968
   Plumptre CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078916
   Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004
   Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0
   Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080
   Selva L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041587
   Shak JR, 2013, MBIO, V4, DOI 10.1128/mBio.00655-13
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   Wu Xiaomeng, 2006, Int J Bioinform Res Appl, V2, P219
   Yoo IH, 2010, FEMS IMMUNOL MED MIC, V60, P28, DOI 10.1111/j.1574-695X.2010.00699.x
NR 26
TC 5
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 7
PY 2015
VL 10
IS 8
AR e0134055
DI 10.1371/journal.pone.0134055
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO4HF
UT WOS:000359121100035
PM 26252211
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zheng, W
   Ruan, JS
   Hu, G
   Wang, K
   Hanlon, M
   Gao, JZ
AF Zheng, Wei
   Ruan, Jishou
   Hu, Gang
   Wang, Kui
   Hanlon, Michelle
   Gao, Jianzhao
TI Analysis of Conformational B-Cell Epitopes in the Antibody-Antigen
   Complex Using the Depth Function and the Convex Hull
SO PLOS ONE
LA English
DT Article
ID SEQUENCE-BASED PREDICTOR; AMINO-ACID; PROTEIN-STRUCTURE; LINEAR
   EPITOPES; ATOM DEPTH; WEB-SERVER; DETERMINANTS; RESIDUES; LOCATION;
   SITES
AB The prediction of conformational b-cell epitopes plays an important role in immunoinformatics. Several computational methods are proposed on the basis of discrimination determined by the solvent-accessible surface between epitopes and non-epitopes, but the performance of existing methods is far from satisfying. In this paper, depth functions and the k-th surface convex hull are used to analyze epitopes and exposed non-epitopes. On each layer of the protein, we compute relative solvent accessibility and four different types of depth functions, i.e., Chakravarty depth, DPX, half-sphere exposure and half space depth, to analyze the location of epitopes on different layers of the proteins. We found that conformational b-cell epitopes are rich in charged residues Asp, Glu, Lys, Arg, His; aliphatic residues Gly, Pro; non- charged residues Asn, Gln; and aromatic residue Tyr. Conformational b-cell epitopes are rich in coils. Conservation of epitopes is not significantly lower than that of exposed non-epitopes. The average depths (obtained by four methods) for epitopes are significantly lower than that of non-epitopes on the surface using the Wilcoxon rank sum test. Epitopes are more likely to be located in the outer layer of the convex hull of a protein. On the benchmark dataset, the cumulate 10th convex hull covers 84.6% of exposed residues on the protein surface area, and nearly 95% of epitope sites. These findings may be helpful in building a predictor for epitopes.
C1 [Zheng, Wei; Ruan, Jishou; Hu, Gang; Wang, Kui; Gao, Jianzhao] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.
   [Zheng, Wei; Ruan, Jishou; Hu, Gang; Wang, Kui; Gao, Jianzhao] Nankai Univ, LPMC, Tianjin 300071, Peoples R China.
   [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.
   [Hanlon, Michelle] Grant MacEwan Univ, Dept Phys Sci, Edmonton, AB, Canada.
RP Gao, JZ (reprint author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.
EM gaojz@nankai.edu.cn
OI Gao, Jianzhao/0000-0002-9943-4786
FU Specialized Research Fund for the Doctoral Program of Higher Education
   (SRFDP) [20130031120001]; Nankai University [68150003]; International
   Development Research Center, Ottawa, Canada [104519-010]; National
   Natural Science Foundation of China (NSFC) [31050110432, 31150110577,
   61170099]; NSFC [11101226, 11301286]
FX JG was supported by Specialized Research Fund for the Doctoral Program
   of Higher Education (SRFDP grant number 20130031120001). WZ was
   supported by the Ph.D. Candidate Research Innovation Fund of Nankai
   University (no. 68150003). JR was supported by the International
   Development Research Center, Ottawa, Canada (no. 104519-010) and the
   National Natural Science Foundation of China (NSFC, grant numbers
   31050110432, 31150110577). GH was supported by NSFC (grant number
   11101226). KW was supported by NSFC (grant number 11301286). This work
   was also supported by the National Natural Science Foundation of China
   (NSFC, grant number 61170099). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5
   Chang HT, 2008, J MOL RECOGNIT, V21, P431, DOI 10.1002/jmr.910
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022
   Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843
   Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834
   De Berg M., 2000, COMPUTATIONAL GEOMET, P1, DOI DOI 10.1007/978-3-662-04245-81
   Ding H, 2014, BIOMED RES INT, DOI 10.1155/2014/286419
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2
   El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011
   Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024
   Gao Jianzhao, 2014, Methods Mol Biol, V1184, P197, DOI 10.1007/978-1-4939-1115-8_11
   Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104
   Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083
   Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hubbard SJ, 1993, NACCESS COMPUTER PRO, V2
   Jia JH, 2015, J THEOR BIOL, V377, P47, DOI 10.1016/j.jtbi.2015.04.011
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829
   Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001
   Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019
   Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458
   Liu R, 2011, J PROTEOM BIOINFORM, V4, P010
   Liu Z, 2015, ANAL BIOCHEM, V474, P69, DOI 10.1016/j.ab.2014.12.009
   Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A
   PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176
   Pintar A, 2003, TRENDS BIOCHEM SCI, V28, P593, DOI 10.1016/j.tibs.2003.09.004
   Pintar A, 2003, BIOPHYS J, V84, P2553, DOI 10.1016/S0006-3495(03)75060-7
   Pintar A, 2003, BIOINFORMATICS, V19, P313, DOI 10.1093/bioinformatics/19.2.313
   Reineke Ulrich, 2009, Methods Mol Biol, V524, pv
   Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009
   Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Shen SY, 2007, PROTEIN J, V26, P183, DOI 10.1007/s10930-006-9060-1
   Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216
   Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075
   Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503
   Tukey JW, 1975, P INT C MATH ZUR 199
   Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146
   Wang HW, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432830
   Wang K, 2013, BIOMED RES INT, DOI 10.1155/2013/409658
   Wang YL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-251
   Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21
   WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4
   Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152
   Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341
   Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6
   Zheng W, 2014, COMPUT BIOL CHEM, V49, P51, DOI 10.1016/j.compbiolchem.2014.02.002
NR 64
TC 8
Z9 8
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 5
PY 2015
VL 10
IS 8
AR UNSP e0134835
DI 10.1371/journal.pone.0134835
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO3MH
UT WOS:000359061400110
PM 26244562
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Szafron, LM
   Balcerak, A
   Grzybowska, EA
   Pienkowska-Grela, B
   Felisiak-Golabek, A
   Podgorska, A
   Kulesza, M
   Nowak, N
   Pomorski, P
   Wysocki, J
   Rubel, T
   Dansonka-Mieszkowska, A
   Konopka, B
   Lukasik, M
   Kupryjanczyk, J
AF Szafron, Lukasz Michal
   Balcerak, Anna
   Grzybowska, Ewa Anna
   Pienkowska-Grela, Barbara
   Felisiak-Golabek, Anna
   Podgorska, Agnieszka
   Kulesza, Magdalena
   Nowak, Natalia
   Pomorski, Pawel
   Wysocki, Juliusz
   Rubel, Tymon
   Dansonka-Mieszkowska, Agnieszka
   Konopka, Bozena
   Lukasik, Martyna
   Kupryjanczyk, Jolanta
TI The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is
   Overexpressed in Highly Proliferating Tissues
SO PLOS ONE
LA English
DT Article
ID KEYHOLE LIMPET HEMOCYANIN; RNA ACTIVATOR SRA; NONCODING RNAS;
   BREAST-CANCER; ANTIGENIC DETERMINANTS; PROTEIN-STRUCTURE; SF3B1
   MUTATIONS; I-TASSER; EXPRESSION; CELLS
AB CRNDE, recently described as the lncRNA-coding gene, is overexpressed at RNA level in human malignancies. Its role in gametogenesis, cellular differentiation and pluripotency has been suggested as well. Herein, we aimed to verify our hypothesis that the CRNDE gene may encode a protein product, CRNDEP. By using bioinformatics methods, we identified the 84-amino acid ORF encoded by one of two CRNDEtranscripts, previously described by our research team. This ORF was cloned into two expression vectors, subsequently utilized in localization studies in HeLa cells. We also developed a polyclonal antibody against CRNDEP. Its specificity was confirmed in immunohistochemical, cellular localization, Western blot and immunoprecipitation experiments, as well as by showing a statistically significant decrease of endogenous CRNDEP expression in the cells with transient shRNA-mediated knockdown of CRNDE. Endogenous CRNDEP localizes predominantly to the nucleus and its expression seems to be elevated in highly proliferating tissues, like the parabasal layer of the squamous epithelium, intestinal crypts or spermatocytes. After its artificial overexpression in HeLa cells, in a fusion with either the EGFP or DsRed Monomer fluorescent tag, CRNDEP seems to stimulate the formation of stress granules and localize to them. Although the exact role of CRNDEP is unknown, our preliminary results suggest that it may be involved in the regulation of the cell proliferation. Possibly, CRNDEP also participates in oxygen metabolism, considering our in silico results, and the correlation between its enforced overexpression and the formation of stress granules. This is the first report showing the existence of a peptide encoded by the CRNDE gene.
C1 [Szafron, Lukasz Michal; Pienkowska-Grela, Barbara; Felisiak-Golabek, Anna; Podgorska, Agnieszka; Kulesza, Magdalena; Dansonka-Mieszkowska, Agnieszka; Konopka, Bozena; Lukasik, Martyna; Kupryjanczyk, Jolanta] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland.
   [Balcerak, Anna; Grzybowska, Ewa Anna; Wysocki, Juliusz] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland.
   [Nowak, Natalia] Nencki Inst Expt Biol, Lab Imaging Tissue Struct & Funct, Neurobiol Ctr, Warsaw, Poland.
   [Pomorski, Pawel] Nencki Inst Expt Biol, NanoBioGeo Consortium, Multimodal Lab Cell Adhes & Motil, Warsaw, Poland.
   [Pomorski, Pawel] Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Dept Biochem, Warsaw, Poland.
   [Rubel, Tymon] Warsaw Univ Technol, Inst Radioelect, Warsaw, Poland.
RP Szafron, LM (reprint author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland.
EM lukszafron@gmail.com
RI Nowak, Natalia/P-9617-2016; Grzybowska, Ewa/F-2711-2013; Rubel,
   Tymon/L-6861-2017; Pomorski, Pawel/R-4170-2016
OI Nowak, Natalia/0000-0003-3140-2056; Rubel, Tymon/0000-0002-1342-414X;
   Grzybowska, Ewa/0000-0003-3148-2439; Podgorska,
   Agnieszka/0000-0002-6915-3334; Pomorski, Pawel/0000-0002-1658-7649;
   Szafron, Lukasz/0000-0003-1670-0274; Konopka,
   Bozena/0000-0003-1187-3504; Lukasik, Martyna/0000-0001-8102-129X;
   Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Kupryjanczyk,
   Jolanta/0000-0001-5820-0214
FU Polish Ministry of Science and Higher Education [N N401 2361 34, N N407
   0272 38]; NanoFun Project [POIG.02.02.00-00-025/09]
FX Funding: This study was supported by the grants no. N N401 2361 34 and N
   N407 0272 38 of the Polish Ministry of Science and Higher Education.
   URL: (http://www.nauka.gov.pl/en/). Immunofluorescence imaging was
   performed in Multimodal Laboratory of Cell Adhesion and Motility in
   Nencki Institute of Experimental Biology PAS, supported by the NanoFun
   Project POIG.02.02.00-00-025/09. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022
   Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138
   BRZEZINSKABLASZCZYK E, 1980, ARCH IMMUNOL THER EX, V28, P533
   Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107
   Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611
   Chen LL, 2010, WIRES RNA, V1, P2, DOI 10.1002/wrna.5
   Cooper C, 2009, NUCLEIC ACIDS RES, V37, P4518, DOI 10.1093/nar/gkp441
   Ellis BC, 2014, BBA-MOL CELL RES, V1843, P372, DOI 10.1016/j.bbamcr.2013.10.016
   Ellis Blake C., 2012, Frontiers in Genetics, V3, P270, DOI 10.3389/fgene.2012.00270
   Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Graham Lloyd D, 2011, Genes Cancer, V2, P829, DOI 10.1177/1947601911431081
   Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481
   Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398
   Harris JR, 2000, EUR UROL, V37, P24, DOI 10.1159/000052389
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80
   Hube F, 2006, DNA CELL BIOL, V25, P418, DOI 10.1089/dna.2006.25.418
   Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310
   Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341
   Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743
   Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356
   Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519
   Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Nagaraj SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-35
   Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410
   Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172
   Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008
   Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075
   Szafron L, 2013, EUR J CANCER, V49, pS215
   Szafron L, 2009, INT J MOL MED, V24, pS40
   Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12
   Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368
   Wahlstrom T, 2014, BIOCHIM BIOPHYS ACTA, V1849, P563, DOI [10.1016/j.bbagrm.2014.07.004, DOI 10.1016/J.BBAGRM.2014.07.004]
   WARBURG O, 1956, SCIENCE, V124, P269
   Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112
   Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 48
TC 10
Z9 12
U1 3
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 15
PY 2015
VL 10
IS 5
AR e0127475
DI 10.1371/journal.pone.0127475
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI7AU
UT WOS:000354916100146
PM 25978564
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lee, E
   Shin, A
   Jeong, KW
   Jin, B
   Jnawali, HN
   Shin, S
   Shin, SY
   Kim, Y
AF Lee, Eunjung
   Shin, Areum
   Jeong, Ki-Woong
   Jin, Bongwhan
   Jnawali, Hum Nath
   Shin, Soyoung
   Shin, Song Yub
   Kim, Yangmee
TI Role of Phenylalanine and Valine(10) Residues in the Antimicrobial
   Activity and Cytotoxicity of Piscidin-1
SO PLOS ONE
LA English
DT Article
ID MOLECULAR RECOGNITION; PEPTIDE ANTIBIOTICS; CATIONIC PEPTIDES;
   LIPID-BILAYER; MEMBRANE; FISH; ANALOGS; NEUTRALIZATION; CONFORMATION;
   MECHANISMS
AB Piscidin-1 (Pis-1) is a linear antibacterial peptide derived from mast cells of aquacultured hybrid striped bass that comprises 22 amino acids with a phenylalanine-rich amino-terminus. Pis-1 exhibits potent antibacterial activity against pathogens but is not selective for distinguishing between bacterial and mammalian cells. To determine the key residues for its antibacterial activity and those for its cytotoxicity, we investigated the role of each Phe residue near the N-terminus as well as the Val(10) residue located near the boundary of the hydrophobic and hydrophilic sectors of the helical wheel diagram. Fluorescence dye leakage and tryptophan fluorescence experiments were used to study peptide-lipid interactions, showing comparable depths of insertion of substituted peptides in different membranes. Phe(2) was found to be the most deeply inserted phenylalanine in both bacterial-and mammalian-mimic membranes. Each Phe was substituted with Ala or Lys to investigate its functional role. Phe(2) plays key roles in the cytotoxicity as well as the antibacterial activities of Pis-1, and Phe(6) is essential for the antibacterial activities of Pis-1. We also designed and synthesized a piscidin analog, Pis-V10K, in which Lys was substituted for Val10, resulting in an elevated amphipathic alpha-helical structure. Pis-V10K showed similar antibacterial activity (average minimum inhibitory concentration (MIC) = 1.6 mu M) to Pis-1 (average MIC = 1.5 mu M). However, it exhibited much lower cytotoxicity than Pis-1. Lys(10-)substituted analogs, Pis-F1K/V10K, Pis-F2K/V10K, and Pis-F6K/V10K in which Lys was substituted for Phe retained antibacterial activity toward standard and drug-resistant bacterial strains with novel bacterial cell selectivity. They exert anti-inflammatory activities via inhibition of nitric oxide production, TNF-alpha secretion, and MIP-1 and MIP-2 production. They may disrupt the binding of LPS to toll-like receptors, eventually suppressing MAPKs-mediated signaling pathways. These peptides may be good candidates for the development of peptide antibiotics with potent antibacterial activity but without cytotoxicity.
C1 [Lee, Eunjung; Shin, Areum; Jeong, Ki-Woong; Jin, Bongwhan; Jnawali, Hum Nath; Shin, Soyoung; Kim, Yangmee] Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea.
   [Shin, Song Yub] Chosun Univ, Sch Med, Res Ctr Proteineous Mat, Kwangju, South Korea.
   [Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Kwangju, South Korea.
RP Kim, Y (reprint author), Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea.
EM ymkim@konkuk.ac.kr
FU Priority Research Centers Program [20090093824]; Basic Science Research
   Program through National Research Foundation of Korea - Ministry of
   Education, Science, and Technology [2011-0022873, 2013R1A1A2058021]
FX This work was supported by grants from the Priority Research Centers
   Program (20090093824) and from the Basic Science Research Program
   (2011-0022873 and 2013R1A1A2058021) through the National Research
   Foundation of Korea funded by the Ministry of Education, Science, and
   Technology. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Bell Susan Givens, 2003, Neonatal Netw, V22, P47
   Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3
   Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297
   Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbhamern.2006.03.034
   Chekmenev EY, 2006, J AM CHEM SOC, V128, P5308, DOI 10.1021/ja058358e
   Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029
   Colorni A, 2008, J FISH DIS, V31, P423, DOI 10.1111/j.1365-2761.2008.00922.x
   Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1
   De Angelis AA, 2011, BIOPHYS J, V101, P1086, DOI 10.1016/j.bpj.2011.07.015
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1111/j.1574-6968.2002.tb11000.x
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jing WG, 2006, BIOCHEM CELL BIOL, V84, P312, DOI 10.1139/006-052
   Kim JK, 2010, BBA-BIOMEMBRANES, V1798, P1913, DOI 10.1016/j.bbamem.2010.06.026
   Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017
   Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200
   Lee E, 2013, BMB REP, V46, P282, DOI 10.5483/BMBRep.2013.46.5.252
   Lee E, 2013, BBA-BIOMEMBRANES, V1828, P271, DOI 10.1016/j.bbamem.2012.10.028
   Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144
   Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u
   Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4
   Noga EJ, 2003, DRUG NEWS PERSPECT, V16, P87, DOI 10.1358/dnp.2003.16.2.829325
   Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j
   Perrin BS, 2014, J AM CHEM SOC, V136, P3491, DOI 10.1021/ja411119m
   Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200
   Saravanan R, 2012, BBA-BIOMEMBRANES, V1818, P1613, DOI 10.1016/j.bbamem.2012.03.015
   Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690
   Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1
   WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yu K, 2000, J PEPT RES, V55, P51, DOI 10.1034/j.1399-3011.2000.00146.x
   Yuan TH, 2012, BIOPOLYMERS, V97, P998, DOI 10.1002/bip.22116
NR 35
TC 20
Z9 21
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 4
PY 2014
VL 9
IS 12
AR e114453
DI 10.1371/journal.pone.0114453
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AW6MB
UT WOS:000346382500030
PM 25473836
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nicolau, DV
   Paszek, E
   Fulga, F
   Nicolau, DV
AF Nicolau, Dan V., Jr.
   Paszek, Ewa
   Fulga, Florin
   Nicolau, Dan V.
TI Mapping Hydrophobicity on the Protein Molecular Surface at Atom-Level
   Resolution
SO PLOS ONE
LA English
DT Article
ID SPATIAL-ORGANIZATION; ORGANIC-MOLECULES; LIGAND-BINDING; FORCE-FIELD;
   FREE-ENERGY; K+-ATPASE; MEMBRANE; PREDICTION; RECOGNITION; EFFICIENT
AB A precise representation of the spatial distribution of hydrophobicity, hydrophilicity and charges on the molecular surface of proteins is critical for the understanding of the interaction with small molecules and larger systems. The representation of hydrophobicity is rarely done at atom-level, as this property is generally assigned to residues. A new methodology for the derivation of atomic hydrophobicity from any amino acid-based hydrophobicity scale was used to derive 8 sets of atomic hydrophobicities, one of which was used to generate the molecular surfaces for 35 proteins with convex structures, 5 of which, i.e., lysozyme, ribonuclease, hemoglobin, albumin and IgG, have been analyzed in more detail. Sets of the molecular surfaces of the model proteins have been constructed using spherical probes with increasingly large radii, from 1.4 to 20 angstrom, followed by the quantification of (i) the surface hydrophobicity; (ii) their respective molecular surface areas, i. e., total, hydrophilic and hydrophobic area; and (iii) their relative densities, i. e., divided by the total molecular area; or specific densities, i. e., divided by property-specific area. Compared with the amino acid-based formalism, the atom-level description reveals molecular surfaces which (i) present an approximately two times more hydrophilic areas; with (ii) less extended, but between 2 to 5 times more intense hydrophilic patches; and (iii) 3 to 20 times more extended hydrophobic areas. The hydrophobic areas are also approximately 2 times more hydrophobicity-intense. This, more pronounced "leopard skin"-like, design of the protein molecular surface has been confirmed by comparing the results for a restricted set of homologous proteins, i. e., hemoglobins diverging by only one residue (Trp37). These results suggest that the representation of hydrophobicity on the protein molecular surfaces at atom-level resolution, coupled with the probing of the molecular surface at different geometric resolutions, can capture processes that are otherwise obscured to the amino acid-based formalism.
C1 [Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
   [Paszek, Ewa; Fulga, Florin; Nicolau, Dan V.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England.
   [Nicolau, Dan V.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada.
RP Nicolau, DV (reprint author), Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England.
EM dan.nicolau@mcgill.ca
OI Nicolau, Dan V/0000-0002-9956-0600
FU Defense Advanced Research Projects Agency (DARPA) [F30602-00-2-0614];
   European Union [214538]
FX This work has been supported by the Defense Advanced Research Projects
   Agency (DARPA, www.darpa.mil), under SymBioSys Program, Grant Contract
   No. F30602-00-2-0614); and by the European Union Seventh Framework
   Programme (FP7/2007-2013, http://ec.europa.eu/research/fp7/index_en.cfm)
   under grant agreement no. 214538 project Bio-Inspired Self-assembled
   Nano-Enabled Surfaces (BISNES). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ABRAHAM DJ, 1987, PROTEINS, V2, P130, DOI 10.1002/prot.340020207
   Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002
   BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0
   Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942
   Brockwell DJ, 2000, CURR OPIN STRUC BIOL, V10, P16, DOI 10.1016/S0959-440X(99)00043-3
   Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012
   Caron G, 2003, MINI-REV MED CHEM, V3, P821, DOI 10.2174/1389557033487665
   CASARI G, 1992, J MOL BIOL, V224, P725, DOI 10.1016/0022-2836(92)90556-Y
   CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985
   CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779
   CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Cozzini P, 2004, CURR MED CHEM, V11, P3093, DOI 10.2174/0929867043363929
   Cristea PD, 2012, PROTEIN SURFACE ATOM, P147
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635
   Efremov RG, 1999, BIOPHYS J, V76, P2448, DOI 10.1016/S0006-3495(99)77400-X
   EFREMOV RG, 1992, J PROTEIN CHEM, V11, P699, DOI 10.1007/BF01024971
   EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968
   EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0
   EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303
   Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y
   FAUCHERE JL, 1988, J MOL GRAPHICS, V6, P203, DOI 10.1016/S0263-7855(98)80004-0
   Fersht A, 1985, ENZYME STRUCTURE MEC
   Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588
   Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o
   GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001
   Hawkins KR, 2007, LAB CHIP, V7, P281, DOI 10.1039/b612894g
   Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387
   Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jamadagni SN, 2011, ANNU REV CHEM BIOMOL, V2, P147, DOI 10.1146/annurev-chembioeng-061010-114156
   JANIN J, 1990, J BIOL CHEM, V265, P16027
   Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13
   Karplus PA, 1997, PROTEIN SCI, V6, P1302
   KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195
   Kavanaugh JS, 1998, BIOCHEMISTRY-US, V37, P4358, DOI 10.1021/bi9708702
   KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0
   Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7
   KELLOGG GE, 1991, J COMPUT AID MOL DES, V5, P545, DOI 10.1007/BF00135313
   Koehler J, 2009, PROTEINS, V76, P13, DOI 10.1002/prot.22315
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LAWRENCE CE, 1991, METHOD ENZYMOL, V202, P20
   LESSER GJ, 1990, PROTEINS, V8, P6, DOI 10.1002/prot.340080104
   MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632
   Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108
   Mukhopadhyay R, 2006, ANAL CHEM, V78, P7379, DOI 10.1021/ac069476c
   Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus
   Nicolau DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058896
   Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006
   OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086
   RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042
   RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055
   Sandelin E, 2004, BIOPHYS J, V86, P23, DOI 10.1016/S0006-3495(04)74080-1
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   SCHIFFER CA, 1993, MOL SIMULAT, V10, P121, DOI 10.1080/08927029308022162
   SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744
   Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9
   Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f
   VILA J, 1991, PROTEINS, V10, P199, DOI 10.1002/prot.340100305
   WESSON L, 1992, PROTEIN SCI, V1, P227
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030
   Yamaotsu N, 2008, BIOL PHARM BULL, V31, P1552, DOI 10.1248/bpb.31.1552
   ZAUHAR RJ, 1990, J COMPUT CHEM, V11, P603, DOI 10.1002/jcc.540110509
NR 68
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2014
VL 9
IS 12
AR e114042
DI 10.1371/journal.pone.0114042
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU8TQ
UT WOS:000345869700086
PM 25462574
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Presslauer, C
   Nagasawa, K
   Dahle, D
   Babiak, J
   Fernandes, JMO
   Babiak, I
AF Presslauer, Christopher
   Nagasawa, Kazue
   Dahle, Dalia
   Babiak, Joanna
   Fernandes, Jorge M. O.
   Babiak, Igor
TI Induced Autoimmunity against Gonadal Proteins Affects Gonadal
   Development in Juvenile Zebrafish
SO PLOS ONE
LA English
DT Article
ID GROWTH-DIFFERENTIATION FACTOR-9; PRIMORDIAL GERM-CELLS; RAINBOW-TROUT;
   DANIO-RERIO; SPATIOTEMPORAL EXPRESSION; MAMMALIAN WILDLIFE; ATLANTIC
   SALMON; GENE-EXPRESSION; GRANULOSA-CELLS; IMMUNE-SYSTEM
AB A method to mitigate or possibly eliminate reproduction in farmed fish is highly demanded. The existing approaches have certain applicative limitations. So far, no immunization strategies affecting gonadal development in juvenile animals have been developed. We hypothesized that autoimmune mechanisms, occurring spontaneously in a number of diseases, could be induced by targeted immunization. We have asked whether the immunization against specific targets in a juvenile zebrafish gonad will produce an autoimmune response, and, consequently, disturbance in gonadal development. Gonadal soma-derived factor (Gsdf), growth differentiation factor (Gdf9), and lymphocyte antigen 75 (Cd205/Ly75), all essential for early gonad development, were targeted with 5 immunization tests. Zebrafish (n5329) were injected at 6 weeks post fertilization, a booster injection was applied 15 days later, and fish were sampled at 30 days. We localized transcripts encoding targeted proteins by in situ hybridization, quantified expression of immune-, apoptosis-, and gonad-related genes with quantitative real-time PCR, and performed gonadal histology and whole-mount immunohistochemistry for Bcl2-interacting-killer (Bik) pro-apoptotic protein. The treatments resulted in an autoimmune reaction, gonad developmental retardation, intensive apoptosis, cell atresia, and disturbed transcript production. Testes were remarkably underdeveloped after anti-Gsdf treatments. Anti-Gdf9 treatments promoted apoptosis in testes and abnormal development of ovaries. Anti-Cd205 treatment stimulated a strong immune response in both sexes, resulting in oocyte atresia and strong apoptosis in supporting somatic cells. The effect of immunization was FSH-independent. Furthermore, immunization against germ cell proteins disturbed somatic supporting cell development. This is the first report to demonstrate that targeted autoimmunity can disturb gonadal development in a juvenile fish. It shows a straightforward potential to develop auto-immunization-based technologies to mitigate fish reproduction before they reach maturation. However, the highly variable results between treatments and individuals suggest significant optimization should be performed to achieve the full potential of this technology.
C1 [Presslauer, Christopher; Nagasawa, Kazue; Dahle, Dalia; Babiak, Joanna; Fernandes, Jorge M. O.; Babiak, Igor] Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway.
RP Babiak, I (reprint author), Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway.
EM Igor.Babiak@uin.no
RI Fernandes, Jorge/A-3526-2013
OI Fernandes, Jorge/0000-0002-2550-1640; Nagasawa,
   Kazue/0000-0003-2819-3302; Babiak, Igor/0000-0002-1462-2690
FU Marine Biotechnology in Northern Norway (MABIT) program [AF0059];
   University of Nordland
FX The study was funded by Marine Biotechnology in Northern Norway (MABIT)
   program (www.mabit.no), grant # AF0059; and by University of Nordland
   (www.uin.no) - all granted to IB. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438
   Benfey Tillmann J., 1999, Reviews in Fisheries Science, V7, P39, DOI 10.1080/10641269991319162
   BOYD JM, 1995, ONCOGENE, V11, P1921
   Buonocore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047957
   Chen J, 2013, CHINESE SCI BULL, V58, P7, DOI 10.1007/s11434-012-5577-1
   Chinnadurai G, ONCOGENE, V27, pS20
   Clelland ES, 2011, GEN COMP ENDOCR, V171, P211, DOI 10.1016/j.ygcen.2011.01.009
   Cooper DW, 2006, REPRODUCTION, V132, P821, DOI 10.1530/REP-06-0037
   Cooper DW, 2001, REPROD FERT DEVELOP, V13, P451, DOI 10.1071/RD01072
   Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999
   Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0
   Draper BW, 2012, PROGENITOR CELLS, V916, P157
   Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003
   Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183
   Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003
   Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892
   Gautier A, 2011, GENE, V472, P7, DOI 10.1016/j.gene.2010.10.014
   Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0
   Gupta SK, 2011, AM J REPROD IMMUNOL, V66, P51, DOI 10.1111/j.1600-0897.2011.01004.x
   Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105
   He Z, 2012, GEN COMP ENDOCR, V178, P355, DOI 10.1016/j.ygcen.2012.06.016
   Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hu YL, 2010, MOL IMMUNOL, V47, P738, DOI 10.1016/j.molimm.2009.10.010
   Huttenhuis HBT, 2005, DEV COMP IMMUNOL, V29, P1033, DOI 10.1016/j.dci.2005.03.005
   Janz DM, 1997, GEN COMP ENDOCR, V105, P186, DOI 10.1006/gcen.1996.6820
   Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, P1
   Jorstad KE, 2008, REV FISH SCI, V16, P285, DOI 10.1080/10641260701678017
   Juengel JL, 2002, BIOL REPROD, V67, P1777, DOI 10.1095/biolreprod.102.007146
   Karlsen O, 2006, AQUACULTURE, V255, P242, DOI 10.1016/j.aquaculture.2005.12.029
   KARLSEN O, 1995, AQUACULTURE, V133, P159, DOI 10.1016/0044-8486(94)00399-9
   Kato M, 1998, IMMUNOGENETICS, V47, P442, DOI 10.1007/s002510050381
   Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x
   Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5
   Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104
   LAIRD LM, 1980, REPROD NUTR DEV, V20, P1781, DOI 10.1051/rnd:19801004
   Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4
   Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668
   Liu ZW, 2012, MOL BIOL REP, V39, P3863, DOI 10.1007/s11033-011-1165-8
   Maack G, 2003, FISH PHYSIOL BIOCHEM, V28, P125, DOI 10.1023/B:FISH.0000030497.59378.88
   Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x
   Matthews M, 2002, LAB ANIMAL, V31, P34
   McClure CA, 2007, AQUACULTURE, V272, P370, DOI 10.1016/j.aquaculture.2007.08.039
   Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x
   Nagasawa K, 2012, FISHERIES SCI, V78, P791, DOI 10.1007/s12562-012-0501-9
   Nagasawa K, 2010, BIOL REPROD, V83, P597, DOI 10.1095/biolreprod.109.082081
   Naz DRK, 2011, AM J REPROD IMMUNOL, V66, P2
   Paulini F, 2011, REPROD DOMEST ANIM, V46, P354, DOI 10.1111/j.1439-0531.2010.01739.x
   Poon SK, 2009, REPRODUCTION, V138, P709, DOI 10.1530/REP-09-0198
   Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181
   Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008
   Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034
   Sambroni E, 2013, J MOL ENDOCRINOL, V50, P1, DOI 10.1530/JME-12-0197
   Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001
   Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891
   Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005
   Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016
   Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102
   Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x
   Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004
   Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034
   Westerfield M, 2000, ZEBRAFISH BOOK GUIDE
   White YAR, 2011, DEV DYNAM, V240, P1929, DOI 10.1002/dvdy.22695
   Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319
   Yoon C, 1997, DEVELOPMENT, V124, P3157
   Zar J. H, 1999, BIOSTATISTICAL ANAL
   Zhao L, 2011, ACTA HISTOCHEM, V113, P771, DOI 10.1016/j.acthis.2010.11.005
NR 67
TC 5
Z9 5
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 1
PY 2014
VL 9
IS 12
AR e114209
DI 10.1371/journal.pone.0114209
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX7SK
UT WOS:000347114900129
PM 25436775
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jaspard, E
   Hunault, G
AF Jaspard, Emmanuel
   Hunault, Gilles
TI Comparison of Amino Acids Physico-Chemical Properties and Usage of Late
   Embryogenesis Abundant Proteins, Hydrophilins and WHy Domain
SO PLOS ONE
LA English
DT Article
ID LEA PROTEINS; ARABIDOPSIS-THALIANA; IN-VITRO; DEVELOPMENTAL
   BIOCHEMISTRY; COTTONSEED EMBRYOGENESIS; SACCHAROMYCES-CEREVISIAE;
   GLOBULAR-PROTEINS; STRESS-PROTEIN; WATER-DEFICIT; DESICCATION
AB Late Embryogenesis Abundant proteins (LEAPs) comprise several diverse protein families and are mostly involved in stress tolerance. Most of LEAPs are intrinsically disordered and thus poorly functionally characterized. LEAPs have been classified and a large number of their physico-chemical properties have been statistically analyzed. LEAPs were previously proposed to be a subset of a very wide family of proteins called hydrophilins, while a domain called WHy (Water stress and Hypersensitive response) was found in LEAP class 8 (according to our previous classification). Since little is known about hydrophilins and WHy domain, the cross-analysis of their amino acids physico-chemical properties and amino acids usage together with those of LEAPs helps to describe some of their structural features and to make hypothesis about their function. Physico-chemical properties of hydrophilins and WHy domain strongly suggest their role in dehydration tolerance, probably by interacting with water and small polar molecules. The computational analysis reveals that LEAP class 8 and hydrophilins are distinct protein families and that not all LEAPs are a protein subset of hydrophilins family as proposed earlier. Hydrophilins seem related to LEAP class 2 (also called dehydrins) and to Heat Shock Proteins 12 (HSP12). Hydrophilins are likely unstructured proteins while WHy domain is structured. LEAP class 2, hydrophilins and WHy domain are thus proposed to share a common physiological role by interacting with water or other polar/charged small molecules, hence contributing to dehydration tolerance.
C1 [Jaspard, Emmanuel] Univ Angers, UMR IRHS 1345, SFR QUASAV 4207, F-49045 Angers, France.
   [Jaspard, Emmanuel] INRA, UMR IRHS 1345, Beaucouze, France.
   [Jaspard, Emmanuel] Agrocampus Ouest, UMR IRHS 1345, Angers, France.
   [Hunault, Gilles] Univ Angers, Lab Hemodynam Interact Fibrose & Invasiv Tumorale, UPRES 3859, IFR 132, F-49045 Angers, France.
RP Jaspard, E (reprint author), Univ Angers, UMR IRHS 1345, SFR QUASAV 4207, F-49045 Angers, France.
EM emmanuel.jaspard@univ-angers.fr
FU Universite d'Angers
FX This work was supported by a grant from Universite d'Angers "Decouverte
   de motifs souples au sein de classes de proteines intrinsequement non
   structurees ou pleinement structurees". The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alsheikh MK, 2005, PLANT CELL ENVIRON, V28, P1114, DOI 10.1111/j.1365-3040.2005.01348.x
   Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725
   BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241
   Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x
   Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x
   Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039
   BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035
   Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a
   Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164
   Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963
   Ciccarelli FD, 2005, BIOINFORMATICS, V21, P1304, DOI 10.1093/bioinformatics/bti221
   Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x
   Dang NX, 2014, PLANTA, V240, P325, DOI 10.1007/s00425-014-2089-z
   Dang NX, 2011, CRYOBIOLOGY, V62, P188, DOI 10.1016/j.cryobiol.2011.03.002
   DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033
   DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962
   EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7
   Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183
   Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306
   Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149
   GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327
   GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695
   GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034
   Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H
   Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668
   Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x
   Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931
   Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480
   Hara M, 2004, PLANT PHYSIOL BIOCH, V42, P657, DOI 10.1016/j.plaphy.2004.06.004
   He SY, 1996, PLANT PHYSIOL, V112, P865, DOI 10.1104/pp.112.3.865
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803
   Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221
   Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118
   HUNTER S, 2009, NUCLEIC ACIDS RES, V37, pD224, DOI DOI 10.1093/NAR/GKN833
   Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136
   JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0
   Jaspard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036968
   Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697
   Kruger C, 2002, J BIOL CHEM, V277, P25062, DOI 10.1074/jbc.M201896200
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Li DX, 2009, BIOMACROMOLECULES, V10, P1469, DOI 10.1021/bm9002688
   Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047
   Lopez-Martinez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033324
   Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951
   Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099
   Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Rahman LN, 2013, BBA-BIOMEMBRANES, V1828, P967, DOI 10.1016/j.bbamem.2012.11.031
   Raschke TM, 2006, CURR OPIN STRUC BIOL, V16, P152, DOI 10.1016/j.sbi.2006.03.002
   Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6
   Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x
   Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x
   Rodriguez-Porrata B, 2012, J APPL MICROBIOL, V112, P512, DOI 10.1111/j.1365-2672.2011.05219.x
   Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/O09-001, 10.1139/o09-001]
   Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f
   Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893
   Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z
   Teixeira J, 2009, GEN PHYSIOL BIOPHYS, V28, P168, DOI 10.4149/gpb_2009_02_168
   Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029
   Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7
   Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001
   Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306
   ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6
NR 65
TC 10
Z9 11
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2014
VL 9
IS 10
AR e109570
DI 10.1371/journal.pone.0109570
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT8TE
UT WOS:000345204000080
PM 25296175
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Goiko, M
   Dierolf, J
   Gleberzon, JS
   Liao, YY
   Grohe, B
   Goldberg, HA
   de Bruyn, JR
   Hunter, GK
AF Goiko, Maria
   Dierolf, Joshua
   Gleberzon, Jared S.
   Liao, Yinyin
   Grohe, Bernd
   Goldberg, Harvey A.
   de Bruyn, John R.
   Hunter, Graeme K.
TI Peptides of Matrix Gla Protein Inhibit Nucleation and Growth of
   Hydroxyapatite and Calcium Oxalate Monohydrate Crystals
SO PLOS ONE
LA English
DT Article
ID GAMMA-CARBOXYGLUTAMIC ACID; GENE-EXPRESSION; CALCIFICATION; BONE;
   OSTEOCALCIN; OSTEOPONTIN; HEART; IDENTIFICATION; SPECTROSCOPY;
   POLYMORPHISM
AB Matrix Gla protein (MGP) is a phosphorylated and gamma-carboxylated protein that has been shown to prevent the deposition of hydroxyapatite crystals in the walls of blood vessels. MGP is also expressed in kidney and may inhibit the formation of kidney stones, which mainly consist of another crystalline phase, calcium oxalate monohydrate. To determine the mechanism by which MGP prevents soft-tissue calcification, we have synthesized peptides corresponding to the phosphorylated and gamma-carboxylated sequences of human MGP in both post-translationally modified and non-modified forms. The effects of these peptides on hydroxyapatite formation and calcium oxalate crystallization were quantified using dynamic light scattering and scanning electron microscopy, respectively. Peptides YGlapS (MGP1-14: Y gamma EpSHEpSMEpSYELNP), YEpS (YEpSHEpSMEpSYELNP), YGlaS (Y gamma ESHESMESYELNP) and SK-Gla (MGP43-56: SKPVH gamma ELNR gamma EACDD) inhibited formation of hydroxyapatite in order of potency YGlapS > YEpS > YGlaS > SK-Gla. The effects of YGlapS, YEpS and YGlaS on hydroxyapatite formation were on both crystal nucleation and growth; the effect of SK-Gla was on nucleation. YGlapS and YEpS significantly inhibited the growth of calcium oxalate monohydrate crystals, while simultaneously promoting the formation of calcium oxalate dihydrate. The effects of these phosphopeptides on calcium oxalate monohydrate formation were on growth of crystals rather than nucleation. We have shown that the use of dynamic light scattering allows inhibitors of hydroxyapatite nucleation and growth to be distinguished. We have also demonstrated for the first time that MGP peptides inhibit the formation of calcium oxalate monohydrate. Based on the latter finding, we propose that MGP function not only to prevent blood-vessel calcification but also to inhibit stone formation in kidney.
C1 [Goiko, Maria; de Bruyn, John R.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada.
   [Dierolf, Joshua; Liao, Yinyin; Grohe, Bernd; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Sch Dent, London, ON, Canada.
   [Gleberzon, Jared S.; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Dept Biochem, London, ON, Canada.
RP Hunter, GK (reprint author), Univ Western Ontario, Sch Dent, London, ON, Canada.
EM graeme.hunter@schulich.uwo.ca
RI Goldberg, Harvey/B-5742-2015
FU Canadian Institutes of Health Research; Natural Sciences and Engineering
   Research Council of Canada
FX This work was supported by the Canadian Institutes of Health Research
   and the Natural Sciences and Engineering Research Council of Canada. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Berne B., 1976, DYNAMIC LIGHT SCATTE
   Canfield AE, 2002, J PATHOL, V196, P228, DOI 10.1002/path.1020
   Chan BPH, 2012, COLLOID SURFACE B, V96, P22, DOI 10.1016/j.colsurfb.2012.03.015
   de Bruyn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056764
   Dowd TL, 2003, BIOCHEMISTRY-US, V42, P7769, DOI 10.1021/bi034470s
   Estepa L, 1997, BIOSPECTROSCOPY, V3, P347, DOI 10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-#
   FRASER JD, 1988, J BIOL CHEM, V263, P11033
   Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087
   Gao B, 2007, J UROLOGY, V177, P2361, DOI 10.1016/j.juro.2007.01.118
   Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010
   Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613
   Grohe B, 2011, UROL RES, V39, P327, DOI 10.1007/s00240-010-0360-8
   Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d
   Hackeng TM, 2001, PROTEIN SCI, V10, P864, DOI 10.1110/ps.44701
   HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hunter GK, 2010, LANGMUIR, V26, P18639, DOI 10.1021/la100401r
   Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009
   Koenigsberger E, 2001, PURE APPL CHEM, V73, P785, DOI [10.1351/pac200173050785, DOI 10.1351/PAC200173050785]
   Lu XL, 2012, GENE, V511, P127, DOI 10.1016/j.gene.2012.09.112
   Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0
   O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k
   Oh J, 2004, PROTEOMICS, V4, P3485, DOI 10.1002/pmic.200401018
   PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374
   Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400
   PRICE PA, 1994, PROTEIN SCI, V3, P822
   PRICE PA, 1985, J BIOL CHEM, V260, P4971
   PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7
   Roberto VP, 2009, AQUACULTURE, V294, P202, DOI 10.1016/j.aquaculture.2009.06.020
   Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x
   Taller A, 2007, BIOPHYS J, V93, P1768, DOI 10.1529/biophysj.106.101881
   TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059
   Tyan YC, 2006, ANAL CHIM ACTA, V579, P158, DOI 10.1016/j.aca.2006.07.033
   Ueland T, 2010, J INTERN MED, V268, P483, DOI 10.1111/j.1365-2796.2010.02264.x
   Uvarov V, 2011, ENVIRON GEOCHEM HLTH, V33, P613, DOI 10.1007/s10653-011-9374-6
   Villines TC, 2009, CALCIFIED TISSUE INT, V85, P494, DOI 10.1007/s00223-009-9300-4
   Wang L, 2000, KIDNEY INT, V58, P528, DOI 10.1046/j.1523-1755.2000.00199.x
   Yasui T, 1999, UROL RES, V27, P255, DOI 10.1007/s002400050119
NR 39
TC 16
Z9 16
U1 1
U2 60
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 12
PY 2013
VL 8
IS 11
AR e80344
DI 10.1371/journal.pone.0080344
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255PK
UT WOS:000327252100146
PM 24265810
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jimenez-Lopez, JC
   Rodriguez-Garcia, MI
   Alche, JD
AF Jimenez-Lopez, Jose C.
   Rodriguez-Garcia, Maria I.
   Alche, Juan D.
TI Analysis of the Effects of Polymorphism on Pollen Profilin Structural
   Functionality and the Generation of Conformational, T- and B-Cell
   Epitopes
SO PLOS ONE
LA English
DT Article
ID POLY-L-PROLINE; BET V 1; 3-DIMENSIONAL SOLUTION STRUCTURE; ACTIN-BINDING
   PROTEIN; HIGH-LEVEL EXPRESSION; FOOD ALLERGENS; CROSS-REACTIVITY; MAJOR
   ALLERGEN; ANTIGENIC DETERMINANTS; ESCHERICHIA-COLI
AB An extensive polymorphism analysis of pollen profilin, a fundamental regulator of the actin cytoskeleton dynamics, has been performed with a major focus in 3D-folding maintenance, changes in the 2-D structural elements, surface residues involved in ligands-profilin interactions and functionality, and the generation of conformational and lineal B-and T-cell epitopes variability. Our results revealed that while the general fold is conserved among profilins, substantial structural differences were found, particularly affecting the special distribution and length of different 2-D structural elements (i.e. cysteine residues), characteristic loops and coils, and numerous micro-heterogeneities present in fundamental residues directly involved in the interacting motifs, and to some extension these residues nearby to the ligand-interacting areas. Differential changes as result of polymorphism might contribute to generate functional variability among the plethora of profilin isoforms present in the olive pollen from different genetic background (olive cultivars), and between plant species, since biochemical interacting properties and binding affinities to natural ligands may be affected, particularly the interactions with different actin isoforms and phosphoinositides lipids species. Furthermore, conspicuous variability in lineal and conformational epitopes was found between profilins belonging to the same olive cultivar, and among different cultivars as direct implication of sequences polymorphism. The variability of the residues taking part of IgE-binding epitopes might be the final responsible of the differences in cross-reactivity among olive pollen cultivars, among pollen and plant-derived food allergens, as well as between distantly related pollen species, leading to a variable range of allergy reactions among atopic patients. Identification and analysis of commonly shared and specific epitopes in profilin isoforms is essential to gain knowledge about the interacting surface of these epitopes, and for a better understanding of immune responses, helping design and development of rational and effective immunotherapy strategies for the treatment of allergy diseases.
C1 [Jimenez-Lopez, Jose C.; Rodriguez-Garcia, Maria I.; Alche, Juan D.] High Council Sci Res CSIC, EEZ, Dept Biochem Cell & Mol Biol plants, Granada, Spain.
RP Jimenez-Lopez, JC (reprint author), High Council Sci Res CSIC, EEZ, Dept Biochem Cell & Mol Biol plants, Granada, Spain.
EM josecarlos.jimenez@eez.csic.es; juandedios.alche@eez.csic.es
RI Jimenez-Lopez, Jose C./H-5896-2011; Rodriguez-Garcia, Maria/K-5833-2014;
   De Dios Alche, Juan/K-6079-2014
OI Jimenez-Lopez, Jose C./0000-0002-1470-360X; Rodriguez-Garcia,
   Maria/0000-0002-7664-3235; De Dios Alche, Juan/0000-0002-7547-6025
FU MCINN BFU [2004-00601/BFI]; BFU [2008-00629]; CICE (Junta de Andalucia)
   [P2010-CVI15767, P2010-AGR6274, P2011-CVI-7487]; Spain/Germany MEC
   [HA2004-0094]; Spanish CSIC [I3P-BPD-CSIC]; European Marie Curie
   research program [PIOF-GA-2011-301550];  [BFU2011-22779]
FX This study was supported by the following European Regional Development
   Fund co-financed grants: MCINN BFU 2004-00601/BFI, BFU 2008-00629,
   BFU2011-22779, CICE (Junta de Andalucia) P2010-CVI15767, P2010-AGR6274
   and P2011-CVI-7487, and by the coordinated project Spain/Germany MEC
   HA2004-0094. JCJ-L thanks Spanish CSIC and the European Marie Curie
   research program for his I3P-BPD-CSIC, and PIOF-GA-2011-301550 grants,
   respectively. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x
   Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x
   Arcangeli C, 2008, J STRUCT BIOL, V164, P119, DOI 10.1016/j.jsb.2008.06.013
   ARCHER SJ, 1993, BIOCHEMISTRY-US, V32, P6680, DOI 10.1021/bi00077a022
   Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P427, DOI 10.1067/mai.2003.1611
   Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1
   Asturias JA, 1997, CLIN EXP ALLERGY, V27, P1307, DOI 10.1046/j.1365-2222.1997.1470952.x
   Asturias JA, 2002, INT IMMUNOL, V14, P993, DOI 10.1093/intimm/dxf070
   Babich M, 2005, P W PHARMACOL SOC, V48, P39
   Babich M, 1996, BIOCHEM BIOPH RES CO, V218, P125, DOI 10.1006/bbrc.1996.0022
   Bannon GA, 2006, MOL NUTR FOOD RES, V50, P638, DOI 10.1002/mnfr.200500276
   Behrendt H, 1997, INT ARCH ALLERGY IMM, V113, P69, DOI 10.1159/000237511
   BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8
   BLASCO R, 1991, J VIROL, V65, P4598
   BOND JF, 1991, J IMMUNOL, V146, P3380
   BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x
   Bufe A, 1998, INT ARCH ALLERGY IMM, V117, P215, DOI 10.1159/000024013
   BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106
   Carlos Jimenez-Lopez Jose, 2011, P245
   CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461
   Czaplewski C, 2004, PROTEIN ENG DES SEL, V17, P29, DOI 10.1093/protein/gzh003
   DEEKS MJ, 2002, TRENDS PLANT SCI, V7, P1360
   Fedorov AA, 1997, INT ARCH ALLERGY IMM, V113, P109, DOI 10.1159/000237520
   FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636
   Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599
   Fritsch R, 1998, J ALLERGY CLIN IMMUN, V102, P679, DOI 10.1016/S0091-6749(98)70287-8
   Gao ZS, 2005, THEOR APPL GENET, V110, P479, DOI 10.1007/s00122-004-1856-9
   Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638
   Gibbon BC, 1998, PLANT CELL, V10, P981, DOI 10.1105/tpc.10.6.981
   Haikarainen T, 2009, ACTA CRYSTALLOGR D, V65, P303, DOI 10.1107/S0907444909000699
   Hamman-Khalifa A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-10
   Hauser M., 2008, OPEN IMMUNOL J, V1, P1
   Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1
   Heiss S, 1996, J ALLERGY CLIN IMMUN, V98, P938, DOI 10.1016/S0091-6749(96)80010-8
   HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026
   Jimenez-Lopez JC, 2012, CURRENT INSIGHTS POL, P71
   Jimenez-Lopez JC, 2012, J MOL MODEL, V18, P4965, DOI 10.1007/s00894-012-1492-2
   Jimenez-Lopez JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030878
   Jimenez-Lopez JC, 2012, MOL BIOL REP, V39, P123, DOI 10.1007/s11033-011-0717-2
   Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704
   Kaiser DA, 1999, J CELL SCI, V112, P3779
   Kolaskar AS, 1999, VIROLOGY, V261, P31, DOI 10.1006/viro.1999.9859
   Kovar DR, 2001, BIOCHEM J, V358, P49, DOI 10.1042/0264-6021:3580049
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000
   Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-12
   LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0
   LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P
   Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687
   Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071
   Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z
   Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953
   Meno KH, 2011, ALLERGY, V66, P19, DOI 10.1111/j.1398-9995.2011.02625.x
   METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008
   MITTERMANN I, 1995, PLANT MOL BIOL, V27, P137, DOI 10.1007/BF00019185
   Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318
   Pierce J, 1980, INTRO INFORM THEORY
   Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102
   Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078
   Psaradellis Telly, 2000, Allergology International, V49, P27, DOI 10.1046/j.1440-1592.2000.00155.x
   Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x
   Rothkegel M, 1996, J CELL SCI, V109, P83
   Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001
   Schimek EM, 2005, J ALLERGY CLIN IMMUN, V116, P1327, DOI 10.1016/j.jaci.2005.09.007
   Schluter K, 1998, J CELL SCI, V111, P3261
   Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0
   Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08
   SILVANOVICH A, 1991, J BIOL CHEM, V266, P1204
   Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7
   Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013
   STAIGER CJ, 1993, PLANT J, V4, P631, DOI 10.1046/j.1365-313X.1993.04040631.x
   Tanabe S, 2004, J NUTR SCI VITAMINOL, V50, P367
   Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9
   THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x
   VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377
   VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985
   VALENTA R, 1994, BIOCHEM BIOPH RES CO, V199, P106, DOI 10.1006/bbrc.1994.1201
   Valenta Rudolf, 1996, P269
   VALLIER P, 1995, CLIN EXP ALLERGY, V25, P332
   Vieira T, 2012, ALLERGOL IMMUNOPATH, V40, P172, DOI 10.1016/j.aller.2011.03.013
   Vieths S, 2002, ANN NY ACAD SCI, V964, P47
   VINSON VK, 1993, J CELL BIOL, V122, P1277, DOI 10.1083/jcb.122.6.1277
   Vrtala S, 1996, BIOCHEM BIOPH RES CO, V226, P42, DOI 10.1006/bbrc.1996.1309
   WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4
   WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0
   Wilkies DE, 2003, J EUKARYOT MICROBIOL, V50, P252, DOI 10.1111/j.1550-7408.2003.tb00130.x
   Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498
   Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188
   Wopfner N, 2002, BIOL CHEM, V383, P1779, DOI 10.1515/BC.2002.199
   Wu ST, 2010, STRUCTURE, V18, P858, DOI 10.1016/j.str.2010.04.007
   ZHU XJ, 1995, J IMMUNOL, V155, P5064
   Zienkiewicz K., 2012, CURRENT INSIGHTS POL, P41
NR 98
TC 12
Z9 129
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 17
PY 2013
VL 8
IS 10
AR e76066
DI 10.1371/journal.pone.0076066
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 239KL
UT WOS:000326022200009
PM 24146818
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xiao, X
   Min, JL
   Wang, P
   Chou, KC
AF Xiao, Xuan
   Min, Jian-Liang
   Wang, Pu
   Chou, Kuo-Chen
TI iGPCR-Drug: A Web Server for Predicting Interaction between GPCRs and
   Drugs in Cellular Networking
SO PLOS ONE
LA English
DT Article
ID AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; TARGET INTERACTION
   NETWORKS; SUPPORT VECTOR MACHINE; GENERAL-FORM; CHOUS PSEAAC;
   PHYSICOCHEMICAL PROPERTIES; SUBCELLULAR-LOCALIZATION; COUPLED RECEPTORS;
   TERTIARY STRUCTURE
AB Involved in many diseases such as cancer, diabetes, neurodegenerative, inflammatory and respiratory disorders, G-protein-coupled receptors (GPCRs) are among the most frequent targets of therapeutic drugs. It is time-consuming and expensive to determine whether a drug and a GPCR are to interact with each other in a cellular network purely by means of experimental techniques. Although some computational methods were developed in this regard based on the knowledge of the 3D (dimensional) structure of protein, unfortunately their usage is quite limited because the 3D structures for most GPCRs are still unknown. To overcome the situation, a sequence-based classifier, called "iGPCR-drug", was developed to predict the interactions between GPCRs and drugs in cellular networking. In the predictor, the drug compound is formulated by a 2D (dimensional) fingerprint via a 256D vector, GPCR by the PseAAC (pseudo amino acid composition) generated with the grey model theory, and the prediction engine is operated by the fuzzy K-nearest neighbour algorithm. Moreover, a user-friendly web-server for iGPCR-drug was established at http://www.jci-bioinfo.cn/iGPCR-Drug/. For the convenience of most experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated math equations presented in this paper just for its integrity. The overall success rate achieved by iGPCR-drug via the jackknife test was 85.5%, which is remarkably higher than the rate by the existing peer method developed in 2010 although no web server was ever established for it. It is anticipated that iGPCR-Drug may become a useful high throughput tool for both basic research and drug development, and that the approach presented here can also be extended to study other drug - target interaction networks.
C1 [Xiao, Xuan; Min, Jian-Liang; Wang, Pu] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.
   [Xiao, Xuan] ZheJiang Text & Fash Coll, Informat Sch, Ningbo, Zhejiang, Peoples R China.
   [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia.
   [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, Belmont, MA USA.
RP Xiao, X (reprint author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.
EM xxiao@gordonlifescience.org
RI Chou, Kuo-Chen/A-8340-2009
FU National Natural Science Foundation of China [60961003, 31260273];
   Chinese Ministry of Education [210116]; Province National Natural
   Science Foundation of JiangXi [2010GZS0122, 20114BAB211013,
   20122BAB201020]; Department of Education of JiangXi Province [GJJ12490];
   Jiangxi Provincial Foreign Scientific and Technological Cooperation
   Project [20120BDH80023]; JiangXi Provincial Foundation for Leaders of
   Disciplines in Science [20113BCB22008]
FX This work was supported by the grants from the National Natural Science
   Foundation of China (60961003 and 31260273), the Key Project of Chinese
   Ministry of Education (210116), the Province National Natural Science
   Foundation of JiangXi (2010GZS0122, 20114BAB211013 and 20122BAB201020),
   the Department of Education of JiangXi Province (GJJ12490), the Jiangxi
   Provincial Foreign Scientific and Technological Cooperation Project
   (20120BDH80023), and the JiangXi Provincial Foundation for Leaders of
   Disciplines in Science (20113BCB22008). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1
   Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257
   Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381
   Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044
   Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943
   Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072
   Chang TH, 2013, J COMPUT AID MOL DES, V27, P91, DOI 10.1007/s10822-012-9628-0
   Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450
   Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843
   Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033
   Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1
   Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a
   Chou KC, 2005, J PROTEOME RES, V4, P1657, DOI 10.1021/pr050135+
   Chou KC, 2005, J PROTEOME RES, V4, P1413, DOI 10.1021/pr050087t
   Chou KC, 2005, BIOCHEM BIOPH RES CO, V331, P56, DOI 10.1016/j.bbrc.2005.03.123
   Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q
   Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667
   CHOU KC, 1995, FEBS LETT, V363, P127, DOI 10.1016/0014-5793(95)00245-5
   Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X
   Chou KC, 2002, BIOCHEM BIOPH RES CO, V292, P702, DOI 10.1006/bbrc.2002.6686
   CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488
   CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406
   CHOU KC, 1994, J BIOL CHEM, V269, P22014
   Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035
   Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006
   Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g
   Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024
   Deng Julong, 1989, Journal of Grey Systems, V1, P1
   Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811
   Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015
   Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011
   Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016
   Finn P, 1998, MACH LEARN, V30, P241, DOI 10.1023/A:1007460424845
   Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003
   Gillet VJ, 2003, J CHEM INF COMP SCI, V43, P338, DOI 10.1021/ci025592e
   Gregori-Puigjane E, 2011, J COMPUT CHEM, V32, P2638, DOI 10.1002/jcc.21843
   Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03
   Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387
   He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603
   Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Huang C, 2013, J MEMBRANE BIOL, V246, P327, DOI 10.1007/s00232-013-9536-9
   Jiang Y, 2013, BIOMED RES INT, DOI 10.1155/2013/287019
   Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361
   Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426
   Khosravian M, 2013, PROTEIN PEPTIDE LETT, V20, P180, DOI 10.2174/092986613804725307
   Knowles J, 2003, NAT REV DRUG DISCOV, V2, P63, DOI 10.1038/nrd986
   Laurent S, 2006, CONTRAST MEDIA MOL I, V1, P128, DOI 10.1002/cmmi.100
   Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393
   Lin S.X., 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054
   Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f
   Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040
   Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756
   Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057
   Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403
   Maggiora GM, 1996, NEURAL NETWORKS QSAR, P255
   Mahalanobis P. C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302
   Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0
   Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341
   Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017
   Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564
   Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4
   NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454
   Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1
   Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283
   Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199
   Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477
   Ren BY, 2002, COMPUT CHEM, V26, P357, DOI 10.1016/S0097-8485(01)00128-0
   Roterman I, 2011, J THEOR BIOL, V283, P60, DOI 10.1016/j.jtbi.2011.05.027
   Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002
   Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531
   Shen H. B., 2010, NAT SCI, V2, P1090, DOI DOI 10.4236/NS.2010.210136
   Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128
   Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012
   Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016
   Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003
   Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e
   TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009
   Voet D, 1995, BIOCHEMISTRY
   Vogt I, 2007, CHEM BIOL DRUG DES, V70, P195, DOI 10.1111/j.1747.0285.2007.0055.x
   Wan SB, 2013, J THEOR BIOL, V323, P40, DOI 10.1016/j.jtbi.2013.01.012
   Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707
   Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505
   WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X
   Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955
   Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293
   Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869
   Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h
   Xiao XA, 2011, MOL DIVERS, V15, P149, DOI 10.1007/s11030-010-9227-8
   Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044
   Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844
   Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162
   Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176
   ZHANG CT, 1995, PROTEIN ENG, V8, P425, DOI 10.1093/protein/8.5.425
   Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9
   Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141
   Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890
   Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616
NR 103
TC 73
Z9 74
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 27
PY 2013
VL 8
IS 8
AR e72234
DI 10.1371/journal.pone.0072234
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 210FR
UT WOS:000323815200031
PM 24015221
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Borley, DW
   Mahapatra, M
   Paton, DJ
   Esnouf, RM
   Stuart, DI
   Fry, EE
AF Borley, Daryl W.
   Mahapatra, Mana
   Paton, David J.
   Esnouf, Robert M.
   Stuart, David I.
   Fry, Elizabeth E.
TI Evaluation and Use of In-Silico Structure-Based Epitope Prediction with
   Foot-and-Mouth Disease Virus
SO PLOS ONE
LA English
DT Article
ID NEUTRALIZING ANTIGENIC SITES; AMINO-ACID SUBSTITUTIONS; B-CELL EPITOPES;
   MONOCLONAL-ANTIBODIES; HUMAN RHINOVIRUS-14; 3-DIMENSIONAL STRUCTURE;
   POLIOVIRUS TYPE-1; CAPSID PROTEINS; SEROTYPE; IDENTIFICATION
AB Understanding virus antigenicity is of fundamental importance for the development of better, more cross-reactive vaccines. However, as far as we are aware, no systematic work has yet been conducted using the 3D structure of a virus to identify novel epitopes. Therefore we have extended several existing structural prediction algorithms to build a method for identifying epitopes on the appropriate outer surface of intact virus capsids (which are structurally different from globular proteins in both shape and arrangement of multiple repeated elements) and applied it here as a proof of principle concept to the capsid of foot-and-mouth disease virus (FMDV). We have analysed how reliably several freely available structure-based B cell epitope prediction programs can identify already known viral epitopes of FMDV in the context of the viral capsid. To do this we constructed a simple objective metric to measure the sensitivity and discrimination of such algorithms. After optimising the parameters for five methods using an independent training set we used this measure to evaluate the methods. Individually any one algorithm performed rather poorly (three performing better than the other two) suggesting that there may be value in developing virus-specific software. Taking a very conservative approach requiring a consensus between all three top methods predicts a number of previously described antigenic residues as potential epitopes on more than one serotype of FMDV, consistent with experimental results. The consensus results identified novel residues as potential epitopes on more than one serotype. These include residues 190-192 of VP2 (not previously determined to be antigenic), residues 69-71 and 193-197 of VP3 spanning the pentamer-pentamer interface, and another region incorporating residues 83, 84 and 169-174 of VP1 (all only previously experimentally defined on serotype A). The computer programs needed to create a semi-automated procedure for carrying out this epitope prediction method are presented.
C1 [Borley, Daryl W.; Mahapatra, Mana; Paton, David J.] Pirbright Inst, Pirbright, England.
   [Borley, Daryl W.; Esnouf, Robert M.; Stuart, David I.; Fry, Elizabeth E.] Univ Oxford, Div Struct Biol, Oxford, England.
   [Stuart, David I.] Diamond Light Source, Harwell, Berks, England.
RP Borley, DW (reprint author), Pirbright Inst, Pirbright, England.
EM daryl.borley@pirbright.ac.uk; liz@strubi.ox.ac.uk
OI Stuart, David/0000-0002-3426-4210; Fry, Elizabeth/0000-0001-9754-5303
FU Biotechnology and Biological Sciences Research Council UK
   [BB/G529532/1]; Medical Research Council; Wellcome Trust Core Award
   Grant [090532/Z/09/Z]; Medical Research Council [G1100525, G1000099]
FX The work performed at the Institute for Animal Health is supported by
   the Biotechnology and Biological Sciences Research Council UK (Grant
   number BB/G529532/1). The work performed at Oxford is supported by the
   Medical Research Council and by Wellcome Trust Core Award Grant Number
   090532/Z/09/Z. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0
   Aktas S, 2000, REV SCI TECH OIE, V19, P744, DOI 10.20506/rst.19.3.1244
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   ARNOLD E, 1988, ACTA CRYSTALLOGR A, V44, P270, DOI 10.1107/S0108767387011875
   Barnett PV, 1998, J GEN VIROL, V79, P1687, DOI 10.1099/0022-1317-79-7-1687
   BAXT B, 1989, J VIROL, V63, P2143
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   Brehm KE, 2008, VACCINE, V26, P1681, DOI 10.1016/j.vaccine.2008.01.038
   Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669
   CROWTHER JR, 1993, EPIDEMIOL INFECT, V111, P391, DOI 10.1017/S0950268800057083
   CROWTHER JR, 1993, J GEN VIROL, V74, P1547, DOI 10.1099/0022-1317-74-8-1547
   DIAMOND DC, 1985, SCIENCE, V229, P1090, DOI 10.1126/science.2412292
   DIEZ J, 1990, J VIROL, V64, P5519
   Dunn CS, 1998, VIROLOGY, V247, P51, DOI 10.1006/viro.1998.9175
   FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625
   Fry E, 1990, SEMIN VIROL, V1, P439
   Fry EE, 2005, J GEN VIROL, V86, P1909, DOI 10.1099/vir.0.80730-0
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Grazioli S, 2004, SESS RES GP STAND TE, P277
   Grazioli S., 2006, SESS RES FOOT MOUTH, P287
   Hewat EA, 1997, EMBO J, V16, P1492, DOI 10.1093/emboj/16.7.1492
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181
   Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08
   KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W
   Kleywegt GJ, 2001, INT TABLES CRYSTALLO, V353-356, P366
   Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9
   LEA S, 1995, STRUCTURE, V3, P571, DOI 10.1016/S0969-2126(01)00191-5
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0
   Mahapatra M, 2008, VET MICROBIOL, V126, P40, DOI 10.1016/j.vetmic.2007.06.022
   Mahapatra M, 2011, VET MICROBIOL, V149, P242, DOI 10.1016/j.vetmic.2010.11.003
   Maree FF, 2011, J GEN VIROL, V92, P2297, DOI 10.1099/vir.0.032839-0
   MATEU MG, 1994, J VIROL, V68, P1407
   MATEU MG, 1990, J GEN VIROL, V71, P629, DOI 10.1099/0022-1317-71-3-629
   Miller ST, 2001, J MOL BIOL, V307, P499, DOI 10.1006/jmbi.2001.4485
   MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283
   MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121
   MINOR PD, 1983, NATURE, V301, P674, DOI 10.1038/301674a0
   MINOR PD, 1986, MICROBIOL SCI, V3, P141
   Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602
   PAGE GS, 1988, J VIROL, V62, P1781
   Paton DJ, 2010, VET REC, V166, P569, DOI 10.1136/vr.c2300
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Reeve R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001027
   RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   SAIZ JC, 1989, VIRUS RES, V13, P45, DOI 10.1016/0168-1702(89)90086-5
   SAIZ JC, 1991, J VIROL, V65, P2518
   SHERRY B, 1986, J VIROL, V57, P246
   SHERRY B, 1985, J VIROL, V53, P137
   STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9
   Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   THOMAS AAM, 1988, J VIROL, V62, P2782
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Valdazo-Gonzalez B, 2011, VET REC, V168, P247, DOI 10.1136/vr.d1352
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   WIEGERS K, 1989, VIROLOGY, V170, P583, DOI 10.1016/0042-6822(89)90452-2
   Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013
   Yang M, 2007, VET IMMUNOL IMMUNOP, V115, P126, DOI 10.1016/j.vetimm.2006.10.002
   Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602
NR 65
TC 18
Z9 20
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2013
VL 8
IS 5
AR e61122
DI 10.1371/journal.pone.0061122
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 154EP
UT WOS:000319654700009
PM 23667434
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stamm, M
   Staritzbichler, R
   Khafizov, K
   Forrest, LR
AF Stamm, Marcus
   Staritzbichler, Rene
   Khafizov, Kamil
   Forrest, Lucy R.
TI Alignment of Helical Membrane Protein Sequences Using AlignMe
SO PLOS ONE
LA English
DT Article
ID HYDROPATHY PROFILE ALIGNMENT; ACID SUBSTITUTION MATRICES; REMOTE
   HOMOLOGY DETECTION; TRANSMEMBRANE PROTEINS; DATA-BANK; HYDROPHOBICITY
   SCALE; STRUCTURE PREDICTION; SECONDARY STRUCTURE; SCORING MATRICES; GAP
   PENALTIES
AB Few sequence alignment methods have been designed specifically for integral membrane proteins, even though these important proteins have distinct evolutionary and structural properties that might affect their alignments. Existing approaches typically consider membrane-related information either by using membrane-specific substitution matrices or by assigning distinct penalties for gap creation in transmembrane and non-transmembrane regions. Here, we ask whether favoring matching of predicted transmembrane segments within a standard dynamic programming algorithm can improve the accuracy of pairwise membrane protein sequence alignments. We tested various strategies using a specifically designed program called AlignMe. An updated set of homologous membrane protein structures, called HOMEP2, was used as a reference for optimizing the gap penalties. The best of the membrane-protein optimized approaches were then tested on an independent reference set of membrane protein sequence alignments from the BAliBASE collection. When secondary structure (S) matching was combined with evolutionary information (using a position-specific substitution matrix (P)), in an approach we called AlignMePS, the resultant pairwise alignments were typically among the most accurate over a broad range of sequence similarities when compared to available methods. Matching transmembrane predictions (T), in addition to evolutionary information, and secondary-structure predictions, in an approach called AlignMePST, generally reduces the accuracy of the alignments of closely-related proteins in the BAliBASE set relative to AlignMePS, but may be useful in cases of extremely distantly related proteins for which sequence information is less informative. The open source AlignMe code is available at https://sourceforge.net/projects/alignme/, and at http://www.forrestlab.org, along with an online server and the HOMEP2 data set.
C1 [Stamm, Marcus; Staritzbichler, Rene; Khafizov, Kamil; Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, Frankfurt, Germany.
RP Forrest, LR (reprint author), Max Planck Inst Biophys, Computat Struct Biol Grp, Frankfurt, Germany.
EM lucy.forrest@biophys.mpg.de
RI Khafizov, Kamil/E-5368-2011; Forrest, Lucy/E-8113-2016
OI Forrest, Lucy/0000-0003-1855-7985
FU German Research Foundation (DFG) Collaborative Research Center 807
FX This study was supported by the German Research Foundation (DFG;
   www.dfg.de/en) Collaborative Research Center 807 "Transport and
   Communication across Biological Membranes". The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3
   Bahr A, 2001, NUCLEIC ACIDS RES, V29, P323, DOI 10.1093/nar/29.1.323
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Bernsel A, 2008, PROTEINS, V71, P1387, DOI 10.1002/prot.21825
   Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1
   Cline M, 2002, BIOINFORMATICS, V18, P306, DOI 10.1093/bioinformatics/18.2.306
   Dayhoff M.O., 1978, MODEL EVOLUTIONARY C
   Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705
   Dong E, 2008, GENE, V422, P41, DOI 10.1016/j.gene.2008.06.006
   Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196
   Edgar RC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-396
   EISENBERG D, 1982, FARADAY SYMP CHEM S, P109
   ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541
   Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499
   Hill JR, 2011, BIOINFORMATICS, V27, pI15, DOI 10.1093/bioinformatics/btr230
   Hill JR, 2012, BIOINFORMATICS
   Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227
   Jimenez-Morales D, 2008, IEEE ENG MED BIO, P1347, DOI 10.1109/IEMBS.2008.4649414
   JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kauko A, 2008, J MOL BIOL, V380, P170, DOI 10.1016/j.jmb.2008.04.052
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x
   Koehler J, 2009, PROTEINS, V76, P13, DOI 10.1002/prot.22315
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338
   Lolkema JS, 2005, MOL MEMBR BIOL, V22, P177, DOI 10.1080/09687860500063324
   Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516
   Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100
   Muller T, 2002, MOL BIOL EVOL, V19, P8, DOI 10.1093/oxfordjournals.molbev.a003985
   Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918
   MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159
   Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   Nugent T, 2009, BMC BIOINFORMATICS, V10, P1
   Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2
   Pedersen J, 1998, PROTEINS, V29, P2
   Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X
   Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636
   Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47
   Remmert M, 2011, NAT METHODS
   ROSE GD, 1978, NATURE, V272, P586, DOI 10.1038/272586a0
   Saigo H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-246
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Shafrir Y, 2004, BIOINFORMATICS, V20, P758, DOI 10.1093/bioinformatics/btg482
   Shu NJ, 2011, BIOINFORMATICS, V27, P1702, DOI 10.1093/bioinformatics/btr235
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Tang CL, 2003, J MOL BIOL, V334, P1043, DOI 10.1016/j.jmb.2003.10.025
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002
   Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340
   Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221
   White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]
   WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269
   Wimley C., 1996, NAT STRUCT BIOL, V3, P842
   Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
NR 72
TC 32
Z9 32
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 4
PY 2013
VL 8
IS 3
AR e57731
DI 10.1371/journal.pone.0057731
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 099PY
UT WOS:000315634900038
PM 23469223
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhao, SH
   Zhou, Y
   Wang, CH
   Yang, Y
   Wu, XB
   Wei, Y
   Zhu, L
   Zhao, W
   Zhang, QW
   Wan, CS
AF Zhao, Suhui
   Zhou, Ying
   Wang, Chunhui
   Yang, Yu
   Wu, Xianbo
   Wei, Yao
   Zhu, Li
   Zhao, Wei
   Zhang, Qiwei
   Wan, Chengsong
TI The N-Terminal Domain of EspF Induces Host Cell Apoptosis after
   Infection with Enterohaemorrhagic Escherichia coli O157:H7
SO PLOS ONE
LA English
DT Article
ID EFFECTOR; PROTEIN; MITOCHONDRIA; OPERON
AB Enterohemorrhagic Escherichia coli (EHEC) employs a type III secretion system (TTSS) to export the translocator and effector proteins required for mucosal colonization. As an important bacterial effector protein in locus of enterocyte effacement four, the EspF protein causes F-actin filament aggregations to form attaching and effacing (A/E) lesions, and induces the destruction of brush-border microvilli and cytoskeletal rearrangements to form pedestals. However, the molecular pathogenesis of A/E lesions due to EHEC O157:H7 infection is unclear. In this study, we constructed an espF-deficient mutant (Delta espF) with a 162-bp deletion in the N-terminal domain by using overlap extension PCR. The results showed that EHEC EspF translocated into intestinal epithelial cells, targeted mitochondria and induced apoptosis. The Delta espF mutant, compared to EHEC prototype Guangzhou strain, had lower cell attachment and effacement abilities, lower caspase-9/3 and lactate dehydrogenase levels, lower bacterial adhesion, weaker mitochondria apoptosis, and a higher mouse survival rate. Our results demonstrate the probable function of the EspF N-terminal domain, which targets mitochondria and binds mitochondria heat shock protein 70 to induce cell apoptosis via A/E lesions. These findings may be invaluable in clarifying the molecular pathogenesis of EspF of EHEC O157:H7.
C1 [Zhao, Suhui; Zhou, Ying; Wang, Chunhui; Yang, Yu; Wu, Xianbo; Wei, Yao; Zhu, Li; Zhao, Wei; Zhang, Qiwei; Wan, Chengsong] So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.
RP Zhang, QW (reprint author), So Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.
EM zhang.qiwei@yahoo.com; gzwcs@126.com
RI Zhang, Qiwei/D-9110-2012
OI Zhang, Qiwei/0000-0002-2770-111X
FU Natural Science Foundation of Guangdong Province project
   [2010B031000005]; Guangdong Province 211 project [GWXY2010]
FX This study was supported by the Natural Science Foundation of Guangdong
   Province project (2010B031000005) and Guangdong Province 211 project
   (GWXY2010). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aitio O, 2012, STRUCTURE
   ALJUMAILI I, 1992, FEMS MICROBIOL LETT, V93, P121
   Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x
   Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021
   Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005
   Campellone KG, 2012, J BIOL CHEM, V287, P20613, DOI 10.1074/jbc.M112.363473
   Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x
   Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103
   Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961
   Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006
   EMINI EA, 1985, J VIROL, V55, P836
   FUJII J, 1994, INFECT IMMUN, V62, P3447
   Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005
   Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x
   Kenny B, 2009, CURR OPIN MICROBIOL, V12, P1, DOI 10.1016/j.mib.2009.01.002
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lodato PB, 2009, MOL MICROBIOL, V71, P273, DOI 10.1111/j.1365-2958.2008.06530.x
   MACLEOD DL, 1989, CAN J MICROBIOL, V35, P623, DOI 10.1139/m89-100
   Marches O, 2006, J BACTERIOL, V188, P3110, DOI 10.1128/JB.188.8.3110-3115.2006
   Mayer BJ, 2001, J CELL SCI, V114, P1253
   McNamara BP, 1998, FEMS MICROBIOL LETT, V166, P71, DOI 10.1016/S0378-1097(98)00313-9
   McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138
   Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142
   Ni XiaoPing, 2002, Chinese Journal of Zoonoses, V18, P74
   Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x
   Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2006.00680.x
   Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739
   RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203
   Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003
   Viswanathan VK, 2004, CELL MICROBIOL, V6, P987, DOI 10.1111/j.1462-5822.2004.00416.x
   Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004
   WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438
   Weflen AW, 2010, CELL MICROBIOL, V12, P919, DOI 10.1111/j.1462-5822.2010.01440.x
   WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049
   [苑丽霞 YUAN Lixia], 2008, [山西农业科学, Journal of Shanxi Agricultural Sciences], V36, P15
   Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200
NR 41
TC 10
Z9 13
U1 1
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2013
VL 8
IS 1
AR e55164
DI 10.1371/journal.pone.0055164
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 093RV
UT WOS:000315210400071
PM 23372831
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hjelm, B
   Forsstrom, B
   Lofblom, J
   Rockberg, J
   Uhlen, M
AF Hjelm, Barbara
   Forsstrom, Bjorn
   Lofblom, John
   Rockberg, Johan
   Uhlen, Mathias
TI Parallel Immunizations of Rabbits Using the Same Antigen Yield
   Antibodies with Similar, but Not Identical, Epitopes
SO PLOS ONE
LA English
DT Article
ID AFFINITY REAGENTS; HUMAN PROTEOME; AMINO-ACID; PREDICTION; DISPLAY;
   GENERATION; PEPTIDE; ATLAS; MODEL
AB A problem for the generation of polyclonal antibodies is the potential difficulties for obtaining a renewable resource due to batch-to-batch variations when the same antigen is immunized into several separate animals. Here, we have investigated this issue by determining the epitopes of antibodies generated from parallel immunizations of rabbits with recombinant antigens corresponding to ten human protein targets. The epitopes were mapped by both a suspension bead array approach using overlapping synthetic 15-mer peptides and a bacterial display approach using expression of random fragments of the antigen on the surface of bacteria. Both methods determined antibody binding with the aid of fluorescent-based analysis. In addition, one polyclonal antibody was fractionated by peptide-specific affinity capture for in-depth comparison of epitopes. The results show that the same antigen immunized in several rabbits yields polyclonal antibodies with similar epitopes, but with larger differences in the relative amounts of antibodies to the different epitopes. In some cases, unique epitopes were observed for one of the immunizations. The results suggest that polyclonal antibodies generated by repeated immunizations do not display an identical epitope pattern, although many of the epitopes are similar.
C1 [Hjelm, Barbara; Forsstrom, Bjorn; Lofblom, John; Rockberg, Johan; Uhlen, Mathias] Royal Inst Technol, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden.
   [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
RP Uhlen, M (reprint author), Royal Inst Technol, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden.
EM mathias.uhlen@scilifelab.se
RI Uhlen, Mathias/B-3262-2016
OI Uhlen, Mathias/0000-0002-4858-8056
FU Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA
   ProNova center grant
FX This work was supported by grants from the Knut and Alice Wallenberg
   Foundation, Swedish Research Council and the VINNOVA ProNova center
   grant. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800
   Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/nmeth.1607, 10.1038/NMETH.1607]
   Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a
   FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X
   GEYSEN HM, 1987, SCIENCE, V235, P1184, DOI 10.1126/science.3823878
   GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998
   Gloriam DE, 2010, MOL CELL PROTEOMICS, V9, P1, DOI 10.1074/mcp.M900185-MCP200
   Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004
   Hjelm B, 2011, PROTEIN SCI, V20, P1824, DOI 10.1002/pro.716
   Hjelm B, 2010, NEW BIOTECHNOL, V27, P129, DOI 10.1016/j.nbt.2009.11.001
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   John SH, 2006, DRUG DISCOV TODAY, V11, P655
   Kiermer V, 2008, NAT METHODS, V5, P860, DOI 10.1038/nmeth1008-860
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Larsson K, 2009, J IMMUNOL METHODS, V342, P20, DOI 10.1016/j.jim.2008.11.013
   Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x
   Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002
   Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072
   Partidos CD, 1997, J GEN VIROL, V78, P3227, DOI 10.1099/0022-1317-78-12-3227
   Petersen G, 1995, MOL GEN GENET, V249, P425
   Rockberg J, 2009, PROTEIN SCI, V18, P2346, DOI 10.1002/pro.245
   Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272
   Ton L, 2007, TRENDS BIOTECHNOL, V25, P390
   Uhlen M, 2008, NAT METHODS, V5, P854, DOI 10.1038/nmeth1008-854
   Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248
   WANG LF, 1995, J IMMUNOL METHODS, V178, P1, DOI 10.1016/0022-1759(94)00235-O
NR 28
TC 9
Z9 9
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 19
PY 2012
VL 7
IS 12
AR e45817
DI 10.1371/journal.pone.0045817
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 059HF
UT WOS:000312694300002
PM 23284606
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Carmona, SJ
   Sartor, PA
   Leguizamon, MS
   Campetella, OE
   Aguero, F
AF Carmona, Santiago J.
   Sartor, Paula A.
   Leguizamon, Maria S.
   Campetella, Oscar E.
   Agueero, Fernan
TI Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic
   Markers Using Multiple Features
SO PLOS ONE
LA English
DT Article
ID B-CELL EPITOPES; TRYPANOSOMA-CRUZI; TANDEM REPEATS; CHAGAS-DISEASE;
   ANTIGENIC DETERMINANTS; ENHANCE IMMUNOGENICITY; ORTHOLOG GROUPS;
   ACUTE-PHASE; PROTEIN; PREDICTION
AB The availability of complete pathogen genomes has renewed interest in the development of diagnostics for infectious diseases. Synthetic peptide microarrays provide a rapid, high-throughput platform for immunological testing of potential B-cell epitopes. However, their current capacity prevent the experimental screening of complete "peptidomes". Therefore, computational approaches for prediction and/or prioritization of diagnostically relevant peptides are required. In this work we describe a computational method to assess a defined set of molecular properties for each potential diagnostic target in a reference genome. Properties such as sub-cellular localization or expression level were evaluated for the whole protein. At a higher resolution (short peptides), we assessed a set of local properties, such as repetitive motifs, disorder (structured vs natively unstructured regions), trans-membrane spans, genetic polymorphisms (conserved vs. divergent regions), predicted B-cell epitopes, and sequence similarity against human proteins and other potential cross-reacting species (e.g. other pathogens endemic in overlapping geographical locations). A scoring function based on these different features was developed, and used to rank all peptides from a large eukaryotic pathogen proteome. We applied this method to the identification of candidate diagnostic peptides in the protozoan Trypanosoma cruzi, the causative agent of Chagas disease. We measured the performance of the method by analyzing the enrichment of validated antigens in the high-scoring top of the ranking. Based on this measure, our integrative method outperformed alternative prioritizations based on individual properties (such as B-cell epitope predictors alone). Using this method we ranked similar to 10 million 12-mer overlapping peptides derived from the complete T. cruzi proteome. Experimental screening of 190 high-scoring peptides allowed the identification of 37 novel epitopes with diagnostic potential, while none of the low scoring peptides showed significant reactivity. Many of the metrics employed are dependent on standard bioinformatic tools and data, so the method can be easily extended to other pathogen genomes. Citation: Carmona SJ, Sartor PA, Leguizamon MS, Campetella OE, Aguero F (2012) Diagnostic Peptide Discovery: Prioritization of Pathogen Diagnostic Markers Using Multiple Features. PLoS ONE 7(12): e50748. doi:10.1371/journal.pone.0050748
C1 [Carmona, Santiago J.; Leguizamon, Maria S.; Campetella, Oscar E.; Agueero, Fernan] Univ Nacl San Martin, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Consejo Invest Cientif & Tecn UNSAM CONICET, San Martin, Buenos Aires, Argentina.
   [Sartor, Paula A.; Leguizamon, Maria S.] Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med, Buenos Aires, DF, Argentina.
RP Aguero, F (reprint author), Univ Nacl San Martin, Inst Tecnol Chascomus IIB INTECH, Inst Invest Biotecnol, Consejo Invest Cientif & Tecn UNSAM CONICET, San Martin, Buenos Aires, Argentina.
EM fernan@unsam.edu.ar
RI Aguero, Fernan/F-5606-2013; Carmona, Santiago J/E-9356-2015
OI Aguero, Fernan/0000-0003-1331-5741; Carmona, Santiago
   J/0000-0002-2495-0671; Campetella, Oscar/0000-0002-7018-375X
FU University of San Martin [PROG07F/1]; Special Programme for Research and
   Training in Tropical Diseases (WHO/World Bank/UNDP/UNICEF)
FX This work was supported by grants from the University of San Martin
   (PROG07F/1) to Dr. Campetella and Dr. Aguero, and the Special Programme
   for Research and Training in Tropical Diseases (WHO/World
   Bank/UNDP/UNICEF) to Dr. Aguero. Dr. Carmona and Dr. Sartor are fellows
   of the National Research Council of Argentina (CONICET). Dr. Leguizamon,
   Dr. Campetella, and Dr. Aguero are members of the Research Career of
   CONICET. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ackermann AA, 2009, NUCLEIC ACIDS RES, V37, pD544, DOI 10.1093/nar/gkn874
   AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9
   Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1
   Alvarez P, 2001, INFECT IMMUN, V69, P7946, DOI 10.1128/IAI.69.12.7946-7949.2001
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Andresen Heiko, 2009, V509, P123, DOI 10.1007/978-1-59745-372-1_8
   Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239
   BUSCHIAZZO A, 1992, MOL BIOCHEM PARASIT, V54, P125, DOI 10.1016/0166-6851(92)90105-S
   CAZZULO JJ, 1992, FASEB J, V6, P3259
   Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123
   Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881
   Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316
   Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102
   Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071
   FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x
   Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840
   Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Horn D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-2
   Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723
   Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151
   Kanduc D, 2010, SELF NONSELF, V1, P255
   Kjerrulf M, 1997, MOL IMMUNOL, V34, P599, DOI 10.1016/S0161-5890(97)00078-3
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   KRONEGG J, 1999, DETECTION PREDICTION
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503
   Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771
   Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032
   Ludin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017546
   Maksimov P, 2012, CLIN VACCINE IMMUNOL, V19, P865, DOI 10.1128/CVI.00119-12
   Mollick Joseph A, 2003, Cancer Immun, V3, P3
   Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602
   PEARSON WR, 1990, METHOD ENZYMOL, V183, P63
   Peeling RW, 2011, INFECT DIS CLIN N AM, V25, P693, DOI 10.1016/j.idc.2011.06.002
   PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A
   PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176
   Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723
   Pereira CM, 1998, FEMS MICROBIOL LETT, V164, P125, DOI 10.1016/S0378-1097(98)00200-6
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075
   Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911
   Torres D, 2006, INFECT IMMUN, V74, P4932, DOI 10.1128/IAI.00442-06
   Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4
   Vanniasinkam T, 2001, J CLIN MICROBIOL, V39, P1633, DOI 10.1128/JCM.39.4.1633-1637.2001
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21
   WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2
   Yankai Z, 2006, BIOCHEM BIOPH RES CO, V345, P1365, DOI 10.1016/j.bbrc.2006.05.022
   ZHENG BJ, 1993, VACCINE, V11, P1191, DOI 10.1016/0264-410X(93)90042-V
NR 63
TC 19
Z9 19
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2012
VL 7
IS 12
AR e50748
DI 10.1371/journal.pone.0050748
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 055AJ
UT WOS:000312386800015
PM 23272069
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kawabe, Y
   Hayashida, Y
   Numata, K
   Harada, S
   Hayashida, Y
   Ito, A
   Kamihira, M
AF Kawabe, Yoshinori
   Hayashida, Yuuki
   Numata, Kensaku
   Harada, Shota
   Hayashida, Yoshifumi
   Ito, Akira
   Kamihira, Masamichi
TI Oral Immunotherapy for Pollen Allergy Using T-Cell Epitope-Containing
   Egg White Derived from Genetically Manipulated Chickens
SO PLOS ONE
LA English
DT Article
ID JAPANESE CEDAR POLLEN; 2ND MAJOR ALLERGEN; FC FUSION PROTEIN; CRY-J-II;
   CHIMERIC CHICKENS; RETROVIRAL VECTOR; TOLERANCE; EXPRESSION; VACCINE;
   POLLINOSIS
AB Peptide immunotherapy using T-cell epitopes is expected to be an effective treatment for allergic diseases such as Japanese cedar (Cryptomeria japonica; Cj) pollinosis. To develop a treatment for pollen allergy by inducing oral tolerance, we generated genetically manipulated (GM) chickens by retroviral gene transduction, to produce a fusion protein of chicken egg white lysozyme and a peptide derived from seven dominant human T-cell epitopes of Japanese cedar pollen allergens (cLys-7crp). The transgene sequence was detected in all chickens transduced with the retroviral vector. Transduction efficiency in blood cells correlated to transgene expression. Western blot analysis revealed that cLys-7crp was expressed in the egg white of GM hens. Mice induced to develop allergic rhinitis by Cj pollinosis were fed with cLys-7crp-containing egg white produced by GM chickens. Total and Cj allergen (Cry j 1)-specific IgE levels were significantly decreased in allergic mice fed with cLys-7crp-containing egg white compared with allergic mice fed with normal egg white. These results suggest that oral administration of T-cell epitope-containing egg white derived from GM chickens is effective for the induction of immune tolerance as an allergy therapy.
C1 [Kawabe, Yoshinori; Hayashida, Yuuki; Numata, Kensaku; Harada, Shota; Hayashida, Yoshifumi; Ito, Akira; Kamihira, Masamichi] Kyushu Univ, Fac Engn, Dept Chem Engn, Fukuoka 812, Japan.
RP Kamihira, M (reprint author), Kyushu Univ, Fac Engn, Dept Chem Engn, 6-10-1 Hakozaki, Fukuoka 812, Japan.
EM kamihira@chem-eng.kyushu-u.ac.jp
RI Kamihira, Masamichi/Q-7438-2019; Ito, Akira/S-8099-2017
OI Kamihira, Masamichi/0000-0003-2570-5712; 
FU Japan Society for the Promotion of Science [18656245, 20360376,
   23360372, 23760753]; Kieikai Research Foundation
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (nos. 18656245, 20360376, 23360372 and 23760753) from the Japan Society
   for the Promotion of Science and the Kieikai Research Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. No additional
   external funding was received for this study.
CR Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754
   du Pre MF, 2011, ALLERGY, V66, P478, DOI 10.1111/j.1398-9995.2010.02519.x
   GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   HASHIMOTO M, 1995, CLIN EXP ALLERGY, V25, P848, DOI 10.1111/j.1365-2222.1995.tb00027.x
   Hirahara K, 2001, J ALLERGY CLIN IMMUN, V108, P94, DOI 10.1067/mai.2001.115481
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hotta A, 2006, J BIOSCI BIOENG, V101, P361, DOI 10.1263/jbb.101.361
   Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005
   Ishii M, 2010, INT IMMUNOPHARMACOL, V10, P1041, DOI 10.1016/j.intimp.2010.06.003
   Ito A, 2009, J BIOSCI BIOENG, V108, P244, DOI 10.1016/j.jbiosc.2009.04.004
   Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005
   Kamihira M, 2009, J BIOTECHNOL, V141, P18, DOI 10.1016/j.jbiotec.2009.02.022
   Kawabe Y, 2006, J BIOSCI BIOENG, V102, P297, DOI 10.1263/jbb.102.297
   Kodama D, 2008, BIOCHEM BIOPH RES CO, V367, P834, DOI 10.1016/j.bbrc.2008.01.020
   KOMIYAMA N, 1994, BIOCHEM BIOPH RES CO, V201, P1021, DOI 10.1006/bbrc.1994.1804
   Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009
   Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104
   Moldaver M, 2011, ALLERGY, V66, P784
   Ohno N, 2000, IMMUNOLOGY, V99, P630, DOI 10.1046/j.1365-2567.2000.00021.x
   Okamoto Yoshitaka, 2009, Allergology International, V58, P155, DOI 10.2332/allergolint.08-RAI-0074
   Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288, DOI 10.1016/S1081-1206(10)63532-6
   Penno CA, 2010, TRANSGENIC RES, V19, P187, DOI 10.1007/s11248-009-9310-z
   Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x
   Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027
   Rosenwasser LJ, 2011, CURR ALLERGY ASTHM R, V11, P178, DOI 10.1007/s11882-011-0179-6
   Saito S., 2000, ANN REP SANKYO RES L, V52, P49
   SAKAGUCHI M, 1990, ALLERGY, V45, P309, DOI 10.1111/j.1398-9995.1990.tb00501.x
   Sakaguchi M, 2011, AURIS NASUS LARYNX, V38, P431, DOI 10.1016/j.anl.2010.12.002
   Shin JH, 2010, OTOLARYNG HEAD NECK, V142, P370, DOI 10.1016/j.otohns.2009.11.025
   SONE T, 1994, BIOCHEM BIOPH RES CO, V199, P619, DOI 10.1006/bbrc.1994.1273
   Song G, 2011, ANN NY ACAD SCI, V1229, P69, DOI 10.1111/j.1749-6632.2011.06087.x
   Stebbins KJ, 2010, EUR J PHARMACOL, V638, P142, DOI 10.1016/j.ejphar.2010.04.031
   Takagi H, 2005, P NATL ACAD SCI USA, V102, P17525, DOI 10.1073/pnas.0503428102
   Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x
   Takagi H, 2008, VACCINE, V26, P6027, DOI 10.1016/j.vaccine.2008.09.019
   Toda M, 2002, EUR J IMMUNOL, V32, P1631, DOI 10.1002/1521-4141(200206)32:6<1631::AID-IMMU1631>3.0.CO;2-O
   Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002
   Tsunematsu M, 2008, BIOMED RES-TOKYO, V29, P119, DOI 10.2220/biomedres.29.119
   Tsunematsu M, 2007, LIFE SCI, V80, P1388, DOI 10.1016/j.lfs.2006.12.038
   Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x
   Worm M, 2011, J ALLERGY CLIN IMMUN, V127, P89, DOI 10.1016/j.jaci.2010.11.029
   Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219
   Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132
NR 44
TC 9
Z9 10
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 29
PY 2012
VL 7
IS 10
AR e48512
DI 10.1371/journal.pone.0048512
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 032HH
UT WOS:000310705300076
PM 23144766
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stranzl, T
   Larsen, MV
   Lund, O
   Nielsen, M
   Brunak, S
AF Stranzl, Thomas
   Larsen, Mette V.
   Lund, Ole
   Nielsen, Morten
   Brunak, Soren
TI The Cancer Exome Generated by Alternative mRNA Splicing Dilutes
   Predicted HLA Class I Epitope Density
SO PLOS ONE
LA English
DT Article
ID MHC CLASS-I; MISSENSE MUTATIONS; PANCREATIC-CANCER; GENE-EXPRESSION;
   DOWN-REGULATION; AMINO-ACIDS; PROTEIN; SEQUENCE; BINDING; LYMPHOCYTES
AB Several studies have shown that cancers actively regulate alternative splicing. Altered splicing mechanisms in cancer lead to cancer-specific transcripts different from the pool of transcripts occurring only in healthy tissue. At the same time, altered presentation of HLA class I epitopes is frequently observed in various types of cancer. Down-regulation of genes related to HLA class I antigen processing has been observed in several cancer types, leading to fewer HLA class I antigens on the cell surface. Here, we use a peptidome wide analysis of predicted alternative splice forms, based on a publicly available database, to show that peptides over-represented in cancer splice variants comprise significantly fewer predicted HLA class I epitopes compared to peptides from normal transcripts. Peptides over-represented in cancer transcripts are in the case of the three most common HLA class I supertype representatives consistently found to contain fewer predicted epitopes compared to normal tissue. We observed a significant difference in amino acid composition between protein sequences associated with normal versus cancer tissue, as transcripts found in cancer are enriched with hydrophilic amino acids. This variation contributes to the observed significant lower likelihood of cancer-specific peptides to be predicted epitopes compared to peptides found in normal
C1 [Stranzl, Thomas; Larsen, Mette V.; Lund, Ole; Nielsen, Morten; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.
RP Brunak, S (reprint author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.
EM brunak@cbs.dtu.dk
RI Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011
OI Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311;
   Brunak, Soren/0000-0003-0316-5866
FU Danish Research Council for Technology and Production Sciences (Project
   "Disease Gene Finding, Somatic Mutations, and Vaccine Design"); National
   Institutes of Health [HHSN26620040006C]
FX This work was supported by a grant from the Danish Research Council for
   Technology and Production Sciences (Project "Disease Gene Finding,
   Somatic Mutations, and Vaccine Design"; principal funding recipient,
   Soren Brunak) and was supported by the National Institutes of Health
   (contract HHSN26620040006C). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BAUMANN G, 1989, PROTEIN ENG, V2, P329, DOI 10.1093/protein/2.5.329
   Darby NJ, 1993, PROTEIN STRUCTURE
   David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010
   Fang F, 2007, CANCER SCI, V98, P1678, DOI 10.1111/j.1349-7006.2007.00589
   Ferris RL, 2006, CLIN CANCER RES, V12, P3890, DOI 10.1158/1078-0432.CCR-05-2750
   Figge MA, 2004, CANCER EPIDEM BIOMAR, V13, P1037
   Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739
   Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325
   Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805
   He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194
   Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203
   Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003
   Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5
   Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4
   MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6
   Miranda NFCCD, 2009, J PATHOL, P69, DOI [10.1002/path, DOI 10.1002/PATH]
   NA F TA C, 2003, GENE DEV, V17, P419
   Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100
   Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796
   Norell H, 2006, CANCER RES, V66, P6387, DOI 10.1158/0008-5472.CAN-06-0029
   Ohnuma S, 2009, SURGERY, V145, P57, DOI 10.1016/j.surg.2008.08.010
   Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526
   RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055
   Romero JM, 2005, INT J CANCER, V113, P605, DOI 10.1002/ijc.20499
   Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Seliger B, 2008, J IMMUNOTOXICOL, V5, P361, DOI 10.1080/15476910802482870
   Simpson R. J., 2002, PROTEINS PROTEOMICS
   Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016
   Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200
   Trinquier G, 1998, PROTEIN ENG, V11, P153, DOI 10.1093/protein/11.3.153
   Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420
   VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703
   Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608
   Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303
   Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252
   WIEDENFELD EA, 1994, CANCER RES, V54, P1175
   Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579
NR 44
TC 12
Z9 12
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 25
PY 2012
VL 7
IS 9
AR e38670
DI 10.1371/journal.pone.0038670
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 016YP
UT WOS:000309556100001
PM 23049726
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yao, B
   Zhang, L
   Liang, SD
   Zhang, C
AF Yao, Bo
   Zhang, Lin
   Liang, Shide
   Zhang, Chi
TI SVMTriP: A Method to Predict Antigenic Epitopes Using Support Vector
   Machine to Integrate Tri-Peptide Similarity and Propensity
SO PLOS ONE
LA English
DT Article
ID B-CELL EPITOPES; PROTEINS; DETERMINANTS; SEQUENCES; DATABASE; LOCATION;
   PROGRAM; CURVES; SITES; SCALE
AB Identifying protein surface regions preferentially recognizable by antibodies (antigenic epitopes) is at the heart of new immuno-diagnostic reagent discovery and vaccine design, and computational methods for antigenic epitope prediction provide crucial means to serve this purpose. Many linear B-cell epitope prediction methods were developed, such as BepiPred, ABCPred, AAP, BCPred, BayesB, BEOracle/BROracle, and BEST, towards this goal. However, effective immunological research demands more robust performance of the prediction method than what the current algorithms could provide. In this work, a new method to predict linear antigenic epitopes is developed; Support Vector Machine has been utilized by combining the Tri-peptide similarity and Propensity scores (SVMTriP). Applied to non-redundant B-cell linear epitopes extracted from IEDB, SVMTriP achieves a sensitivity of 80.1% and a precision of 55.2% with a five-fold cross-validation. The AUC value is 0.702. The combination of similarity and propensity of tri-peptide subsequences can improve the prediction performance for linear B-cell epitopes. Moreover, SVMTriP is capable of recognizing viral peptides from a human protein sequence background. A web server based on our method is constructed for public use. The server and all datasets used in the current study are available at http://sysbio.unl.edu/SVMTriP.
C1 [Yao, Bo; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68583 USA.
   [Zhang, Lin] Univ Nebraska, Dept Stat, Lincoln, NE USA.
   [Liang, Shide] Osaka Univ, Immunol Frontier Res Ctr, Syst Immunol Lab, Suita, Osaka, Japan.
RP Yao, B (reprint author), Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68583 USA.
EM shideliang@hotmail.com; czhang5@unl.edu
RI Zhang, Chi/C-4996-2009
OI Zhang, Chi/0000-0002-1827-8137
FU University of Nebraska, Lincoln, NE
FX The work was supported by funding under Chi Zhang's startup funds from
   University of Nebraska, Lincoln, NE. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   EMINI EA, 1985, J VIROL, V55, P836
   Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104
   GETZOFF ED, 1988, ADV IMMUNOL, V43, P1
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Joachims T, 1999, MAKING LARGE SCALE S
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291
   MILICH DR, 1989, ADV IMMUNOL, V45, P195, DOI 10.1016/S0065-2776(08)60694-X
   Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A
   PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2
   Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721
   Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Schonbach C, 2000, NUCLEIC ACIDS RES, V28, P222, DOI 10.1093/nar/28.1.222
   Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   Wang YL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-251
   Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21
NR 28
TC 67
Z9 70
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 12
PY 2012
VL 7
IS 9
AR e45152
DI 10.1371/journal.pone.0045152
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 005GJ
UT WOS:000308738500120
PM 22984622
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gao, JZ
   Faraggi, E
   Zhou, YQ
   Ruan, JS
   Kurgan, L
AF Gao, Jianzhao
   Faraggi, Eshel
   Zhou, Yaoqi
   Ruan, Jishou
   Kurgan, Lukasz
TI BEST: Improved Prediction of B-Cell Epitopes from Antigen Sequences
SO PLOS ONE
LA English
DT Article
ID BINDING RESIDUES; SOLVENT ACCESSIBILITY; PROTEIN ANTIGENS;
   NEURAL-NETWORK; SERVER; PROGRAM; SCALE; DETERMINANTS; DESCRIPTORS;
   INFORMATION
AB Accurate identification of immunogenic regions in a given antigen chain is a difficult and actively pursued problem. Although accurate predictors for T-cell epitopes are already in place, the prediction of the B-cell epitopes requires further research. We overview the available approaches for the prediction of B-cell epitopes and propose a novel and accurate sequence-based solution. Our BEST (B-cell Epitope prediction using Support vector machine Tool) method predicts epitopes from antigen sequences, in contrast to some method that predict only from short sequence fragments, using a new architecture based on averaging selected scores generated from sliding 20-mers by a Support Vector Machine (SVM). The SVM predictor utilizes a comprehensive and custom designed set of inputs generated by combining information derived from the chain, sequence conservation, similarity to known (training) epitopes, and predicted secondary structure and relative solvent accessibility. Empirical evaluation on benchmark datasets demonstrates that BEST outperforms several modern sequence-based B-cell epitope predictors including ABCPred, method by Chen et al. (2007), BCPred, COBEpro, BayesB, and CBTOPE, when considering the predictions from antigen chains and from the chain fragments. Our method obtains a cross-validated area under the receiver operating characteristic curve (AUC) for the fragment-based prediction at 0.81 and 0.85, depending on the dataset. The AUCs of BEST on the benchmark sets of full antigen chains equal 0.57 and 0.6, which is significantly and slightly better than the next best method we tested. We also present case studies to contrast the propensity profiles generated by BEST and several other methods.
C1 [Gao, Jianzhao; Ruan, Jishou] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.
   [Gao, Jianzhao; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China.
   [Faraggi, Eshel; Zhou, Yaoqi] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA.
   [Faraggi, Eshel; Zhou, Yaoqi] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA.
   [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.
   [Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.
RP Gao, JZ (reprint author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.
EM gaojz@nankai.edu.cn; lkurgan@ece.ualberta.ca
RI Zhou, Yaoqi/B-3284-2009; Kurgan, Lukasz/B-5721-2009
OI Zhou, Yaoqi/0000-0002-9958-5699; Kurgan, Lukasz/0000-0002-7749-0314;
   Gao, Jianzhao/0000-0002-9943-4786
FU National Science Foundation of China (NSFC) [31050110432, 31150110577];
   National Institutes of Health [GM R01 085003]; NSERC (National Science
   and Engineering Research Council) Canada [298328]; International
   Development Research Center, Ottawa, Canada [104519-010]; Tianjin
   science and technology support project [08ZCHHZ00200]; Fundamental
   Research Funds for the Central Universities [65011491]
FX This work was supported by National Science Foundation of China (NSFC)
   grants 31050110432 and 31150110577 to LK and JR, National Institutes of
   Health grant GM R01 085003 to YZ, and by the Discovery grant 298328 from
   NSERC (National Science and Engineering Research Council) Canada to LK.
   JR was also supported by the International Development Research Center,
   Ottawa, Canada (No. 104519-010) and Tianjin science and technology
   support project 08ZCHHZ00200. JG was supported by the Fundamental
   Research Funds for the Central Universities grant 65011491. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432
   Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328
   Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Beck A, 2007, J PEPT SCI, V13, P588, DOI 10.1002/psc.852
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Chen K, 2012, BIOINFORMATICS, V28, P331, DOI 10.1093/bioinformatics/btr657
   Chen K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S4
   Chen Ping, 2011, Virologica Sinica, V26, P1, DOI 10.1007/s12250-011-3159-4
   Disfani F. M., 2012, BIOINFORMAT IN PRESS
   Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193
   Flower Darren R., 2007, V409, P1, DOI 10.1007/978-1-60327-118-9_1
   HASTE A, 2006, PROTEIN SCI, V15, P2558, DOI DOI 10.1110/PS.062405906
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460
   Kurgan L, 2011, CURR PROTEIN PEPT SC, V12, P470, DOI 10.2174/138920311796957711
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381
   Liu R, 2011, J PROTEOM BIOINFORM, V4, P010
   Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376
   Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229
   Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373
   Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414
   Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087
   Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A
   PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176
   PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2
   Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287
   Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009
   Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771
   Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417
   Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199
   Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075
   Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038
   Wang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-385
   Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21
   WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4
   Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602
   Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433
   Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341
   Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6
NR 53
TC 44
Z9 47
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2012
VL 7
IS 6
AR e40104
DI 10.1371/journal.pone.0040104
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 966GL
UT WOS:000305825800088
PM 22761950
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, Y
   Vaughan, K
   Greenbaum, J
   Peters, B
   Law, M
   Sette, A
AF Kim, Yohan
   Vaughan, Kerrie
   Greenbaum, Jason
   Peters, Bjoern
   Law, Mansun
   Sette, Alessandro
TI A Meta-Analysis of the Existing Knowledge of Immunoreactivity against
   Hepatitis C Virus (HCV)
SO PLOS ONE
LA English
DT Article
ID ENDOPLASMIC-RETICULUM MEMBRANE; IMMUNE EPITOPE DATA; INFLUENZA-A VIRUS;
   NS2 PROTEIN; NEUTRALIZING ANTIBODIES; ANTIGENIC DETERMINANTS; ENVELOPE
   GLYCOPROTEINS; VIRAL REPLICATION; ATOMIC MOBILITY; CORE PROTEIN
AB Approximately 3% of the world population is infected by HCV, which represents a major global health challenge. Almost 400 different scientific reports present immunological data related to T cell and antibody epitopes derived from HCV literature. Analysis of all HCV-related epitope hosted in the Immune Epitope Database (IEDB), a repository of freely accessible immune epitope data, revealed more than 1500 and 1900 distinct T cell and antibody epitopes, respectively. The inventory of all data revealed specific trends in terms of the host and the HCV genotypes from which sequences were derived. Upon further analysis we found that this large number of epitopes reflects overlapping structures, and homologous sequences derived from different HCV isolates. To access and visualize this information we developed a novel strategy that assembles large sets of epitope data, maps them onto reference genomes and displays the frequency of positive responses. Compilation of the HCV immune reactivity from hundreds of different studies, revealed a complex and thorough picture of HCV immune epitope data to date. The results pinpoint areas of more intense reactivity or research activities at the level of antibody, CD4 and CD8 responses for each of the individual HCV proteins. In general, the areas targeted by the different effector immune functions were distinct and antibody reactivity was positively correlated with hydrophilicity, while T cell reactivity correlated with hydrophobicity. At the sequence level, epitopes frequently recognized by both T cell and B cell correlated with low variability, and our analysis thus highlighted areas of potential interest for practical applications. The human reactivity was further analyzed to pinpoint differential patterns of reactivity associated with acute versus chronic infection, to reveal the apparent impact of glycosylation on T cell, but not antibody responses, and to highlight a paucity of studies involved antibody epitopes associated with virus neutralization.
C1 [Kim, Yohan; Vaughan, Kerrie; Greenbaum, Jason; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Immune Epitope Database IEDB, La Jolla, CA USA.
   [Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.
RP Kim, Y (reprint author), La Jolla Inst Allergy & Immunol, Immune Epitope Database IEDB, La Jolla, CA USA.
EM kvaughan@liai.org
FU National Institutes of Health National Institute of Allergy and
   Infectious Diseases [HHSN26620040006C]
FX The La Jolla Institute of Allergy and Immunology is supported by the
   National Institutes of Health National Institute of Allergy and
   Infectious Diseases, contract number HHSN26620040006C, under the Immune
   Epitope Database and Analysis Program. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Angus AGN, 2011, FUTURE MICROBIOL, V6, P279, DOI [10.2217/FMB.11.9, 10.2217/fmb.11.9]
   Bansal A, 2005, AIDS, V19, P241
   BARTENSCHLAGER R, 1995, J VIROL, V69, P7519
   Beld M, 1999, HEPATOLOGY, V29, P1288, DOI 10.1002/hep.510290442
   Berkhoff EGM, 2007, J GEN VIROL, V88, P530, DOI 10.1099/vir.0.82120-0
   Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10
   Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104
   Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778
   Diepolder HM, 1997, J VIROL, V71, P6011
   Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004
   Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005
   Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005
   GRAKOUI A, 1993, J VIROL, V67, P1385
   Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0
   HARADA S, 1991, J VIROL, V65, P3015
   HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873
   LIN C, 1995, J VIROL, V69, P4373
   Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07
   Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003
   Moutaftsi M, 2010, FUTURE MICROBIOL, V5, P221, DOI 10.2217/FMB.09.110
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253
   Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133
   SANTOLINI E, 1994, J VIROL, V68, P3631
   SANTOLINI E, 1995, J VIROL, V69, P7461
   Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
   TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441
   TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0
   TANJI Y, 1995, J VIROL, V69, P1575
   Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015
   VALLARI DS, 1992, J CLIN MICROBIOL, V30, P552
   Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Vita R, 2008, CYTOM PART A, V73A, P1066, DOI 10.1002/cyto.a.20585
   Wang Y, 2011, VIRUSES-BASEL, V3, P2127, DOI 10.3390/v3112127
   WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J
   WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0
   Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200
   Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23041704.115702
   Zarebski LM, 2008, EXPERT REV VACCINES, V7, P55, DOI 10.1586/14760584.7.1.55
NR 44
TC 15
Z9 16
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2012
VL 7
IS 5
AR e38028
DI 10.1371/journal.pone.0038028
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TY
UT WOS:000305338500075
PM 22675428
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jaspard, E
   Macherel, D
   Hunault, G
AF Jaspard, Emmanuel
   Macherel, David
   Hunault, Gilles
TI Computational and Statistical Analyses of Amino Acid Usage and
   Physico-Chemical Properties of the Twelve Late Embryogenesis Abundant
   Protein Classes
SO PLOS ONE
LA English
DT Article
ID INTRINSICALLY DISORDERED PROTEIN; SALSUGINEA DEHYDRINS TSDHN-1;
   ARABIDOPSIS-THALIANA; GLOBULAR-PROTEINS; DEVELOPMENTAL BIOCHEMISTRY;
   COTTONSEED EMBRYOGENESIS; SEQUENCE ALIGNMENTS; SECONDARY STRUCTURE;
   STRESS-PROTEINS; LEA PROTEINS
AB Late Embryogenesis Abundant Proteins (LEAPs) are ubiquitous proteins expected to play major roles in desiccation tolerance. Little is known about their structure - function relationships because of the scarcity of 3-D structures for LEAPs. The previous building of LEAPdb, a database dedicated to LEAPs from plants and other organisms, led to the classification of 710 LEAPs into 12 non-overlapping classes with distinct properties. Using this resource, numerous physico-chemical properties of LEAPs and amino acid usage by LEAPs have been computed and statistically analyzed, revealing distinctive features for each class. This unprecedented analysis allowed a rigorous characterization of the 12 LEAP classes, which differed also in multiple structural and physico-chemical features. Although most LEAPs can be predicted as intrinsically disordered proteins, the analysis indicates that LEAP class 7 (PF03168) and probably LEAP class 11 (PF04927) are natively folded proteins. This study thus provides a detailed description of the structural properties of this protein family opening the path toward further LEAP structure - function analysis. Finally, since each LEAP class can be clearly characterized by a unique set of physico-chemical properties, this will allow development of software to predict proteins as LEAPs.
C1 [Jaspard, Emmanuel; Macherel, David] LUNAM Univ, SFR QUASAV 4207, Univ Angers, Inst Rech Hort & Semences,INRA,Agrocampus Ouest, Angers, France.
   [Hunault, Gilles] LUNAM Univ, Lab Hemodynam Interact Fibrose & Invas Tumorale H, Univ Angers, UPRES 3859,IFR 132, Angers, France.
RP Jaspard, E (reprint author), LUNAM Univ, SFR QUASAV 4207, Univ Angers, Inst Rech Hort & Semences,INRA,Agrocampus Ouest, Angers, France.
EM emmanuel.jaspard@univ-angers.fr
RI Macherel, David/B-2084-2012
OI Macherel, David/0000-0002-3352-2185
FU Region des Pays-de-la Loire (program COSAVE)
FX This work was supported by the Region des Pays-de-la Loire (program
   COSAVE). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047
   BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241
   Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x
   Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x
   Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039
   BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035
   Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485
   Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a
   Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   CUMING AC, 1999, SEED PROTEINS, P753, DOI DOI 10.1007/978-94-011-4431-5-32
   Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033
   DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962
   EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183
   Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149
   GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327
   GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695
   GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034
   Gao J, 2010, BIOPOLYMERS, V93, P340, DOI 10.1002/bip.21342
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200
   Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480
   Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786
   Haaning S, 2008, J BIOL CHEM, V283, P31142, DOI 10.1074/jbc.M805024200
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259
   Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221
   Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118
   Hundertmark M, 2012, BIOCHEM BIOPH RES CO, V417, P122, DOI 10.1016/j.bbrc.2011.11.067
   Hundertmark M, 2011, BBA-BIOMEMBRANES, V1808, P446, DOI 10.1016/j.bbamem.2010.09.010
   HUNTER S, 2009, NUCLEIC ACIDS RES, V37, pD224, DOI DOI 10.1093/NAR/GKN833
   Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460
   Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136
   JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0
   Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171
   Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697
   Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208
   Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Li DX, 2009, BIOMACROMOLECULES, V10, P1469, DOI 10.1021/bm9002688
   Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052
   Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106
   Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162
   Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951
   MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102
   Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Popova AV, 2011, BBA-BIOMEMBRANES, V1808, P1879, DOI 10.1016/j.bbamem.2011.03.009
   Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Rahman LN, 2011, AMINO ACIDS, V40, P1485, DOI 10.1007/s00726-010-0759-0
   Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]
   Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014
   Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/O09-001, 10.1139/o09-001]
   Shih MD, 2004, PLANT MOL BIOL, V56, P689, DOI 10.1007/s11103-004-4680-3
   Shih MD, 2010, PLANT CELL PHYSIOL, V51, P395, DOI 10.1093/pcp/pcq005
   Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893
   Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205
   Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891
   Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521
   Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z
   Thalhammer A, 2010, BBA-BIOMEMBRANES, V1798, P1812, DOI 10.1016/j.bbamem.2010.05.015
   Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104
   Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029
   Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/o09-163, 10.1139/O09-163]
   Tunnacliffe A, 2010, SLEEPING BEAUTIES DO, P91
   Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y
   Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7
   Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52
   Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
   Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306
   ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6
NR 85
TC 26
Z9 26
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2012
VL 7
IS 5
SI 1
AR e36968
DI 10.1371/journal.pone.0036968
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UR
UT WOS:000305341300049
PM 22615859
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kapoor, P
   Singh, H
   Gautam, A
   Chaudhary, K
   Kumar, R
   Raghava, GPS
AF Kapoor, Pallavi
   Singh, Harinder
   Gautam, Ankur
   Chaudhary, Kumardeep
   Kumar, Rahul
   Raghava, Gajendra P. S.
TI TumorHoPe: A Database of Tumor Homing Peptides
SO PLOS ONE
LA English
DT Article
ID CANCER-THERAPY; NANOPARTICLES; PREDICTION; SEQUENCES; RECEPTORS;
   DELIVERY; HORMONES
AB Background: Cancer is responsible for millions of immature deaths every year and is an economical burden on developing countries. One of the major challenges in the present era is to design drugs that can specifically target tumor cells not normal cells. In this context, tumor homing peptides have drawn much attention. These peptides are playing a vital role in delivering drugs in tumor tissues with high specificity. In order to provide service to scientific community, we have developed a database of tumor homing peptides called TumorHoPe.
   Description: TumorHoPe is a manually curated database of experimentally validated tumor homing peptides that specifically recognize tumor cells and tumor associated microenvironment, i.e., angiogenesis. These peptides were collected and compiled from published papers, patents and databases. Current release of TumorHoPe contains 744 peptides. Each entry provides comprehensive information of a peptide that includes its sequence, target tumor, target cell, techniques of identification, peptide receptor, etc. In addition, we have derived various types of information from these peptide sequences that include secondary/tertiary structure, amino acid composition, and physicochemical properties of peptides. Peptides in this database have been found to target different types of tumors that include breast, lung, prostate, melanoma, colon, etc. These peptides have some common motifs including RGD (Arg-Gly-Asp) and NGR (Asn-Gly-Arg) motifs, which specifically recognize tumor angiogenic markers. TumorHoPe has been integrated with many web-based tools like simple/complex search, database browsing and peptide mapping. These tools allow a user to search tumor homing peptides based on their amino acid composition, charge, polarity, hydrophobicity, etc.
   Conclusion: TumorHoPe is a unique database of its kind, which provides comprehensive information about experimentally validated tumor homing peptides and their target cells. This database will be very useful in designing peptide-based drugs and drug-delivery system. It is freely available at http://crdd.osdd.net/raghava/tumorhope/.
C1 [Kapoor, Pallavi; Singh, Harinder; Gautam, Ankur; Chaudhary, Kumardeep; Kumar, Rahul; Raghava, Gajendra P. S.] Inst Microbial Technol, CSIR, Bioinformat Ctr, Sect 39A, Chandigarh, India.
RP Kapoor, P (reprint author), Inst Microbial Technol, CSIR, Bioinformat Ctr, Sect 39A, Chandigarh, India.
EM raghava@imtech.res.in
RI Chaudhary, Kumardeep/Q-9740-2018; Raghava, Gajendra/B-1717-2009
OI Chaudhary, Kumardeep/0000-0002-4117-6403; Raghava,
   Gajendra/0000-0002-8902-2876
FU Council of Scientific and Industrial Research (CSIR); Open Source Drug
   Discovery (OSDD); Department of Biotechnology, Government of India
FX The authors are thankful to Council of Scientific and Industrial
   Research (CSIR), Open Source Drug Discovery (OSDD) and Department of
   Biotechnology, Government of India for providing research fellowships.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Blanco E, 2011, CANCER SCI, V102, P1247, DOI 10.1111/j.1349-7006.2011.01941.x
   Brahmachary M, 2004, NUCLEIC ACIDS RES, V32, pD586, DOI 10.1093/nar/gkh032
   Corti A., 2011, MED RES REV
   Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862
   EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115
   Ellerby HM, 1999, NAT MED, V5, P1032
   Engel JB, 2007, MOL PHARM, V4, P652, DOI 10.1021/mp0700514
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Jiang YQ, 2006, MOL MED, V12, P81, DOI 10.2119/2006-00011.Jiang
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007
   Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626
   Khandare JJ, 2006, CRIT REV THER DRUG, V23, P401
   Laakkonen P, 2010, INTEGR BIOL-UK, V2, P326, DOI 10.1039/c0ib00013b
   Lata Sneh, 2009, BMC Res Notes, V2, P61, DOI 10.1186/1756-0500-2-61
   Pearson W R, 2000, Methods Mol Biol, V132, P185
   Rashid M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-307
   Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007
   Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101
   Ru BB, 2010, MOLECULES, V15, P8279, DOI 10.3390/molecules15118279
   Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104
   Ruoslahti ESR, 1997, US005622699A, Patent No. US005622699A
   Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79
   Tang Y, 2010, PHARM RES-DORDR, V27, P2242, DOI 10.1007/s11095-010-0231-6
   Temming K, 2006, BIOCONJUGATE CHEM, V17, P1385, DOI 10.1021/bc060087z
   Thomas S, 2009, NUCLEIC ACIDS RES, V38, pD774
NR 28
TC 53
Z9 55
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 16
PY 2012
VL 7
IS 4
AR e35187
DI 10.1371/journal.pone.0035187
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959VO
UT WOS:000305345000047
PM 22523575
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wei, DD
   Shao, RF
   Yuan, ML
   Dou, W
   Barker, SC
   Wang, JJ
AF Wei, Dan-Dan
   Shao, Renfu
   Yuan, Ming-Long
   Dou, Wei
   Barker, Stephen C.
   Wang, Jin-Jun
TI The Multipartite Mitochondrial Genome of Liposcelis bostrychophila:
   Insights into the Evolution of Mitochondrial Genomes in Bilateral
   Animals
SO PLOS ONE
LA English
DT Article
ID TRANSFER-RNA GENES; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; MULTIPLE
   ORIGINS; KINETOPLAST DNA; SISTER GROUP; PHTHIRAPTERA; LICE; INSECTA;
   REARRANGEMENTS
AB Booklice (order Psocoptera) in the genus Liposcelis are major pests to stored grains worldwide and are closely related to parasitic lice (order Phthiraptera). We sequenced the mitochondrial (mt) genome of Liposcelis bostrychophila and found that the typical single mt chromosome of bilateral animals has fragmented into and been replaced by two medium-sized chromosomes in this booklouse; each of these chromosomes has about half of the genes of the typical mt chromosome of bilateral animals. These mt chromosomes are 8,530 bp (mt chromosome I) and 7,933 bp (mt chromosome II) in size. Intriguingly, mt chromosome I is twice as abundant as chromosome II. It appears that the selection pressure for compact mt genomes in bilateral animals favors small mt chromosomes when small mt chromosomes co-exist with the typical large mt chromosomes. Thus, small mt chromosomes may have selective advantages over large mt chromosomes in bilateral animals. Phylogenetic analyses of mt genome sequences of Psocodea (i.e. Psocoptera plus Phthiraptera) indicate that: 1) the order Psocoptera (booklice and barklice) is paraphyletic; and 2) the order Phthiraptera (the parasitic lice) is monophyletic. Within parasitic lice, however, the suborder Ischnocera is paraphyletic; this differs from the traditional view that each suborder of parasitic lice is monophyletic.
C1 [Wei, Dan-Dan; Yuan, Ming-Long; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.
   [Shao, Renfu; Barker, Stephen C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
   [Shao, Renfu] Univ Sunshine Coast, Sch Sci Educ & Engn, Maroochydore, Qld, Australia.
RP Wei, DD (reprint author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.
EM rshao@usc.edu.au; jjwang7008@yahoo.com
FU National Natural Sciences Foundation [30871631, 31000860]; Program for
   Innovative Research Team in University [IRT0976]; Natural Science
   Foundation of Chongqing (CSTC) [2009BA1042]; Specialized Research Fund
   for the Doctoral Program of Higher Education of China [200806350009]
FX This study was funded in part by the National Natural Sciences
   Foundation (30871631, 31000860), the Program for Innovative Research
   Team in University (IRT0976), the Natural Science Foundation of
   Chongqing (CSTC, 2009BA1042) and the Specialized Research Fund for the
   Doctoral Program of Higher Education (200806350009) of China, awarded to
   Jin-Jun Wang. The funders had no role in study design, data collection
   and analysis, the decision to publish, or the preparation of the
   manuscript.
CR Armstrong MR, 2000, GENETICS, V154, P181
   Awata H, 2005, MOL GENET GENOMICS, V273, P441, DOI 10.1007/s00438-005-1157-2
   Bogenhagen DF, 2011, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbagrm.2011.1011.1005, DOI 10.1016/J.BBAGRM.2011.1011.1005]
   Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767
   Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012
   Burger G, 2003, IUBMB LIFE, V55, P205, DOI 10.1080/1521654031000137380
   Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100
   Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8
   Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x
   Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x
   Domes K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-532
   Fan J, 2002, MOL BIOL EVOL, V19, P999, DOI 10.1093/oxfordjournals.molbev.a004180
   FAURON C, 1995, TRENDS GENET, V11, P228, DOI 10.1016/S0168-9525(00)89056-3
   Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y
   Grimaldi D, 2006, P ROY SOC B-BIOL SCI, V273, P625, DOI 10.1098/rspb.2005.3337
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Helfenbein KG, 2004, P NATL ACAD SCI USA, V101, P10639, DOI 10.1073/pnas.0400941101
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889
   Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0
   Johnson KP, 2004, P ROY SOC B-BIOL SCI, V271, P1771, DOI 10.1098/rspb.2004.2798
   Johnson KP, 2002, MOL PHYLOGENET EVOL, V22, P101, DOI 10.1006/mpev.2001.1028
   Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821
   Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013
   Klingbeil MM, 2001, PROTIST, V152, P255, DOI 10.1078/1434-4610-00066
   Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351
   Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573
   Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045
   Li F. S., 2002, PSOCOPTERA CHINA, P77
   Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008
   Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955
   LYAL CHC, 1985, SYST ENTOMOL, V10, P145
   Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005
   Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033
   Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419
   MILLIGAN BG, 1998, MOL GENETIC ANAL POP, P29
   Murrell A, 2005, PARASITOL RES, V97, P274, DOI 10.1007/s00436-005-1413-8
   Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7
   PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Price RD, 2003, ILLINOIS NATURAL HIS, P1
   Rand DM, 2009, GENOME RES, V19, P700, DOI 10.1101/gr.091132.109
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867
   Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108
   Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176
   SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651
   Smith DR, 2011, GENOME BIOL EVOL, DOI [10.1093/gbe/evr1127, DOI 10.1093/GBE/EVR1127]
   Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058
   Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25
   THOMPSON, 1997, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876
   Voigt O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-350
   Watanabe KI, 1999, J MOL BIOL, V286, P645, DOI 10.1006/jmbi.1998.2523
   Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177
   Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371
   Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371
   Yoshizawa K, 2003, MOL PHYLOGENET EVOL, V29, P102, DOI 10.1016/S1055-7903(03)00073-3
   Yoshizawa K, 2010, MOL PHYLOGENET EVOL, V55, P939, DOI 10.1016/j.ympev.2010.02.026
   Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597
NR 67
TC 38
Z9 42
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 30
PY 2012
VL 7
IS 3
AR e33973
DI 10.1371/journal.pone.0033973
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959UC
UT WOS:000305339100091
PM 22479490
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xiao, X
   Wang, P
   Chou, KC
AF Xiao, Xuan
   Wang, Pu
   Chou, Kuo-Chen
TI iNR-PhysChem: A Sequence-Based Predictor for Identifying Nuclear
   Receptors and Their Subfamilies via Physical-Chemical Property Matrix
SO PLOS ONE
LA English
DT Article
ID AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINE; PROTEIN SUBCELLULAR
   LOCATION; STRUCTURAL CLASS PREDICTION; DISCRETE WAVELET TRANSFORM;
   MODIFIED MAHALANOBIS DISCRIMINANT; FUNCTIONAL DOMAIN COMPOSITION;
   APPROXIMATE ENTROPY; APOPTOSIS PROTEINS; DIPEPTIDE COMPOSITION
AB Nuclear receptors (NRs) form a family of ligand-activated transcription factors that regulate a wide variety of biological processes, such as homeostasis, reproduction, development, and metabolism. Human genome contains 48 genes encoding NRs. These receptors have become one of the most important targets for therapeutic drug development. According to their different action mechanisms or functions, NRs have been classified into seven subfamilies. With the avalanche of protein sequences generated in the postgenomic age, we are facing the following challenging problems. Given an uncharacterized protein sequence, how can we identify whether it is a nuclear receptor? If it is, what subfamily it belongs to? To address these problems, we developed a predictor called iNR-PhysChem in which the protein samples were expressed by a novel mode of pseudo amino acid composition ( PseAAC) whose components were derived from a physical-chemical matrix via a series of auto-covariance and cross-covariance transformations. It was observed that the overall success rate achieved by iNR-PhysChem was over 98% in identifying NRs or non-NRs, and over 92% in identifying NRs among the following seven subfamilies: NR1-thyroid hormone like, NR2-HNF4-like, NR3-estrogen like, NR4-nerve growth factor IB-like, NR5-fushi tarazu-F1 like, NR6-germ cell nuclear factor like, and NR0-knirps like. These rates were derived by the jackknife tests on a stringent benchmark dataset in which none of protein sequences included has >= 60% pairwise sequence identity to any other in a same subset. As a user-friendly web-server, iNR-PhysChem is freely accessible to the public at either http://www.jci-bioinfo.cn/iNR-PhysChem or http://icpr.jci.edu.cn/bioinfo/iNR-PhysChem. Also a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated mathematics involved in developing the predictor. It is anticipated that iNR-PhysChem may become a useful high throughput tool for both basic research and drug design.
C1 [Xiao, Xuan; Wang, Pu] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.
   [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA.
RP Xiao, X (reprint author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.
EM xiaoxuan0326@yahoo.com.cn; kcchou@gordonlifescience.org
RI Chou, Kuo-Chen/A-8340-2009
FU National Natural Science Foundation of China [60961003]; Chinese
   Ministry of Education [210116]; Province National Natural Science
   Foundation of JiangXi [2010GQS0127, 2010GZS0122]; Department of
   Education of JiangXi Province [GJJ11557]
FX This work was supported by the grants from the National Natural Science
   Foundation of China (No. 60961003), the Key Project of Chinese Ministry
   of Education (No. 210116), the Province National Natural Science
   Foundation of JiangXi (2010GQS0127 and 2010GZS0122), and the Department
   of Education of JiangXi Province (No. GJJ11557). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1
   Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1
   Auwerx J, 1999, CELL, V97, P161
   Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350
   Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200
   Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2
   Chang C. C., 2001, LIBSVM LIB SUPPORT V
   Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420
   Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200
   Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107
   CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488
   CHOU KC, 1994, J BIOL CHEM, V269, P22014
   Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035
   Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494
   Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006
   Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a
   Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024
   Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Dawson R.M.C., 1986, DATA BIOCH RES
   Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708
   Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045
   Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007
   Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811
   Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018
   Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003
   Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173
   Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693
   Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346
   Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795
   Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9
   Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443
   Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473
   Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368
   Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998
   Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8
   Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207
   Laudet V., 2002, NUCL RECEPTORS FACTS
   Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566
   Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930
   Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P186, DOI 10.2174/092986611794475084
   Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681
   Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004
   Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017
   Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564
   Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4
   NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454
   Nanni L, 2011, IEEE ACM T COMPUT BI, DOI [10.1109/TCBB.2011.1117, DOI 10.1109/TCBB.2011.1117]
   Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1
   Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335
   Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200
   Qiu JD, 2011, J MOL GRAPH MODEL, V30, P129, DOI 10.1016/j.jmgm.2011.06.014
   Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372
   Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009
   Robert C.W., 1985, CRC HDB CHEM PHYS
   Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247
   Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002
   Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012
   TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009
   Vapnik V., 1995, NATURE STAT LEARNING
   Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505
   Wang YC, 2010, PROTEIN PEPTIDE LETT, V17, P1441, DOI 10.2174/0929866511009011441
   WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X
   Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b
   Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001
   Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028
   Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184
   Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015
   Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251
   Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365
   Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071
   Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001
   Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616
NR 79
TC 59
Z9 59
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 21
PY 2012
VL 7
IS 2
AR e30869
DI 10.1371/journal.pone.0030869
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 926ZM
UT WOS:000302873700013
PM 22363503
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Su, CH
   Pal, NR
   Lin, KL
   Chung, IF
AF Su, Chun-Hung
   Pal, Nikhil R.
   Lin, Ken-Li
   Chung, I-Fang
TI Identification of Amino Acid Propensities That Are Strong Determinants
   of Linear B-cell Epitope Using Neural Networks
SO PLOS ONE
LA English
DT Article
ID SUPPORT VECTOR MACHINES; PROTEIN ANTIGENIC DETERMINANTS; FUNCTIONAL
   DOMAIN COMPOSITION; SUBCELLULAR-LOCALIZATION; EVOLUTION INFORMATION;
   CLEAVAGE SITES; WEB SERVER; TURN TYPES; PREDICTION; SEQUENCES
AB Background: Identification of amino acid propensities that are strong determinants of linear B-cell epitope is very important to enrich our knowledge about epitopes. This can also help to obtain better epitope prediction. Typical linear B-cell epitope prediction methods combine various propensities in different ways to improve prediction accuracies. However, fewer but better features may yield better prediction. Moreover, for a propensity, when the sequence length is k, there will be k values, which should be treated as a single unit for feature selection and hence usual feature selection method will not work. Here we use a novel Group Feature Selecting Multilayered Perceptron, GFSMLP, which treats a group of related information as a single entity and selects useful propensities related to linear B-cell epitopes, and uses them to predict epitopes.
   Methodology/Principal Findings: We use eight widely known propensities and four data sets. We use GFSMLP to rank propensities by the frequency with which they are selected. We find that Chou's beta-turn and Ponnuswamy's polarity are better features for prediction of linear B-cell epitope. We examine the individual and combined discriminating power of the selected propensities and analyze the correlation between paired propensities. Our results show that the selected propensities are indeed good features, which also cooperate with other propensities to enhance the discriminating power for predicting epitopes. We find that individually polarity is not the best predictor, but it collaborates with others to yield good prediction. Usual feature selection methods cannot provide such information.
   Conclusions/Significance: Our results confirm the effectiveness of active (group) feature selection by GFSMLP over the traditional passive approaches of evaluating various combinations of propensities. The GFSMLP-based feature selection can be extended to more than 500 remaining propensities to enhance our biological knowledge about epitopes and to obtain better prediction. A graphical-user-interface version of GFSMLP is available at: http://bio.classcloud.org/GFSMLP/.
C1 [Su, Chun-Hung; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.
   [Pal, Nikhil R.] Indian Stat Inst, Elect & Commun Sci Unit, Kolkata 700035, W Bengal, India.
   [Lin, Ken-Li] Chung Hua Univ, Ctr Comp, Hsinchu, Taiwan.
RP Su, CH (reprint author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.
EM ifchung@ym.edu.tw
FU National Science Council (NSC) [NSC100-2221-E-010-011]
FX This work is supported by National Science Council (NSC)
   (NSC100-2221-E-010-011). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   Cai YD, 2004, J THEOR BIOL, V228, P551, DOI 10.1016/j.jtbi.2004.02.019
   Cai YD, 2004, J THEOR BIOL, V226, P373, DOI 10.1016/j.jtbi.2003.08.015
   Cai YD, 2003, PEPTIDES, V24, P629, DOI 10.1016/S0196-9781(03)00100-1
   Cai YD, 2003, PEPTIDES, V24, P159, DOI 10.1016/S0196-9781(02)00289-9
   Cai YD, 2002, J COMPUT CHEM, V23, P267, DOI 10.1002/jcc.10017
   Cai YD, 2002, J PEPT SCI, V8, P297, DOI 10.1002/psc.401
   Chakraborty D, 2008, IEEE T NEURAL NETWOR, V19, P381, DOI 10.1109/TNN.2007.910730
   Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9
   Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177
   Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293
   Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200
   Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011
   Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125
   Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494
   Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006
   Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027
   Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162
   Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258
   Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024
   Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335
   Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Davydov YI, 2009, MOL BIOL+, V43, P150, DOI 10.1134/S0026893309010208
   EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   EMINI EA, 1985, J VIROL, V55, P836
   Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016
   He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972
   JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998
   Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   LERNER RA, 1982, NATURE, V299, P592, DOI 10.1038/299592a0
   Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A
   PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2
   PONNUSWAMY PK, 1980, BIOCHIM BIOPHYS ACTA, V623, P301, DOI 10.1016/0005-2795(80)90258-5
   Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344
   Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79
   Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   SCHMIDT MA, 1989, BIOTECHNOL ADV, V7, P187, DOI 10.1016/0734-9750(89)90358-3
   Shen H. B., 2010, NAT SCI, V2, P1090, DOI DOI 10.4236/NS.2010.210136
   Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098
   Sollner J, 2006, J MOL RECOGNIT, V19, P209, DOI 10.1002/jmr.770
   Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771
   Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1
   Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505
   WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4
   Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005
   Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592
   Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h
   Xiao Y, 2001, IMMUNOL LETT, V77, P3, DOI 10.1016/S0165-2478(01)00187-0
   Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254
NR 60
TC 8
Z9 10
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 8
PY 2012
VL 7
IS 2
AR e30617
DI 10.1371/journal.pone.0030617
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 924ZP
UT WOS:000302730100018
PM 22347389
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Barbarini, N
   Tiengo, A
   Bellazzi, R
AF Barbarini, Nicola
   Tiengo, Alessandra
   Bellazzi, Riccardo
TI Prediction of Peptide Reactivity with Human IVIg through a
   Knowledge-Based Approach
SO PLOS ONE
LA English
DT Article
ID B-CELL EPITOPES; GLOBULAR-PROTEINS; ANTIGENIC DETERMINANTS; NEUTRALIZING
   ANTIBODY; IMMUNE-SYSTEM; AMINO-ACIDS; IDENTIFICATION; BINDING;
   SELECTION; RESIDUES
AB The prediction of antibody-protein (antigen) interactions is very difficult due to the huge variability that characterizes the structure of the antibodies. The region of the antigen bound to the antibodies is called epitope. Experimental data indicate that many antibodies react with a panel of distinct epitopes (positive reaction). The Challenge 1 of DREAM5 aims at understanding whether there exists rules for predicting the reactivity of a peptide/epitope, i.e., its capability to bind to human antibodies. DREAM 5 provided a training set of peptides with experimentally identified high and low reactivities to human antibodies. On the basis of this training set, the participants to the challenge were asked to develop a predictive model of reactivity. A test set was then provided to evaluate the performance of the model implemented so far. We developed a logistic regression model to predict the peptide reactivity, by facing the challenge as a machine learning problem. The initial features have been generated on the basis of the available knowledge and the information reported in the dataset. Our predictive model had the second best performance of the challenge. We also developed a method, based on a clustering approach, able to "in-silico'' generate a list of positive and negative new peptide sequences, as requested by the DREAM5 "bonus round" additional challenge. The paper describes the developed model and its results in terms of reactivity prediction, and highlights some open issues concerning the propensity of a peptide to react with human antibodies.
C1 [Barbarini, Nicola; Tiengo, Alessandra; Bellazzi, Riccardo] Univ Pavia, Dept Comp Engn & Syst Sci, Lab Biomed Informat Mario Stefanelli, I-27100 Pavia, Italy.
RP Barbarini, N (reprint author), Univ Pavia, Dept Comp Engn & Syst Sci, Lab Biomed Informat Mario Stefanelli, Via Palestro 3, I-27100 Pavia, Italy.
EM nicola.barbarini@unipv.it
FU Italian "Ministero dell'Universita edella Ricerca"; Innovative Medicines
   Initiative (IMI)
FX This project was partially funded by the Italian "Ministero
   dell'Universita edella Ricerca" through FIRB ITALBIONET project and by
   Innovative Medicines Initiative (IMI) through SUMMIT European research
   project. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006
   BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P242
   Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505
   Carugo O, 1997, PROTEIN ENG, V10, P777, DOI 10.1093/protein/10.7.777
   Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x
   Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001
   DIBRINO M, 1993, J IMMUNOL, V151, P5930
   Dimitrov I, 2010, BIOINFORMATICS, V26, P2066, DOI 10.1093/bioinformatics/btq324
   EMINI EA, 1985, J VIROL, V55, P836
   Frank E, 1998, P 15 INT C MACH LEAR, P144
   GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8
   Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066
   Janeway C. A., 1999, IMMUNOBIOLOGY IMMUNE
   JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0
   John GH, 1995, P 11 C UNC ART INT, P338
   Jorgensen KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015877
   Kaczanowski S., 2010, THEOR CHEM ACC, V125, P543
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071
   Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233
   Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460
   Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026
   Liu L, 2008, IFMBE PROC, V19, P167, DOI 10.1007/978-3-540-79039-6_43
   Lorenz P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6_18
   Lundegaard C, 2007, BIOINFORMATICS, V23, P3265, DOI 10.1093/bioinformatics/btm471
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040
   NOVOTNY J, 1986, BIOCHEMISTRY-US, V25, P6748, DOI 10.1021/bi00370a004
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A
   Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64
   Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343
   Quinlan R., 1993, C4 5 PROGRAMS MACHIN, P302
   Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5
   Sollner J, 2006, J MOL RECOGNIT, V19, P209, DOI 10.1002/jmr.770
   Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Tiengo A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S11
   Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004
   Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/i.sbi.2008.02.004
NR 52
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 24
PY 2011
VL 6
IS 8
AR e23616
DI 10.1371/journal.pone.0023616
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 832TW
UT WOS:000295832000039
PM 21887285
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sulkowski, MJ
   Iyer, SC
   Kurosawa, MS
   Iyer, EPR
   Cox, DN
AF Sulkowski, Mikolaj J.
   Iyer, Srividya Chandramouli
   Kurosawa, Mathieu S.
   Iyer, Eswar Prasad R.
   Cox, Daniel N.
TI Turtle Functions Downstream of Cut in Differentially Regulating Class
   Specific Dendrite Morphogenesis in Drosophila
SO PLOS ONE
LA English
DT Article
ID SYNAPSE MATURATION-1 DASM1; SELF-AVOIDANCE; IMMUNOGLOBULIN SUPERFAMILY;
   SENSORY NEURONS; IG SUPERFAMILY; REQUIRE DSCAM; FAMILY-MEMBER; AXON
   GUIDANCE; CNS MIDLINE; ARBORIZATION
AB Background: Dendritic morphology largely determines patterns of synaptic connectivity and electrochemical properties of a neuron. Neurons display a myriad diversity of dendritic geometries which serve as a basis for functional classification. Several types of molecules have recently been identified which regulate dendrite morphology by acting at the levels of transcriptional regulation, direct interactions with the cytoskeleton and organelles, and cell surface interactions. Although there has been substantial progress in understanding the molecular mechanisms of dendrite morphogenesis, the specification of class-specific dendritic arbors remains largely unexplained. Furthermore, the presence of numerous regulators suggests that they must work in concert. However, presently, few genetic pathways regulating dendrite development have been defined.
   Methodology/Principal Findings: The Drosophila gene turtle belongs to an evolutionarily conserved class of immunoglobulin superfamily members found in the nervous systems of diverse organisms. We demonstrate that Turtle is differentially expressed in Drosophila da neurons. Moreover, MARCM analyses reveal Turtle acts cell autonomously to exert class specific effects on dendritic growth and/or branching in da neuron subclasses. Using transgenic overexpression of different Turtle isoforms, we find context-dependent, isoform-specific effects on mediating dendritic branching in class II, III and IV da neurons. Finally, we demonstrate via chromatin immunoprecipitation, qPCR, and immunohistochemistry analyses that Turtle expression is positively regulated by the Cut homeodomain transcription factor and via genetic interaction studies that Turtle is downstream effector of Cut-mediated regulation of da neuron dendrite morphology.
   Conclusions/Significance: Our findings reveal that Turtle proteins differentially regulate the acquisition of class-specific dendrite morphologies. In addition, we have established a transcriptional regulatory interaction between Cut and Turtle, representing a novel pathway for mediating class specific dendrite development.
C1 [Sulkowski, Mikolaj J.; Iyer, Srividya Chandramouli; Kurosawa, Mathieu S.; Iyer, Eswar Prasad R.; Cox, Daniel N.] George Mason Univ, Sch Syst Biol, Manassas, VA USA.
   [Sulkowski, Mikolaj J.; Iyer, Srividya Chandramouli; Kurosawa, Mathieu S.; Iyer, Eswar Prasad R.; Cox, Daniel N.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.
RP Sulkowski, MJ (reprint author), George Mason Univ, Sch Syst Biol, Manassas, VA USA.
EM dcox5@gmu.edu
RI Cox, Daniel/H-3036-2013; Iyer, Eswar/E-8443-2017
OI Cox, Daniel/0000-0001-9191-9212
FU National Institutes of Health [MH086928]
FX This work was funded by National Institutes of Health grant MH086928.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Al-Anzi B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-31
   Ascoli GA, 2000, NEUROCOMPUTING, V32, P1003, DOI 10.1016/S0925-2312(00)00272-1
   Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2
   Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1
   Bodily KD, 2001, J NEUROSCI, V21, P3113, DOI 10.1523/JNEUROSCI.21-09-03113.2001
   Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199
   Brummendorf T, 2001, CURR OPIN CELL BIOL, V13, P611, DOI 10.1016/S0955-0674(00)00259-3
   CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U
   Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423
   Crozatier M, 2008, DEV BIOL, V315, P232, DOI 10.1016/j.ydbio.2007.12.030
   Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038
   Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028
   Ferguson K, 2009, J NEUROSCI, V29, P14151, DOI 10.1523/JNEUROSCI.2497-09.2009
   Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514
   Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882
   Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017
   Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002
   Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0
   Grueber WB, 2002, DEVELOPMENT, V129, P2867
   Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013
   Iyer E. P. R., 2009, JOVE-J VIS EXP, V34, P1599, DOI DOI 10.3791/1599
   JAN YN, 1993, P NATL ACAD SCI USA, V90, P8305, DOI 10.1073/pnas.90.18.8305
   Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836
   Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031
   Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029
   Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220
   Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013
   Mishra A, 2008, MOL CELL BIOL, V28, P2782, DOI 10.1128/MCB.02102-07
   Rose PK, 2007, ARCH ITAL BIOL, V145, P175
   Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744
   Seto H, 2006, GENES CELLS, V11, P499, DOI 10.1111/j.1365-2443.2006.00956.x
   Shi SH, 2004, P NATL ACAD SCI USA, V101, P13346, DOI 10.1073/pnas.0405371101
   Shi SH, 2004, P NATL ACAD SCI USA, V101, P13341, DOI 10.1073/pnas.0405370101
   Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450
   Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029
   Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391
   Vetter P, 2001, J NEUROPHYSIOL, V85, P926
   Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848
   Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151
   Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3
   Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976
NR 45
TC 21
Z9 21
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 21
PY 2011
VL 6
IS 7
AR e22611
DI 10.1371/journal.pone.0022611
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 795FA
UT WOS:000292956800076
PM 21811639
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, JH
   Karpyak, VM
   Biernacka, JM
   Nam, HW
   Lee, MR
   Preuss, UW
   Zill, P
   Yoon, G
   Colby, C
   Mrazek, DA
   Choi, DS
AF Kim, Jeong-Hyun
   Karpyak, Victor M.
   Biernacka, Joanna M.
   Nam, Hyung Wook
   Lee, Moonnoh R.
   Preuss, Ulrich W.
   Zill, Peter
   Yoon, Gihyun
   Colby, Colin
   Mrazek, David A.
   Choi, Doo-Sup
TI Functional Role of the Polymorphic 647 T/C Variant of ENT1 (SLC29A1) and
   Its Association with Alcohol Withdrawal Seizures
SO PLOS ONE
LA English
DT Article
ID EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; REGULATES ETHANOL INTOXICATION;
   INDUCED MOTOR INCOORDINATION; MICE LACKING ENT1; KINASE-C-EPSILON;
   GLUTAMATERGIC NEUROTRANSMISSION; EXTRACELLULAR ADENOSINE; PROTEIN;
   SENSITIVITY; RECEPTORS
AB Background: Adenosine is involved in several neurological and behavioral disorders including alcoholism. In cultured cell and animal studies, type 1 equilibrative nucleoside transporter (ENT1, slc29a1), which regulates adenosine levels, is known to regulate ethanol sensitivity and preference. Interestingly, in humans, the ENT1 (SLC29A1) gene contains a non-synonymous single nucleotide polymorphism (647 T/C; rs45573936) that might be involved in the functional change of ENT1.
   Principal Findings: Our functional analysis showed that prolonged ethanol exposure increased adenosine uptake activity of mutant cells (ENT1-216Thr) compared to wild-type (ENT1-216Ile) transfected cells, which might result in reduced extracellular adenosine levels. We found that mice lacking ENT1 displayed increased propensity to ethanol withdrawal seizures compared to wild-type littermates. We further investigated a possible association of the 647C variant with alcoholism and the history of alcohol withdrawal seizures in subjects of European ancestry recruited from two independent sites. Analyses of the combined data set showed an association of the 647C variant and alcohol dependence with withdrawal seizures at the nominally significant level.
   Conclusions: Together with the functional data, our findings suggest a potential contribution of a genetic variant of ENT1 to the development of alcoholism with increased risk of alcohol withdrawal-induced seizures in humans.
C1 [Kim, Jeong-Hyun; Nam, Hyung Wook; Lee, Moonnoh R.; Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA.
   [Karpyak, Victor M.; Biernacka, Joanna M.; Mrazek, David A.; Choi, Doo-Sup] Mayo Clin, Dept Psychiat, Coll Med, Rochester, MN USA.
   [Biernacka, Joanna M.; Colby, Colin] Mayo Clin, Dept Hlth Sci Res, Coll Med, Rochester, MN USA.
   [Preuss, Ulrich W.] Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat, Halle, Germany.
   [Zill, Peter] Univ Munich, Sect Psychiat Genet & Neurochem, Munich, Germany.
   [Yoon, Gihyun] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.
RP Kim, JH (reprint author), Sogang Univ, Dept Life Sci, Seoul, South Korea.
EM choids@mayo.edu
RI Choi, Doo-Sup/G-9474-2012
OI Choi, Doo-Sup/0000-0002-6796-9938; Karpyak, Victor/0000-0002-9552-6130
FU Mayo Clinic; National Institutes of Health [AA015164, AA018779,
   AA017830-Project 1]; Ludwig-Maximilians-University, Munich, Germany
FX This work was supported by the Samuel Johnson Genomics of Addiction
   Program at Mayo Clinic (VMK, JMB, DAM, DSC), and in part by the National
   Institutes of Health grant AA015164, AA018779, and AA017830-Project 1
   (DSC). The study in Germany was supported by the FoFoLe Program of the
   Ludwig-Maximilians-University, Munich, Germany (UWP). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x
   Becker HC, 1997, PHARMACOL BIOCHEM BE, V57, P179, DOI 10.1016/S0091-3057(96)00303-6
   Boison D, 2005, NEUROSCIENTIST, V11, P25, DOI 10.1177/10738404269112
   Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002
   Boison D, 2006, TRENDS PHARMACOL SCI, V27, P652, DOI 10.1016/j.tips.2006.10.008
   Bone DBJ, 2007, MOL MEMBR BIOL, V24, P294, DOI 10.1080/09687860701210617
   Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r
   Chen JH, 2010, BEHAV BRAIN RES, V208, P636, DOI 10.1016/j.bbr.2010.01.011
   Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008
   Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288
   Choi DS, 2002, J NEUROSCI, V22, P9905
   Choi DS, 2009, PHARMACOL THERAPEUT, P817
   Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4
   Coe IR, 1996, J PHARMACOL EXP THER, V276, P365
   Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x
   DAR MS, 1990, PHARMACOL BIOCHEM BE, V37, P747, DOI 10.1016/0091-3057(90)90558-Y
   DAR MS, 1990, J PHARMACOL EXP THER, V255, P1202
   DRAGUNOW M, 1991, ANN NEUROL, V29, P575, DOI 10.1002/ana.410290524
   Duka T, 2004, ALCOHOL CLIN EXP RES, V28, P233, DOI 10.1097/01.ALC.000113780.41701.81
   Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105
   Hammond JR, 2000, N-S ARCH PHARMACOL, V361, P373, DOI 10.1007/s002100000214
   Harwood HJ, 1998, RECENT DEV ALCOHOL, V14, P307, DOI 10.1007/0-306-47148-5_14
   Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983
   Kaplan GB, 1999, ALCOHOL, V19, P157, DOI 10.1016/S0741-8329(99)00033-6
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100
   Levran O, 2009, GENES BRAIN BEHAV, V8, P531, DOI 10.1111/j.1601-183X.2009.00501.x
   LISKOW BI, 1987, J STUD ALCOHOL, V48, P356, DOI 10.15288/jsa.1987.48.356
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MESSING RO, 1991, J BIOL CHEM, V266, P23428
   Nagel J, 2002, BEHAV BRAIN RES, V134, P485, DOI 10.1016/S0166-4328(02)00062-1
   NAGY LE, 1989, MOL PHARMACOL, V36, P744
   NAGY LE, 1990, J BIOL CHEM, V265, P1946
   Nam HW, 2010, NEUROSCI LETT, V479, P277, DOI 10.1016/j.neulet.2010.05.079
   Osato DH, 2003, PHARMACOGENETICS, V13, P297, DOI 10.1097/01.fpc.0000054083.64000.2a
   ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949
   ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K
   SAPRU MK, 1994, J PHARMACOL EXP THER, V271, P542
   Schmidt LG, 2000, EUR PSYCHIAT, V15, P135, DOI 10.1016/S0924-9338(00)00220-0
   Schork NJ, 1998, ALCOHOL, V16, P71, DOI 10.1016/S0741-8329(97)00179-1
   SCHUCKIT MA, 1995, ADDICTION, V90, P1335, DOI 10.1111/j.1360-0443.1995.tb03551.x
   SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w
   Tsai GC, 1998, ANNU REV MED, V49, P173
   Tsai GCE, 1998, AM J PSYCHIAT, V155, P726
   Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200
   Wu JH, 2010, ALCOHOL CLIN EXP RES, V34, P1110, DOI 10.1111/j.1530-0277.2010.01187.x
   1997, NEURON, V19, P755
NR 51
TC 20
Z9 20
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2011
VL 6
IS 1
AR e16331
DI 10.1371/journal.pone.0016331
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 710PJ
UT WOS:000286523400030
PM 21283641
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Azzi, S
   Parissi, V
   Maroun, RG
   Eid, P
   Mauffret, O
   Fermandjian, S
AF Azzi, Sandy
   Parissi, Vincent
   Maroun, Richard G.
   Eid, Pierre
   Mauffret, Olivier
   Fermandjian, Serge
TI The HIV-1 Integrase alpha 4-Helix Involved in LTR-DNA Recognition Is
   also a Highly Antigenic Peptide Element
SO PLOS ONE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; PHOTO-CROSS-LINKING; C-TERMINAL DOMAIN;
   IN-VITRO; TYPE-1 INTEGRASE; VIRAL-DNA; CRYSTAL-STRUCTURE; CATALYTIC
   DOMAIN; ACTIVE-SITE; MONOCLONAL-ANTIBODY
AB Monoclonal antibodies (MAbas) constitute remarkable tools to analyze the relationship between the structure and the function of a protein. By immunizing a mouse with a 29mer peptide (K159) formed by residues 147 to 175 of the HIV-1 integrase (IN), we obtained a monoclonal antibody (MAba4) recognizing an epitope lying in the N-terminal portion of K159 (residues 147-166 of IN). The boundaries of the epitope were determined in ELISA assays using peptide truncation and amino acid substitutions. The epitope in K159 or as a free peptide (pep-a4) was mostly a random coil in solution, while in the CCD (catalytic core domain) crystal, the homologous segment displayed an amphipathic helix structure (alpha 4-helix) at the protein surface. Despite this conformational difference, a strong antigenic crossreactivity was observed between pep-a4 and the protein segment, as well as K156, a stabilized analogue of pep-a4 constrained into helix by seven helicogenic mutations, most of them involving hydrophobic residues. We concluded that the epitope is freely accessible to the antibody inside the protein and that its recognition by the antibody is not influenced by the conformation of its backbone and the chemistry of amino acids submitted to helicogenic mutations. In contrast, the AA -> Glu mutations of the hydrophilic residues Gln148, Lys156 and Lys159, known for their interactions with LTRs (long terminal repeats) and inhibitors (5 CITEP, for instance), significantly impaired the binding of K156 to the antibody. Moreover, we found that in competition ELISAs, the processed and unprocessed LTR oligonucleotides interfered with the binding of MAba4 to IN and K156, confirming that the IN alpha 4-helix uses common residues to interact with the DNA target and the MAba4 antibody. This also explains why, in our standard in vitro concerted integration assays, MAba4 strongly impaired the IN enzymatic activity.
C1 [Azzi, Sandy; Mauffret, Olivier; Fermandjian, Serge] CNRS, ENS Cachan, LBPA, Cachan, France.
   [Azzi, Sandy; Eid, Pierre] Univ Paris 11, INSERM, U1014, Villejuif, France.
   [Parissi, Vincent] Univ Bordeaux 2, CNRS, UMR 5234, Lab Microbiol Cellulaire & Mol & Pathogenicite, F-33076 Bordeaux, France.
   [Maroun, Richard G.] Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, CST Mar Roukoz, Beirut, Lebanon.
RP Azzi, S (reprint author), CNRS, ENS Cachan, LBPA, Cachan, France.
EM serge.fermandjian@lbpa.ens-cachan.fr
FU Centre National de la Recherche Scientifique (CNRS)-France
   [A/18-1/01251]; Conseil National de la Recherche Scientifique
   (CNRS)-Lebanon; Conseil de la Recherche de l'Universite Saint Joseph [09
   S F 24/L 45]; Association Arc en ciel-Lebanon
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The project was
   funded by the Centre National de la Recherche Scientifique
   (CNRS)-France, Sidaction (Ref: A/18-1/01251), the Conseil National de la
   Recherche Scientifique (CNRS)-Lebanon, the Conseil de la Recherche de
   l'Universite Saint Joseph and the Program CEDRE (09 S F 24/L 45). S.A.
   was supported by Association Arc en ciel-Lebanon.
CR Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6
   Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200
   Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6
   Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200
   Bujacz G, 1996, FEBS LETT, V398, P175, DOI 10.1016/S0014-5793(96)01236-7
   Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567
   Camacho LH, 2008, EXPERT OPIN INV DRUG, V17, P371, DOI [10.1517/13543784.17.3.371, 10.1517/13543784.17.3.371 ]
   Caumont A, 1999, FEBS LETT, V455, P154, DOI 10.1016/S0014-5793(99)00859-5
   Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297
   Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885
   Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978
   DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186
   Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x
   Drake RR, 1998, P NATL ACAD SCI USA, V95, P4170, DOI 10.1073/pnas.95.8.4170
   DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124
   ENGELMAN A, 1994, J VIROL, V68, P5911
   ENGELMAN A, 1992, J VIROL, V66, P6361
   Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046
   Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832
   Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241
   Gerton JL, 1998, J VIROL, V72, P5046
   Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08
   Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040
   Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784
   Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515
   Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c
   Hobaika Z, 2010, NEUROCHEM RES, V35, P888, DOI 10.1007/s11064-009-0098-2
   Hobaika Z, 2009, NUCLEIC ACIDS RES, V37, P7691, DOI 10.1093/nar/gkp824
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x
   Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849
   Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200
   Johnson AA, 2006, J BIOL CHEM, V281, P32428, DOI 10.1074/jbc.M605101200
   KATAYANAGI K, 1993, J BIOL CHEM, V268, P22092
   KOSHLAND ME, 1966, BIOCHEMISTRY-US, V5, P641, DOI 10.1021/bi00866a034
   KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331
   Lataillade M, 2007, ANTIVIR THER, V12, P563
   LEAVITT AD, 1993, J BIOL CHEM, V268, P2113
   Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796
   Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005
   Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200
   Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004
   Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005
   LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125
   Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200
   Mahler M, 2003, J MOL MED-JMM, V81, P194, DOI 10.1007/s00109-003-0423-1
   Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002
   Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07
   Maroun RG, 1999, EUR J BIOCHEM, V260, P145, DOI 10.1046/j.1432-1327.1999.00130.x
   Maroun RG, 1999, J BIOL CHEM, V274, P34174, DOI 10.1074/jbc.274.48.34174
   Merad H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004081
   Moreau K, 2003, EUR J BIOCHEM, V270, P4426, DOI 10.1046/j.1432-1033.2003.03833.x
   Moreau K, 2009, VIROLOGY, V392, P94, DOI 10.1016/j.virol.2009.06.031
   Mould DR, 2007, CURR OPIN DRUG DISC, V10, P84
   MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0
   Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660
   Queffelec C, 2008, EUR J MED CHEM, V43, P2268, DOI 10.1016/j.ejmech.2007.12.013
   Ramcharan J, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-34
   Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029
   Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74
   Routsias JG, 2006, CRIT REV CL LAB SCI, V43, P203, DOI 10.1080/10408360500523837
   SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119
   Sourgen F, 1996, EUR J BIOCHEM, V240, P765, DOI 10.1111/j.1432-1033.1996.0765h.x
   Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002
   TANESE N, 1988, DNA-J MOLEC CELL BIO, V7, P407, DOI 10.1089/dna.1.1988.7.407
   Yi JZ, 2000, J BIOL CHEM, V275, P38739, DOI 10.1074/jbc.M005499200
   Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200
NR 67
TC 5
Z9 6
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 30
PY 2010
VL 5
IS 12
AR e16001
DI 10.1371/journal.pone.0016001
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 701DD
UT WOS:000285793600056
PM 21209864
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, GJ
   Han, GC
   Feng, JN
   Wang, JA
   Wang, RX
   Xu, RN
   Shen, BF
   Qian, JH
   Li, Y
AF Chen, Guojiang
   Han, Gencheng
   Feng, Jiannan
   Wang, Jianan
   Wang, Renxi
   Xu, Ruonan
   Shen, Beifen
   Qian, Jiahua
   Li, Yan
TI Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains
   Expand CD4(+)CD25(+) Regulatory T Cells
SO PLOS ONE
LA English
DT Article
AB Background: CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on the structural properties of the epitopes used.
   Methodology/Principal Findings: Splenic lymphocytes from nonobese diabetic (NOD) mice were stimulated with different glutamic acid decarboxylase (GAD)-derived epitopes for 7-10 days and the frequency and function of Tregs was analyzed. We found that, although all expanded Tregs showed suppressive functions in vitro, only p524 (GAD524-538)-expanded CD4(+)CD25(+) T cells inhibited diabetes development in the co-transfer models, while p509 (GAD509-528)- or p530 (GAD530-543)-expanded CD4(+)CD25(+) T cells had no such effects. Using computer-guided molecular modeling and docking methods, the differences in structural characteristics of these epitopes and the interaction mode (including binding energy and identified domains in the epitopes) between the above-mentioned epitopes and MHC class II I-A(g7) were analyzed. The theoretical results showed that the epitope p524, which induced protective Tregs, possessed negative surface-electrostatic potential and bound two chains of MHC class II I-A(g7), while the epitopes p509 and p530 which had no such ability exhibited positive surface-electrostatic potential and bound one chain of I-A(g7). Furthermore, p524 bound to I-A(g7) more stably than p509 and p530. Of importance, we hypothesized and subsequently confirmed experimentally that the epitope (GAD570-585, p570), which displayed similar characteristics to p524, was a protective epitope by showing that p570-expanded CD4(+)CD25(+) T cells suppressed the onset of diabetes in NOD mice.
   Conclusions/Significance: These data suggest that molecular modeling-based structural analysis of epitopes may be an instrumental tool for prediction of protective epitopes to expand functional Tregs.
RP Chen, GJ (reprint author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.
EM liyan62033@yahoo.com.cn
OI Wang, Renxi/0000-0003-4130-3334
CR Arneson LS, 2000, J IMMUNOL, V165, P2059, DOI 10.4049/jimmunol.165.4.2059
   ATKINSON MA, 1992, LANCET, V339, P458, DOI 10.1016/0140-6736(92)91061-C
   Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387
   Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062
   Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005
   Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733
   Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102
   Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505
   Dai YD, 2008, EUR J IMMUNOL, V38, P968, DOI 10.1002/eji.200737703
   Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447
   Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2007.03328.x
   Ellis TM, 1996, NAT MED, V2, P148, DOI 10.1038/nm0296-148
   Fanelli F, 1998, METHODS, V14, P302, DOI 10.1006/meth.1998.0586
   Fisson S, 2006, EUR J IMMUNOL, V36, P817, DOI 10.1002/eji.200535445
   Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
   Garnier J, 1996, METHOD ENZYMOL, V266, P540
   Geng LP, 1998, P NATL ACAD SCI USA, V95, P10055, DOI 10.1073/pnas.95.17.10055
   Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516
   Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490
   Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010
   JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0
   KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0
   Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605
   Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053
   Nicholson MJ, 2005, IMMUNITY, V23, P351, DOI 10.1016/j.immuni.2005.09.009
   Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791
   Ortiz AR, 1999, PROTEINS, P177
   Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398
   Quinn A, 2001, J IMMUNOL, V166, P2982, DOI 10.4049/jimmunol.166.5.2982
   Roncarolo MG, 2006, IMMUNOL REV, V212, P28
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225
   Severe S, 2007, MOL IMMUNOL, V44, P2950, DOI 10.1016/j.molimm.2007.01.008
   Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759
   Song L, 2004, GENE THER, V11, P1487, DOI 10.1038/sj.gt.3302327
   Stockinger B, 2001, NAT IMMUNOL, V2, P757, DOI 10.1038/ni0901-757
   Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139
   Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631
   Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180
   Tarbell KV, 2002, J EXP MED, V196, P481, DOI 10.1084/jem.20011845
   Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561
   Tisch R, 1998, DIABETES, V47, P894, DOI 10.2337/diabetes.47.6.894
   TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0
   WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4
   Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958
   Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183
   Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878
   Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046
   Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455
NR 51
TC 12
Z9 13
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2009
VL 4
IS 9
AR e7034
DI 10.1371/journal.pone.0007034
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 494FM
UT WOS:000269796100001
PM 19759824
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Denisova, G
   Denisov, D
   Evelegh, C
   Weissgram, M
   Beck, J
   Foley, SR
   Bramson, JL
AF Denisova, Galina
   Denisov, Dimitri
   Evelegh, Carole
   Weissgram, Michaela
   Beck, Jochen
   Foley, Stephen Ronan
   Bramson, Jonathan Lorne
TI Characterizing Complex Polysera Produced by Antigen-Specific
   Immunization through the Use of Affinity-Selected Mimotopes
SO PLOS ONE
LA English
DT Article
AB Background: Antigen-based (as opposed to whole organism) vaccines are actively being pursued for numerous indications. Even though different formulations may produce similar levels of total antigen-specific antibody, the composition of the antibody response can be quite distinct resulting in different levels of therapeutic activity.
   Methodology/Principal Findings: Using plasmid-based immunization against the proto-oncogene HER-2 as a model, we have demonstrated that affinity-selected epitope mimetics (mimotopes) can provide a defined signature of a polyclonal antibody response. Further, using novel computer algorithms that we have developed, these mimotopes can be used to predict epitope targets.
   Conclusions/Significance: By combining our novel strategy with existing methods of epitope prediction based on physical properties of an individual protein, we believe that this method offers a robust method for characterizing the breadth of epitope-specificity within a specific polyserum. This strategy is useful as a tool for monitoring immunity following vaccination and can also be used to define relevant epitopes for the creation of novel vaccines.
RP Denisova, G (reprint author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.
EM bramsonj@mcmaster.ca
OI Bramson, Jonathan/0000-0003-2874-6886
CR Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Batori V, 2006, J MOL RECOGNIT, V19, P21, DOI 10.1002/jmr.752
   Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589
   Bonnycastle LLC, 1996, J MOL BIOL, V258, P747, DOI 10.1006/jmbi.1996.0284
   Bramson JL, 2003, VACCINE, V21, P1363, DOI 10.1016/S0264-410X(02)00694-1
   Chen Y, 2001, GENE THER, V8, P316, DOI 10.1038/sj.gt.3301396
   Dayball K, 2003, J IMMUNOL, V171, P3379, DOI 10.4049/jimmunol.171.7.3379
   Denisov DA, 2009, MOL IMMUNOL, V46, P429, DOI 10.1016/j.molimm.2008.10.013
   DENISOVA G, 1995, FASEB J, V9, P127
   Denisova G, 1996, AIDS RES HUM RETROV, V12, P901, DOI 10.1089/aid.1996.12.901
   Denisova G, 2003, MOL IMMUNOL, V40, P231, DOI 10.1016/s0161-5890(03)00147-0
   Denisova GF, 2008, MOL IMMUNOL, V46, P125, DOI 10.1016/j.molimm.2008.07.020
   Denisova GF, 2000, MOL IMMUNOL, V37, P53, DOI 10.1016/S0161-5890(00)00022-5
   Enshell-Seijffers D, 2003, J MOL BIOL, V334, P87, DOI 10.1016/j.jmb.2003.09.002
   ENSHELLSEIJFFER.D, 2002, CURR PROTOC IMMUNOL, pCH9
   FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V
   Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2
   GERSHONI JM, 1993, FASEB J, V7, P1185
   Gershoni JM, 1997, IMMUNOL TODAY, V18, P108, DOI 10.1016/S0167-5699(97)01024-4
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   IKEDA Y, 1987, BIOCHEM BIOPH RES CO, V144, P191, DOI 10.1016/S0006-291X(87)80494-1
   Kianizad K, 2007, CANCER RES, V67, P6459, DOI 10.1158/0008-5472.CAN-06-4336
   Lane C, 2004, CANCER RES, V64, P1509, DOI 10.1158/0008-5472.CAN-03-3227
   LUZZAGO A, 1993, GENE, V128, P51, DOI 10.1016/0378-1119(93)90152-S
   NOVOTNY J, 1986, J MOL BIOL, V189, P715, DOI 10.1016/0022-2836(86)90502-4
   Paley EL, 2007, MOL IMMUNOL, V44, P541, DOI 10.1016/j.molimm.2006.02.006
   Pupa SM, 2005, CANCER RES, V65, P1071
   Quaglino E, 2004, CANCER RES, V64, P2858, DOI 10.1158/0008-5472.CAN-03-2962
   Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133
   SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028
   Shak S, 1999, SEMIN ONCOL, V26, P71
   SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152
   Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101
   SMITH GP, PHAGE DISPLAY VECTOR
   Stern B, 1997, FASEB J, V11, P147
   THALI M, 1993, J VIROL, V67, P3978
   THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0
   Yip YL, 2001, J IMMUNOL, V166, P5271, DOI 10.4049/jimmunol.166.8.5271
   ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7
NR 41
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 23
PY 2009
VL 4
IS 4
AR e5309
DI 10.1371/journal.pone.0005309
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437VE
UT WOS:000265514200020
PM 19390580
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Hiss, JA
   Przyborski, JM
   Schwarte, F
   Lingelbach, K
   Schneider, G
AF Hiss, Jan Alexander
   Przyborski, Jude Marek
   Schwarte, Florian
   Lingelbach, Klaus
   Schneider, Gisbert
TI The Plasmodium Export Element Revisited
SO PLOS ONE
LA English
DT Article
AB We performed a bioinformatical analysis of protein export elements (PEXEL) in the putative proteome of the malaria parasite Plasmodium falciparum. A protein family-specific conservation of physicochemical residue profiles was found for PEXEL-flanking sequence regions. We demonstrate that the family members can be clustered based on the flanking regions only and display characteristic hydrophobicity patterns. This raises the possibility that the flanking regions may contain additional information for a family-specific role of PEXEL. We further show that signal peptide cleavage results in a positional alignment of PEXEL from both proteins with, and without, a signal peptide.
C1 [Hiss, Jan Alexander; Schwarte, Florian; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Prote, Frankfurt, Germany.
   [Przyborski, Jude Marek; Lingelbach, Klaus] Univ Marburg, Fac Biol, Marburg, Germany.
RP Hiss, JA (reprint author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Prote, Frankfurt, Germany.
EM hiss@bioinformatik.uni-frankfurt.de
OI Hiss, Jan Alexander/0000-0003-0559-4330
FU Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre
   for Membrane Proteomics at Goethe-University, Frankfurt am Main; DFG
   priority program [1131]
FX This research was supported by the Beilstein-Institut zur Forderung der
   Chemischen Wissenschaften, and the Centre for Membrane Proteomics at
   Goethe-University, Frankfurt am Main. J.M.P is supported by the DFG
   priority program (SPP) 1131.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307
   BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3
   Baumeister S, 1999, Novartis Found Symp, V226, P145
   BAUMEISTER S, 1999, NOVART FDN SYMP, V226, P154
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821
   Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3
   CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0
   Cochrane G, 2006, NUCLEIC ACIDS RES, V34, pD10, DOI 10.1093/nar/gkj130
   Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008
   ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004
   HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108
   Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19
   JONES DD, 1975, J THEOR BIOL, V50, P167, DOI 10.1016/0022-5193(75)90031-4
   Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005
   KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288
   Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333
   Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051
   Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452
   Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9
   NIELSEN H, 1998, P 6 INT C INT SYST M, P122
   Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x
   Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011
   Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720
   Ralph SA, 2004, MOL BIOL EVOL, V21, P2183, DOI 10.1093/molbev/msh233
   Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004
   Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12
   Sargent F, 2006, FEMS MICROBIOL LETT, V254, P198, DOI 10.1111/j.1574-6968.2005.00049.x
   Schmuker M, 2007, J MOL MODEL, V13, P225, DOI 10.1007/s00894-006-0140-0
   SCHNEIDER G, 1993, J MOL EVOL, V36, P586, DOI 10.1007/BF00556363
   Schneider G, 1999, GENE, V237, P113, DOI 10.1016/S0378-1119(99)00310-8
   Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a
   SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X
   Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005
   SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1
   Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636
   Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3
   Zuegge J, 2001, J MOL GRAPH MODEL, V19, P304, DOI 10.1016/S1093-3263(00)00074-7
NR 43
TC 16
Z9 18
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2008
VL 3
IS 2
AR e1560
DI 10.1371/journal.pone.0001560
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 367EQ
UT WOS:000260535700028
PM 18253504
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

EF